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QUILL ON SCALPEL

This section provides a medium through which Canadian surgeons can declare themselves, briefly
and informally, on the day-to-day affairs of surgery.

Noninvasive Evaluation of the Carotid Circulation

Pasteur died of a stroke. So did Lenin,
von Hindenburg and Franklin D.
Roosevelt. Through most of medical
history it was thought that strokes were
cataclysmal intracranial vascular acci
dents, unpredictable and without satis
factory treatment or possibility of premorbid diagnosis. The recently appre
ciated fact that most patients with
ischemic strokes have potentially oper
able extracranial carotid lesions has
provoked interest in their early recog
nition and localization. Although ar
teriograms are necessary to define the
anatomy of carotid bifurcation lesions
prior to operation, it is desirable to
be able to screen patients without the
inconvenience, expense and small risk
associated with arteriography, particu
larly when serial examinations are
required. Patients with asymptomatic
bruits, atypical neurologic symptoms
and previous strokes are of special
interest.
The noninvasive methods that have
been developed have elucidated several
clinical observations. As a stenosis in
creases the associated bruit becomes
longer and of higher pitch, and as the
occlusion becomes nearly complete, the
bruit may no longer be audible. Caro
tid phonoangiography provides photo
graphic representation of the wave
forms produced by such bruits and al
lows their differentiation from trans
mitted cardiac murmurs or more prox
imal bruits. By comparing the wave
forms with the arteriogram one can de
duce the degree of stenosis represented
on the former. A pansystolic bruit
represents a 40% to 50% stenosis and
a bruit extending into diastole indicates
an even greater stenosis and a more
VOLUME 21, NO. 4, JULY 1978
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marked pressure gradient.1 The carotid
vessels can also be studied with a di
rectional Doppler flow probe to gen
erate a flow map on the storage oscil
loscope and thus provide a graphic
projection of blood flow velocities, al
lowing localization of a stenotic lesion
and an estimate of the amount of nar
rowing. At the same time, recordings
can be made of the audiosignal for
subsequent study and interpretation,
and a tracing generated of the analog
blood flow signals.2,3
The ophthalmic artery is a direct
continuation of the intracerebral por
tion of the internal carotid artery and
can be studied with a Doppler flow
probe, as can its supraorbital branch.
A hemodynamically significant internal
carotid artery stenosis may be reflected
by a reversal of ophthalmic or supra
orbital artery flow.4 Since the collateral
circulation through the ipsilateral ex
ternal carotid or the opposite internal
carotid artery across the circle of
Willis is quite variable, it may or may
not allow normal or near normal pres
sure in the internal carotid artery dis
tal to the middle cerebral artery to
generate antegrade signals. Bone and
Barnes3 have added refinements such
as carotid compression to the technique
of Doppler ophthalmic examination and
report a higher degree of accuracy;
yet these additions add small but
definite risks to an already complex
technique and make its application as
a simple screening test performed by a
technician more difficult. Those nonin
vasive techniques that depend solely
on evaluation of ophthalmic or supra
orbital artery flow have been found
to overlook a sizeable number of sig

nificant stenoses, and many give pc itive results only with near or total
occlusion of the internal carotid ar
tery.6'8 The results of such determina
tions are helpful if positive but not of
much value if they are negative.
Oculoplethysmography is performed
by applying small suction cups to the
cornea to record the volume changes
in each globe produced by pulsatile
arterial flow. At the same time record
ings are made of ear lobe pulses to
detect any delays between the internal
and external carotid pulses which are
indicative of an internal carotid steno
sis. Such pulse delays are often
minimal and the study may over
look patients with bilateral disease. In
experienced hands an accuracy rate of
90% can be attained by combining
oculoplethysmography with carotid
phonoangiography, permitting greater
discrimination in recommending arte
riography and increasing the yield of
those arteriograms performed.1’8
Prospective clinical studies6,8 have
compared the accuracy of several non
invasive studies. The clinical diagnosis
of cerebrovascular disease was not al
ways accurate, nor was the correlation
between lesions and the presence of a
bruit. None of the methods detected ste
noses of less than 50%. With greater de
grees of stenosis the methods were of
varying accuracy and those studies that
used more than one means of evalua
tion achieved maximum accuracy. Our
own preference has been for the com
bined carotid Echo Doppler scan con
sisting of four parts: carotid bifurcation
imaging, recording of carotid Doppler
audiosignals, strip chart recording of
analog blood flow signals and deter-
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minations of ophthalmic artery flow
direction. Using this combination, an
accuracy of 93% of that attainable
with arteriography has been possible,
and lesser degrees of stenosis have been
recognized.9
What are the uses and abuses of
noninvasive studies? Patients with
asymptomatic bruits, nonhemispheric
neurologic symptoms, prior strokes, or
known risk factors for cerebrovascular
disease can be studied noninvasively in
an attempt to identify those at parti
cular risk of stroke and to improve the
selection of patients for arteriography.
Patients who require repeated examina
tions to follow the progression of
asymptomatic bruits or nonhemodynamically significant stenoses obvious
ly cannot be subjected to repeat arteri
ography at regular intervals, but can
be studied noninvasively with no risk
and minimal expense and inconve
nience. The major limitation of non
invasive studies has been their inability
to detect ulcerated plaques, particu

larly if they are nonstenotic. The most
common cause of transient ischemic
attacks (TIAs) is emboli, most of which
originate from ulcerated plaques at the
carotid bifurcation. Single or multiple
TIAs represent a considerable stroke
risk and are a bona fide indication for
arteriography. If noninvasive techniques
are used instead of arteriography in pa
tients who present with TIAs a con
siderable number of patients who might
benefit from carotid endarterectomy
will be overlooked.
F rederic J arrett, md , frcs [c]
Department of surgery,
University of Wisconsin Hospitals,
1300 University Ave.,
Madison, WI 53706
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Nerve Entrapment Syndromes

In this issue (page 354) Wiens and Lau
draw attention to a particular type of
peripheral nerve entrapm ent syndrome
affecting the anterior interosseous nerve
of the forearm. Although the article
deals exclusively with a relatively rare
form, it is well to be reminded of
the existence of nerve entrapment syn
dromes.
The subject merits periodic emphasis
in the literature because entrapment
syndromes in general are not rare. The
symptoms develop insidiously, are
somewhat bizarre and frequently mimic
those caused by other pathologic en
tities. An example of this mimicry is
the resemblance between “spinal claudi
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cation”, due to entrapment of the cauda
equina and the lumbar nerve roots in
spondylitic spinal stenosis, and vascular
claudication. Only a careful and com
plete history and physical examination
will make the distinction between them
apparent. The symptoms of entrap
ment of the lateral femoral cutaneous
nerve near the anterior superior iliac
spine (meralgia paresthetica) can be
confused with those of “atypical” vas
cular claudication. I have encountered
many patients with this form of entrap
ment syndrome who have needlessly
been shunted back and forth between a
variety of health care professionals in
the search for relief of their symptoms.
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Awareness and recognition of nerve
entrapment syndromes should there
fore be of interest to surgeons as well
as to primary care physicians. An ex
cellent monograph1 is available to those
wishing to extend their knowledge of
the subject.
R.U. R epo , m d , frcs [c]
Assistant professor of orthopedic surgery,
McMaster University,
Hamilton, Ont.
Reference
1. K o p e l l HP, T h o m p so n WAL: Peri
pheral Entrapment Neuropathies, Bal
timore, Williams & Wilkins, 1966
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REVIEW ARTICLES

Parathyroid Hormone and Hyperparathyroidism:
Current Concepts
D avid Goltzman ,

Our expanding knowledge of the
physiologic and biochemical factors
governing calcium homeostasis has
improved our capacity to evaluate
hypercalcemia, of which an increased
incidence is being discovered through
the widespread use of multiphasic
screening. Consequently, we are
diagnosing mild forms of hyperpara
thyroidism more often than formerly.
The enhanced recognition of virtually
symptom-free hyperparathyroidism pre
sents a problem in patient management
because the natural history of this
form of hyperparathyroidism is unknown
and the pathologic lesion underlying
the condition may be ambiguous,
resulting in difficult decisions in
surgical management. Further study is
required to resolve this issue in order
to provide optimal care for the
affected individual.
Notre connaissance croissante des
facteurs physiologiques et biochimiques
qui gouvernent I'homeostase du cal
cium a ameliore notre capacite
d'evaluer I’hypercalcemie que Ton
decouvre maintenant avec une frequence
accrue grace a I'emploi repandu des
epreuves de depistage. En consequence,
on diagnostique de plus en plus
souvent les formes benignes d’hyperthyroidie. La reconnaissance plus
frequente d'un hyperthyroidie virtuellement asymptomatique pose un probleme
de traitement puisque devolution
naturelle de cette forme d'hyperthyroidie est inconnue et que la lesion
pathologique sous-jacente peut etre
ambigue, entrainant de difficiles
decisions de traitement chirurgical.
D'autres etudes sont requises pour
resoudre cette question de facon a
assurer des soins optimums aux
personnes qui en sont atteintes.

From the department of medicine,
McGill University and Royal Victoria
Hospital, Montreal, PQ
Reprint requests to: Dr. D. Goltzman,
Rm. A-417, Royal Victoria Hospital,
687 Pine Ave. W, Montreal, PQ
H3A 1A1
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The increase in our knowledge of
parathyroid physiology and chemistry
coupled with the widespread use of
biochemistry to assess patients has
greatly altered our understanding of
the pathogenesis of hyperparathyroid
ism and our concepts regarding its
management.
Calcium Homeostasis

The calcium of the extracellular
fluid appears to be maintained in tight
control by the net result of calcium
fluxes across the intestine, kidney and
bone (Fig. 1). The mechanisms influ
encing calcium transport in these tis
sues have come under intensive scrutiny
in recent years, and considerable new
insight has been gained into the actions
of vitamin D and parathyroid hormone
(PTH), the two major humoral factors
controlling calcium homeostasis. Vita
min D has been shown to undergo
metabolic transformation from a pre
cursor of low potency to a highly
active entity.1 It is known that this
sterol, ingested in food or converted
by ultraviolet irradiation from an inert
precursor,
7-dehydrocholesterol,
is
transported by a plasma protein to the

K ID N E Y

FIG. 1—Sites of known (-») and po
tential (- - ►) action of vitamin D (D)
and parathyroid hormone (PTH) as me
chanisms influencing calcium transport
across gut, bone and kidney in maintenance,
of calcium of extracellular fluid (ECF).
/

liver where it is hydroxylated at the
25 position. This 25-hydroxy vitamin
D derivative is then carried in the cir
culation as a protein-bound entity to
the kidney (mainly), where one of at
least two additional hydroxylations
may occur. In association with states
of hypocalcemia, phosphate depletion
and PTH excess, the activity of a
renal hydroxylase enzyme is aug
mented and a 1,25-dihydroxy vitamin
D derivative is formed.1,2 This is the
most potent metabolite of vitamin D
yet discovered. It acts chiefly on the
intestine to enhance calcium absorption
and restore normocalcemia; at least in
pharmacologic concentrations it is
capable of producing bone resorption
as well. Additionally, perhaps by an
indirect mechanism, the vitamin seems
necessary for the full resorptive action
of PTH on bone. In calcium-replete
states, the major circulating dihydroxy
metabolite is believed to be 24,25-di
hydroxy vitamin D, the primary func
tion of which is currently being evalu
ated. The major role of PTH in
influencing absorption of calcium from
the gut is therefore indirect through
its “activation” of 25-hydroxy vitamin
D to its potent, 1,25-hydroxy meta
bolite.
In physiologic circumstances the
major direct role of PTH in maintain
ing calcium homeostasis may be to en
hance calcium absorption from the
(distal) renal tubule and thereby to
diminish calcium loss through the kid
ney.3 In contrast, by interfering with
phosphate reabsorption in the (prox
imal) tubule, PTH enhances phosphate
loss through the kidney, so that in
states of PTH excess the result is a
well-recognized hypophosphatemia. A
number of other influences of PTH
excess on the nephron have also been
observed, such as interference with
bicarbonate reabsorption with resultant
renal tubular acidosis.4 These metabolic
alterations induced by the hormone
are all seen in accentuated form in
clinical states of augmented PTH pro
duction.
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The most notable effect of increased
circulating PTH is enhanced bone re
sorption.3 Although this is unquestioned
in the elevated concentrations of the
hormone seen in hyperparathyroidism,
it has been observed that in much
lower concentrations, such as occur
in physiologic states, the hormone
may be anabolic in bone.5 Other
agents inducing bone resorption, such
as prostaglandins, have been identified
and have occasionally been implicated
(especially in association with neopla
sia) in states of hypercalcemia and
bone resorption simulating hyperpara
thyroidism.6
PTH Biosynthesis and Metabolism

Parathyroid hormone is an 84amino acid single-chain polypeptide3
synthesized in the parathyroid cell (Fig.
2).7 The peptide product of the para
thyroid ribosomes appears to have a
31-amino acid extension at the NH2
terminus of the molecule and this
elongated precursor is known as
pre-proparathyroid hormone (pre-pro
PTH).8 The greater part (25 amino
acids) of this precursor extension is
most likely removed from the nascent
chain by an enzyme as the newly-syn
thesized peptide passes into the cisternae of the endoplasmic reticulum,
leaving a smaller precursor, extended
by only 6 amino acids (pro PTH).9
This peptide is converted to the hor
mone by a tryptic-like cleavage11’
probably within the Golgi complex,
and the 84-amino acid hormone is then
packaged into secretory granules and
released in response to hypocalcemia.
The biologic activity of pre-pro PTH
and its fate (i.e., whether this entity is
released into the circulation) are cur
rently unknown. Pro PTH appears to
have little if any intrinsic biologic
activity until it is converted to the
hormone,11 and it is unlikely, although
this has not been proved, that this
precursor ever enters the circulation.
The extent to which further intraglandular metabolism of the 84-amino
acid form of the hormone occurs is
currently under intensive investigation.
However, it is generally accepted that
further metabolism in peripheral tis
sues, mainly liver12 and kidney,13 does
occur. The consequence of the meta
bolism of the hormone is the produc
tion of hormonal fragments,1417 most
notably an inert middle and carboxyl
terminal fragment which, by virtue of
its long half-life, is the form of para
thyroid hormone generally circulating
in highest concentration in the blood.
The fate of the amino-terminal portion
of the molecule is uncertain, yet is
most important since the entire biolo
gic activity of the hormone appears to
reside in the amino-terminal-34 resi
286

dues.18 One group of workers19 has
reported the existence of a biologically
active amino-terminal fragment (in
addition to the intact hormone) in the
circulation of man. This has raised the
possibility that the 84-amino acid form
of the hormone itself may be an inert
precursor requiring conversion to an
active amino-terminal fragment for
hormonal action. However, recent
evidence has indicated that cleavage of
the 84-amino acid form of the hormone
may not be required for at least some
forms of biologic activity.20 Conse
quently the apparently specific meta
bolism undergone by the 84-amino acid
species may limit the quantities of
biologically active circulating moiety
or generate an amino fragment with a
site or duration of activity different
from what is possessed by the intact
molecule.
Etiology and Pathogenesis of
Hyperparathyroidism

The most common cause of hyper
parathyroidism is still a solitary para
thyroid adenoma in which the under
lying disturbance appears to be a
defect in cell growth localized to one
gland whose proliferating cells main
tain their biosynthetic function. How
ever, the generalized abnormality re
sulting in hyperplasia of all four glands
is now being recognized more often,21
and appears to be inceasing in fre
quency as a cause of hyperparathyroid
ism recurring postoperatively.22

Although one might suspect an ex
ternal stimulus to be causative in at
least some of these cases of hyperpla
sia, no such stimulus has yet been
identified. Consequent upon the investi
gation of factors other than the calcium
ion, such as /^-adrenergic agents23 and
vitamin D metabolites,24 which may
influence glandular release of hor
mone (perhaps by modulating the ef
fect of calcium), a subset of cases of
parathyroid hyperplasia with a disor
dered external drive to parathyroid
gland secretion may eventually be dis
covered.
An unknown controlling ionic or
humoral factor need not be implicated
if a defect in the “sensing” mechanism
in glandular tissue is identified, where
by normal concentrations of ambient
calcium are interpreted as low by the
defective cells and consequently induce
inappropriate glandular secretion of
hormone. Such a mechanism has been
postulated in certain cases of familial
hyperparathyroidism.25 Finally, those
cases of four-gland enlargement asso
ciated with the multiple endocrine neo
plasia (MEN) syndromes are believed
to emanate from defects in embryogenesis, which subsequently manifest
as disorders of cell growth in a number
of endocrine glands (including all four
parathyroid glands) to which the
daughter cells with common defective
ancestry migrate.
The identification on histologic
grounds of the underlying lesion of
hyperparathyroidism, that is, the dis
tinction between adenoma and hyper
plasia, is extremely difficult and is
made considerably more so when the
hyperplasia is asymmetrical so that
only one or two of the four glands may
appear enlarged on gross examination.
Nevertheless a means of making this
distinction is of the utmost importance
in deciding on an appropriate surgical
approach to therapy. The recognition
of distinguishing characteristics may
have to await further insight into the
mechanisms causing adenomas and
hyperplasias.
Clinical Aspects and
Differential Diagnosis

FIG. 2— Biosynthesis and metabolism
of parathyroid hormone. Schematic repre
sentation of different portions of PTH
molecule are as follows: »**»» , 25-amino
acid N H 2-terminal extension of pre-pro
PTH; -v\ , 6-amino acid N H 2-terminal
extension of pro PTH; i/w/i, N H 2-terminal
portion of major species of PTH contain
ing biologic activity; lu ll , inactive mid
dle and carboxyl-terminal portion of major
species of PTH. Both well-established
pathways (-») and potential pathways
( - - - ► ) of metabolism are noted.
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The widespread use of multiphasic
screening has markedly altered the
mode of presentation of primary hy
perparathyroidism so that asymptomatic
hypercalcemia appears to constitute a
large proportion of the clinical in
stances of the disorder.26,27 Renal mani
festations, notably those of nephroli
thiasis, are currently the most common
form of symptomatic disease, while
osseous abnormalities are detected
relatively infrequently.27 Gastrointes
tinal symptoms, including those of
pancreatitis and dyspepsia, may quite
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frequently accompany the hypercalce
mia. However, proved peptic ul
ceration should alert the physician to
the possibility of an accompanying
Zollinger-Ellison syndrome,28 and there
fore of the MEN syndrome, type I.
Other components of this syndrome,
including other pancreatic islet-cell
neoplasms and pituitary tumours,
should then be considered (Fig. 3).
Alternatively, the association of hy
perparathyroidism with thyromegaly
and hypertension should raise the pos
sibility of medullary carcinoma of the
thyroid and pheochromocytoma(s) con
stituting the MEN syndrome, type II.2"
Although both syndromes are inherited
as autosomal dominant entities, the on
ly endocrinopathy shared by the two
appears to be hyperparathyroidism.
More recently patients with MEN syn
drome, type II together with mucosal
neuromas have been designated MEN,
type III, partly in view of a reported
lower frequency of hyperparathyroid
ism in the latter entity.30 The impor
tance of recognizing other endocrinopathies in association with primary
hyperparathyroidism is not only of con
sequence to the affected patient, but
obviously is of importance in the man
agement of family members as well.
Causes of hypercalcemia that must
be considered in the differential diag
nosis of hyperparathyroidism can gen
erally be grouped, on a pathogenetic
basis, into those due primarily to ex
cessive bone resorption, those due to
excess absorption from the gut and
those due to reduced renal excretion
(Table I). Yet in view of our increased
knowledge concerning the interaction
of factors controlling calcium home
ostasis, it is obvious that several patho
genetic mechanisms are generally in
volved in any single disorder; for
example, in hyperparathyroidism, the

increased bone resorption due to PTH
excess may be accompanied by en
hanced absorption of calcium from
the gut owing to augmented concentra
tions of 1,25-dihydroxy vitamin D as
sociated with increased PTH produc
tion. Similarly the hypercalcemia of
vitamin D intoxication may result
primarily from enhanced absorption of
calcium from the gut, and also from
increased bone resorption. Neverthe
less a pathogenetic classification should
provide a more rational basis for
reaching the diagnosis in a given pa
tient.
Establishing the diagnosis of hyper
parathyroidism in the patient with
hypercalcemia may not be exceedingly
difficult if an adequate history is taken
and physical examination is performed,
inasmuch as many diseases associated
with hypercalcemia may be thereby
excluded. The absence from the his
tory and physical examination of an
adequate explanation for the presence
of mild hypercalcemia (especially if
this hypercalcemia can be documented
as of long standing and is accompanied
by few signs and symptoms) makes the
diagnosis of hyperparathyroidism more
probable. In contrast the investigation
of severe hypercalcemia of recent on
set should include consideration of
neoplasia as a highly likely underlying
cause.
Laboratory investigation should then
permit the distinction of PTH-associated from non-PTH-associated hyper
calcemia and also of excess PTH pro
duction from glandular as opposed to
ectopic sites.
Laboratory Investigation

In view of the well-defined metabolic
disturbances of hypophosphatemia and
mild hyperchloremic acidosis induced
by PTH excess, various combinations
of serum phosphorus, chloride and bi
carbonate concentrations have been
advocated as indices to distinguish
PTH-induced from non-PTH-induced
hypercalcemia.31 Their accessibility

Table I— Etiology of Hypercalcemia

FIG. 3—Interrelation of endocrinopathies constituting multiple endocrine
neoplasia (MEN) syndromes types I and
II. Individual endocrinopathies depicted
have been reported as occurring on occa
sion as familial diseases without other
associated components of MEN I and
MEN II. Triad of medullary thyroid car
cinoma, mucosal neuromas and pheochromocytomas has occasionally been
designated MEN III.
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Excess bone resorption
Hyperparathyroidism
Malignant condition
Producing PTH
Producing other hormonal agents
Immobilization
Thyrotoxicosis
Excess absorption from gut
Sarcoidosis (other granulomas)
Vitamin D intoxication
? milk-alkali syndrome
? adrenal insufficiency
? idiopathic hypercalcemia of infancy
Excess renal reabsorption
? thiazide diuretics

makes these values useful but they are
not highly specific. Similarly the renal
tubular reabsorption of phosphate,
known to be diminished by PTH,
suffers from lack of specificity, espe
cially in view of the finding that hyper
calcemia, in the absence of PTH, may
induce phosphaturia.32 The radiologic
or pathologic demonstration, or both,
of the pathognomonic skeletal lesion of
hyperparathyroidism, osteitis fibrosa
cystica (and especially subperiosteal re
sorption, a relatively early sign), is ob
viously helpful when present. However,
because of the relatively low frequency
of bone involvement in patients cur
rently presenting with the disease, these
signs are often not reliable. The use
of a 10-day course of corticosteroids33
in an attempt to suppress hypercalcemia
has occasionally been useful in dis
tinguishing PTH-related causes of the
derangement (in which suppression
does not occur) from non-PTH-related
causes (in which suppression of hyper
calcemia is often observed).
Several newer tests have been intro
duced as diagnostic aids in distinguish
ing PTH-related from non-PTH-related
hypercalcemia. These include measure
ment of urinary cyclic AMP and the
radioimmunoassay for PTH. However,
such measurements are rather difficult
to obtain partly because special ex
pertise is required to perform the tests
and interpret the measurements. The
measurement of urinary cyclic AMP
is based upon the identification of this
nucleotide as an intermediary in the
mechanism of action of PTH, particu
larly at the level of the kidney.34 Ex
cess circulating PTH has been asso
ciated with increased concentrations
of urinary cyclic AMP (relative to
urinary creatinine excretion). However,
amounts excreted by patients with
hyperparathyroidism and by normal
individuals may overlap.35’37 The dis
crimination of this test might be en
hanced by measuring specifically uri
nary cyclic AMP of nephrogenous
origin (presumably related primarily to
the action of PTH on the kidney), but
this would demand associated assay of
plasma cyclic AMP, an even more
complex and meticulous process.
The radioimmunoassay for PTH pro
vides the most specific means of estab
lishing the diagnosis of hyperparathy
roidism, yet problems of technique and
of interpretation persist. Because the
human hormone for development of
antisera and use as reagent in the assay
is not widely available, heterologous
assays (usually employing antisera to
bovine PTH) are generally used with
a consequent lack of maximal sensi
tivity. A second problem, that of hor
monal heterogeneity6,17 (Fig. 2), relates
to the several circulating forms of PTH
(at least an 84-amino acid form and a
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middle and carboxyl fragment). Be
cause of this heterogeneity, species of
the hormone recognized by antisera
developed in one laboratory may not
be recognized by those developed in
another, and consequently different
“levels” of hormone may be measured
in the same blood specimen.
PTH concentrations are best inter
preted in conjunction with simultane
ous measurement of serum calcium 18
since detectable values of PTH that
fall within the normal range would be
considered inappropriately high if the
serum calcium concentration was
elevated. Such “normal” concentrations
of PTH found concomitantly with in
creased concentrations of serum cal
cium are indicative of insufficient
suppression of glandular secretion, con
sistent with the diagnosis of hyper
parathyroidism. In contrast with other
endocrinopathies, formal stimulation or
suppression tests with measurement of
hormonal response by radioimmunoas
say have not generally been helpful.
In some degree this is owing to the
continued partial responsiveness of
many parathyroid adenomas to the
calcium stimulus. 38,39 Induced hypercal
cemia (by infusion of calcium) in a pa
tient with hyperparathyroidism may
substantially suppress the abnormal
gland and diminish radioimmunoassayable PTH. On the other hand, induced
hypocalcemia (by infusion of ethylenediamine tetra-acetic acid) may stimu
late the gland and augment radioimmunoassayable PTH. Sufficient data are
not yet available to provide limits for
normal as opposed to abnormal stimu
lation or suppression of radioimmunoassayable PTH in formal testing and
this difficulty is compounded by the
lack of interlaboratory uniformity of
PTH radioimmunoassay methods and
results. Consequently we depend on
several basal values of PTH in con
junction with calcium determinations
to provide sufficient information.
The usefulness of the assay has been
extended by employing it in conjunc
tion with selective venous catheteriza
tion for preoperative localization of
the site of excess PTH production . 40
Several other techniques introduced for
preoperative location of abnormal
parathyroid tissue, including selenome
thionine scanning and arteriography,
have in general been less helpful. The
technique of selective venous catheteriz
ation is arduous, requiring the interest
and experience of a cooperative venographer. Catheterization of at least the
inferior thyroid veins on both sides is
required , 41 since excessive dilutional
effects occur when larger veins are
sampled.
In several centres this technique is
now reserved for problem cases in
which hypercalcemia has recurred after
288

neck exploration and reintervention is
required. Although most useful in
these situations, the technique is also
susceptible to failure because of the
distorted venous architecture follow
ing surgery and requires close correla
tion of the site of sampling with the
venogram. It should prove particularly
useful for distinguishing glandular
from ectopic sites of PTH production.
Therapy

If the underlying cause of the PTH
excess is an intrinsic defect within
parathyroid tissue, as may be true in
the majority of cases of adenoma and
hyperplasia, then the preferred treat
ment (in the absence of available me
dical therapy to diminish “uncon
trolled” cell growth) is to diminish the
quantity of hypersecreting tissue by
excising it. On the other hand, if the
underlying cause of PTH excess is a
defect extrinisic to the parathyroid
cells, as it may be in some cases of
hyperplasia, then the rational solution
would be to eliminate the external de
fect stimulating thei gland; inasmuch
as no such defect has yet been iden
tified, the approach here also has been
to excise excess tissue, although with a
lower rate of cure. How much tissue
to excise may be a hard decision in
view of the difficulties in distinguishing
modest glandular enlargement from
normal glands17 and parathyroid ade
nomas from asymmetrical hyperplasia.
Medical therapy for hyperparathy
roidism is of limited value. One might
expect three categories of agents to be
helpful: those that interfere with hor
mone release, those that antagonize
the action of the hormone and those
that counteract the metabolic disturb
ances induced by the hormone. To
date only agents in the last category
are available, most notably the phos
phate anion. However, with long-term
oral phosphate therapy, although hyper
calcemia may be reduced, PTH secre
tion continues unabated or even ac
celerated with the possibility of con
tinued bone resorption and the danger
of metastatic calcium deposition. This
form of therapy therefore is less than
ideal and is generally employed only
when the degree of hypercalcemia it
self represents a threat to the patient’s
well-being and surgical therapy for
hyperparathyroidism is absolutely con
traindicated.
The difficult decision in therapy
arises in the patients discovered to have
asymptomatic hypercalcemia as the
only manifestation of hyperparathy
roidism. Although prospective studies
have conclusively demonstrated the
hazards of other untreated conditions
not initially recognized by the patients
and considered to be asymptomatic

VOLUM E 21, NO. 4, JU L Y 1978

/

(such as prolonged untreated hyperten
sion), no such studies are currently
available for patients found to have
mild elevations of serum calcium.
Furthermore, it is not certain whether
hyperparathyroidism with asympto
matic hypercalcemia represents the
same disease state as hyperparathyroid
ism with obvious osseous or renal
manifestations. Nevertheless where
such mild hyperparathyroidism has
been reversed by parathyroid surgery,
sensitive biochemical and morphologic
indicators of calcium and skeletal
homeostasis have been found to im
prove42 and clinical well-being may be
enhanced as well, indicating the ben
efit of the surgery.
The somewhat exacting technical
requirements of parathyroid surgery
leave open the question of whether
or not to intervene in what may be
a relatively benign disorder.
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SESAP II Question
20. A 42-year-old man had a Billroth II subtotal gastrectomy for duodenal ulcer two years ago. He is now asymp
tomatic. Laboratory studies disclose the following values: hemoglobin 10.0 gm/100 ml, hematocrit 30 per cent,
normal leukocyte count and differential. Which of the following studies would be most useful in further evalu
ating this patient?
(A) Examination of the stool for occult blood
(B) Gastric analysis with test for occult blood
(C) Measurement of prothrombin time
(D) Determination of mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH) and mean
corpuscular hemoglobin concentration (MCHC)
(E) Erythrocyte fragility test
For this question select the one answer that is BEST from those noted above.
For the critique of Item 20 see page 329 of this issue.
(Reproduced by permission of the American College of Surgeons from SESAP II Syllabus: Surgical Education
and Self-assessment Program No. 2. For enrolment in the Surgical Education and Self-assessment Program No. 2
please apply to the American College of Surgeons, 55 East Erie St., Chicago, IL 60611.)
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Surgical Considerations in Hyperparathyroidism:
Current Concepts
M a r v in J. W e x l e r ,

The pathologic and histologic alterations
seen in the parathyroid glands removed
at operation have changed drama
tically in recent years as a result of
early diagnosis and treatment, often
in asymptomatic patients. This situation
has resulted in considerable disagree
ment over optimal surgical therapy
and the number of parathyroid glands
the surgeon should remove. These
areas of controversy are analysed and
current concepts critically reviewed.
Les alterations pathologiques et histologiques retrouvees sur les glandes
parathyroi'des a la chirurgie ont change
dramatiquement au cours des dernieres
annees, resultat d’un diagnostic et
d'un traitement precoces, souvent
chez des patients asymptomatiques.
Cette situation a entraine de serieux
disaccords en ce qui concerne le
traitement chirurgical optimal et le
nombre de glandes parathyroi'des devant
etre enlevees par le chirurgien. Ces
sujets controversy sont analyses et
les notions actuelles sont revues de
fapon critique.

Surgical interest in the parathyroid
glands has grown phenomenally since
1925 when Mandl1 first removed a
parathyroid tumour from a patient
with generalized bone disease and hypercalciuria. Once considered rare,
primary hyperparathyroidism is now
being diagnosed with greater frequency
and at an earlier stage as clinicians
become increasingly aware of its exist
ence and varied symptomatology, and
as use of the multichannel autoanalyser
has become routine in the general
medical investigation of most patients.2
The advanced stages of this disease,
characterized by extensive renal dam
age or widespread skeletal involvement
with osteitis fibrosa cystica, multiple
cysts and brown tumours, are rarely
seen today. Patients now present with
From the department of surgery,
McGill University and Royal Victoria
Hospital, Montreal, PQ
Reprint requests to: Dr. M.J. Wexler,
Department of surgery, Royal Victoria
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minimal or no bone changes and
it is the discovery of renal calculi that
generally initiates an investigation for
hyperparathyroidism. Less commonly,
patients present with symptoms re
lating to the gastrointestinal tract, the
pancreas, or the cardiovascular or ner
vous systems.3 Accordingly, the histo
pathologic features of the lesions in
the parathyroid glands removed at
operation have also changed notably.
This situation has given rise to altera
tion in our pathologic and surgical
concepts and, more recently, to con
siderable controversy over the basic
clinical question: How many parathy
roid glands should the surgeon remove?
Incidence of Multiglandular Disease

The history of parathyroid surgery
has followed closely the evolutionary
pattern of other surgical endocrinopathies such as Cushing’s syndrome,
pituitary and thyroid disease and hy
peraldosteronism. The pathologic con
dition initially suspected was either an
adenoma or a carcinoma. Later, with
increased knowledge and earlier diag
nosis, surgeons recognized that these
entities were possibly the later phases
of an initial hyperplasia, so that they
might expect to find a simple diffuse
hyperplasia early in the course of the
disease. Although the water-clear cell
type of primary hyperplasia of the
parathyroid was identified by Albright
and associates in 1934,4 chief cell hy
perplasia of all four parathyroid glands
was not described until 1958,5 yet ac
counted for 25 of the subsequent 100

cases dealt with at the Massachusetts
General Hospital.3
In the case of a neoplasm, the deci
sion is simple—one removes the
tumour, leaving the normal undiseased
tissue behind. The hyperplasias demand
more of the surgeon because he has to
decide how much tissue to resect and
how much to leave. Complete expo
sure and identification of each and
every gland become crucial. The gen
eral practice in the past has been to
remove 3 Vi glands in the belief that
hyperplasia is always a diffuse process
involving all four glands. Part of the
most accessible and best vascularized
gland was left behind to prevent the
development of hypoparathyroidism.
As can be seen in Table I, the re
ported frequency of multiglandular
disease varies considerably, ranging
from 10% to 65%.6-15 Clearly this is
a reflection of the inconsistent criteria
used for distinguishing between nor
mal tissue, hyperplasia and adenoma.
Authors who report a 10% to 20%
frequency of multiglandular disease
base their diagnoses on gross appear
ance, size and weight of the glands;
those who claim rates from 40% to
65% rely on histologic distinctions
that at best are less than pathogno
monic and far from universally ac
cepted.
Essentially three surgical “philoso
phies” have evolved and enjoy current
popularity. All have as their objective
the removal of abnormal and potential
ly abnormal tissue without creating
hypoparathyroidism yet obviating the

Table I—Incidence of Multiglandular Disease in Selected Series

Author
Paloyan, Paloyan and Pickleman0
Muller7
Haff and Ballinger8
Esselstyn and colleagues9
Bruining10
Block and colleagues11
Palmer and colleagues12
Myers13
Clark, Way and Hunt14
Davies15
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Total
no. of
patients

No. with
multiglandular
disease, %

98
352
38
100
267
182
250
82
295
350

65
50
50
49
45
20
15
13
12
10
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The radical approach, first urged
and still championed by Paloyan,6'19
Haff and Ballinger8 and others,20 is
based upon these workers’ own data,
which indicate that recurrence of dis
ease after simple excision of an ade
noma is frequent, and on the premise
that hyperparathyroidism is a second
ary manifestation of chronic extrinsic
stimulation. Accordingly, prophylactic
near-total removal of the end organs
is necessary. In all patients 3 Vi glands
are excised, leaving 75 to 100 mg of
well-vascularized glandular tissue. If a
gland cannot be located, ipsilateral
thyroid lobectomy and thymectomy are
performed.
According to proponents of this ap
proach, gross inspection is unreliable in
distinguishing normal from abnormal
tissue and they suggest that the true
incidence of multiglandular disease is
high. The pathologist must be supplied
with sufficient material to permit a
comparison of the changes in the
various glands. Finally, this technique
provides irrefutable proof that the sur
geon has visualized all glands.

evidence of hyperfunction and in cases
where the cells of two or more glands
Advocates of a moderate, middle-of- showed evidence of hyperfunction, the
the-road, selective approach as repre diagnosis of adenoma was not applied.
sented by Palmer and associates,12 Paloyan, Paloyan and Pickleman6 de
Myers13 and Clark, Way and Hunt,14 fined cases of hyperplasia as those in
argue that persistence rates due to tech which there is either gravimetric and
nically inadequate primary exploration histologic evidence of cellular over
are unacceptably high. True recurrence activity in more than one gland, hyper
rates, due to misinterpretation of dif plasia alone, an adenoma coexisting
fuse hyperplasia, are low. Therefore, with hyperplasia, or multiple parathy
an uncompromising effort is made to roid adenomas. The mere existence of
identify all parathyroid tissue, includ the latter entity is now disputed by
ing exploration of the common sites of some.17’23 Clearly, arguments for sur
ectopic or supernumerary glands as gical management based on reported
Palmer and Sutton advocate in this is rates of multiglandular disease or hy
sue (page 350). Only grossly enlarged perplasia are factitious. It is now rec
glands are excised and biopsy of one ognized by pathologists that the entire
or more seemingly normal glands is spectrum of adenoma, hyperplasia,
done for positive identification, but transitional cells and normal histology
routine biopsy of all glands is not per may be present not only in a single pa
formed. This approach, like the more tient, but in some instances in a single
conservative one, is also based on the gland.21
Most pathologists experienced in
belief that one can tell by its appear
ance whether a gland is abnormal, that parathyroid histology concede that
a gland of normal size does not and there are few, if any, reliable histologic
will not have abnormal secretory func criteria that permit consistent and pre
tion. This selective surgery is associated cise differentiation between normal
with a low rate of postoperative hypo parathyroid tissue and hyperplasia and
between hyperplasia and adenoma.11,24’2->
calcemia.
Four important questions must be Furthermore, the surgeon cannot rely
answered to reconcile these conflicting on frozen sections of biopsy specimens
in making the diagnosis; the pathologist
approaches:
can do little more than confirm the
• What is hyperplasia?
• Is histologic evidence of hyper presence of parathyroid tissue.
The concept of an abnormal external
plasia in a normal-sized gland of clinical
stimulus bringing about early hyper
importance?
• What is the true incidence of plasia of all parathyroid glands, with
polyglandular disease and is all multi the later development of an autonomous
adenoma in one that causes suppres
glandular disease hyperplasia?
• Can the surgeon distinguish be sion of the remainder, is undoubtedly
tween normal and abnormal glands by too simplistic. Primary hyperparathy
roidism probably represents a collec
their gross appearance at operation?
tion of diseases of varied etiology and
Adenoma versus Hyperplasia
pathogenesis. Abnormal stimuli may
Prior to the general recognition in originate from without and perhaps
the 1960s of chief cell hyperplasia of also within a single gland and hyper
all four parathyroid glands as a clinical plasia need not be a process affecting
entity, most surgeons were content to all four glands (Fig. 1). Whether the
seek and remove only one enlarged surgeon can distinguish between nor
gland and made little or no attempt mal and abnormal glands at operation
to determine the status of the remain is a question difficult to answer. This
ing normal-appearing glands, or even does appear possible from a clinical
to identify them at all. According to and functional aspect, but cannot be
some,21 this practice accounted for the done on histologic grounds. Evidence
popular figure of 80% for adenomas
reported in most series of that time.22
In an attempt to solve this problem
Esselstyn and colleagues9 routinely did
biopsies of all four glands in 100 pa
GLANDS RESPOND
tients with primary hyperparathyroid
ism and subjected the tissue to histo
logic study. They reported hyperplasia
in 49% of this group. They rigidly
OR MULTIPLE GLANDS
defined an adenoma as a “discrete,
usually diffuse lesion” of a single para
thyroid gland; the presence of a definite
ADENOMAS + FOCAL HYPERPLASIA
rim of normal capsule tended to con
firm the diagnosis but was not absolute
FIG. 1—Pathogenesis of hyperparathy
ly essential to it. Nonadenomatous roidism. Possible interrelation between
glands could show no morphologic adenoma and hyperplasia.
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necessity for future re-exploration with
its inherent difficulties. Fundamental
differences in theories of the patho
genesis of hyperparathyroidism and
conflicting data regarding success in
achieving the stated objectives underlie
these alternative approaches. These are
best summarized as follows:
The “Right” Approach

The conservative approach advocates
that at first only one side of the neck
should be explored. If one enlarged and
one normal gland are found on gross
examination, the “adenoma” is excised
and the operation terminated. Roth,
Wang and Potts,16 the principal pro
ponents of this mode of surgical treat
ment, offer evidence that: over 80%
of primary hyperparathyroidism is due
to a solitary adenoma, excision of
which results in a very low recurrence
rate. These workers claim that double
adenomas, if they ever exist, are very
rare.17 The coexistence of a grossly en
larged and a normal-sized gland is
assumed to refute the diagnosis of
hyperplasia. In the uncommon event
of a recurrence in such a circumstance,
one side of the neck remains for easy
exploration and a healthy, functioning,
normal gland remains undisturbed on
the side originally operated on. Un
necessary trauma to normal glands is
avoided and the very real danger of
permanent hypoparathyroidism asso
ciated with re-exploration is eliminated.
If it is necessary to explore both sides,
clinically enlarged glands can be re
moved without the need for biopsy of
apparently normal glands.18
The “Left” Approach

/

The “M iddle” Way
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continues to mount that microscopic
hyperplasia in a normal-sized or even
a suppressed gland is common but of
no functional importance and of no
clinical consequence.23,26 Alternatively,
diagnosing hyperplasia in slightly en
larged glands without histologic sup
port can also lead to error owing to
varying amounts of surrounding fatty
tissue.

thyroid hormone (PTH) concentrations
are needed. Recurrences reported 5 to
15 years after the initial operation are
not unusual. Monitoring on a regular
basis, particularly if sensitive PTH as
says are included, may provide earlier
evidence for recurrence. It is still pos
sible that recurrent disease is the result
of a physiologically insignificant
amount of hyperfunctioning tissue be
ing left at the first operation and later
proliferating to produce eventual re
Persistent versus Recurrent
currence. As such it represents un
Hyperparathyroidism
recognized abnormal tissue and there
From a clinical standpoint, the fore persistent disease. However, as
answer to the dispute over how much shown by the data currently available,
and how many glands to remove lies in true recurrent disease as distinct from
the outcomes of the various surgical persistent disease is relatively uncom
approaches. Unfortunately the relevant mon even with the most conservative
data are imprecise because of the fail of selective approaches. On this basis,
ure of most surgeons to distinguish there is no support for routine prophy
clearly between persistent disease and lactic subtotal parathyroidectomy ex
true recurrence following surgical treat cept in patients with multiple endocrine
ment. This accounts for reported adenomatosis type I, familial hyper
“recurrence” rates ranging from 0.4% 14 parathyroidism, or secondary hyper
to 19%.20
parathyroidism in which recurrence
Persistent disease is considered by rates are reported as high as 33% with
most surgeons to represent overlooked lesser surgery.14 The hypothetical pos
disease. Recurrent disease, defined as sibility of producing delayed recur
return of hypercalcemia at least 6 rence of hyperparathyroidism from
months after a period of normocalce- eventual autonomy of an overstressed
mia, implies newly developed patholo remnant remains if we elect routine
gic change. Clark, Way and Hunt14 re subtotal parathyroidectomy. Total para
cently summarized all reports in the thyroidectomy with auto-transplanta
English literature of surgically treated tion of tissue to the forearm as de
hyperparathyroidism since Paloyan and scribed by Wells and colleagues28 may
colleagues19 first advocated routine pro prove to be the ultimate solution in
phylactic subtotal parathyroidectomy in such cases. At present the indications
1969. In this collected series of 3204 for this procedure are unclear.29,30
patients, treated by the selective ap
Unfortunately a recent clinical and
proach described earlier in which only pathological study of 112 patients re
abnormally enlarged parathyroid glands quiring parathyroid reoperation17 did
were removed, recurrent hyperparathy not distinguish between persistent and
roidism developed in only 24 (0.7%). recurrent disease. Nevertheless, the
This low figure suggests that true re findings supported the concept that
currence is rare, even with a selective persistence due to a technically inade
approach, but persistence may be com quate operation and failure to find an
mon owing to an inadequate primary adenoma is the major problem of post
operation. It must be recognized, how operative recurrence rather than mis
ever, that most reported series consist interpretation of diffuse hyperplasia
of retrospective reviews in which fol and failure to perform routine subtotal
low-up data are incomplete and are excision. Of the causes of unsuc
often based upon an isolated serum cessful parathyroid exploration, the
calcium determination. In reports of commonest was the failure of the sur
follow-up studies as long as 15 to 40 geon to be familiar with the normal
years after operation,12,14,15 patients lost location of the parathyroid glands and
to follow-up are infrequently acknowl the way a gland may be displaced when
edged and the majority of patients have diseased. In this series 66 adenomas
usually been under observation for less and 7 carcinomas were found. In only
than 5 years. Even in a recent prospec 29 patients was the histology that of
tive study of 198 patients with hyper primary hyperplasia, which had con
parathyroidism from whom a single tinued despite excision of one or more
enlarged gland was removed between diseased glands at the initial operation.
1968 and 1970 and who were kept un It is also notable that in more than
der surveillance to the end of 1975, half the unsuccessful cases attributed
25% either died or were lost to follow to technical incompetence the initial
up within 5 years and a further 25% diagnosis of parathyroid tissue was
were under observation for less than 5 later revised when, at histologic ex
years.27 Reliable long-term and prospec amination, the tissue was found to be
tive follow-up studies with regular lymph node or fat or thyroid.
monitoring of serum calcium and para
Assuming that the surgeon is com
292
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petent in this area, aberrant locations
of glands and supernumerary glands
(fifth or sixth) overlooked at the initial
exploration are the principal causes of
reoperation in patients treated accord
ing to traditional surgical guidelines.30
Recurrent hyperparathyroidism due to
enlargement of a parathyroid gland
previously observed to be normal is
rarely documented.
Postoperative Hypocalcemia

The biggest argument against routine
prophylactic subtotal parathyroidecto
my is the high incidence of postoper
ative hypocalcemia (13% to 30%)
reported by some10,18,26,31 compared
with a negligible incidence (1% to
4%) when only glands that are en
larged are removed.10,12,14,28,27 Close
scrutiny reveals that the high figures
usually include a group of patients in
whom the hypocalcemia is transient
and who are easily treated until suffi
cient compensation is afforded by the
remaining tissue. The greater the
amount of residual tissue, the less the
likelihood that hypocalcemia will oc
cur and the faster the recovery if it
does occur. It is important to caution
against the overzealous administration
of calcium during the early postoper
ative period. This may suppress the re
maining parathyroid function and
eventually produce atrophy. Variations
in the degree of treatment with calcium
may also account for reported discre
pancies in different series. Paloyan,
Paloyan and Pickleman,6 while they
reported only two instances of hypo
parathyroidism in 100 patients who
underwent subtotal parathyroidectomy,
disregarded this group in which hypo
calcemia is transient and considered
only those with permanent hypopara
thyroidism. In the evaluation of post
operative calcium problems it is im
portant to recognize that these are not
necessarily the result of excision of ex
cessive amounts of parathyroid tissue.
They can occur after removal of only
a single large adenoma, as a result of
rapid bone absorption of calcium sub
sequent to removal of the influences of
excessive PTH. Calcium taken orally is
usually sufficient to correct symptoms
and is rarely required for more than
a few weeks. In a recent study,28 12
of 50 patients who were operated upon
by a “radical” surgeon required treat
ment for symptomatic postoperative
hypocalcemia. However, only five had
had a formal subtotal parathyroidec
tomy; the others had had only one or
two glands removed and biopsy of a
varying number of the remaining
glands. These results suggest that biop
sy alone may induce postoperative
hypocalcemia owing to manipulative
damage, since the incidence was re-
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duced to 2% in a subsequent 50 pa
tients in whom a conservative approach
was used and only the enlarged
gland(s) removed.
As clearly stated by Ballinger,20 the
crucial question is whether the risk of
hypocalcemia is greater than the risk
of leaving hyperfunctioning parathyroid
tissue in situ with development of in
sidious nephrocalcinosis and the in
creased danger of permanent hypocal
cemia resulting from subsequent ex
plorations. It would appear that, taken
in proper context, the risk of either
eventuality is extraordinarily small. The
patients at highest risk for the develop
ment of permanent hypocalcemia are
those with either previous incomplete
neck exploration for hyperparathyroid
ism or previous or concomitant thyro
idectomy. It is in this latter group that
parathyroid autotransplantation may
find its role.
Conclusion
“The success of parathyroid surgery
must lie in the ability of the surgeon
to know a parathyroid gland when he
sees it, to know the distribution of the
glands, where they hide, and also be
delicate enough in technic to be able
to use this knowledge.”3 Resolution of
the controversy over the frequency of
recurrent disease is, at least in part,
dependent on clearly distinguishing it
from what is actually persistent disease
and on eliminating the latter as far as
possible at the primary operation.
The question of whether surgeons,
even those most experienced in para
thyroid surgery, can identify a para
thyroid gland without confirmation by
biopsy is paramount. Frequently the
answer must be in the negative.” It
would therefore appear to be vital to
visualize all four glands and to do a
biopsy of all glands that appear normal
to confirm their identification. This
can be accomplished easily with iris
scissors with little apparent damage to
the residual tissue but with full knowl
edge, as emphasized by the study of
Edis and associates,26 that the fre
quency of postoperative hypocalce
mia will be increased although it will
usually be temporary and easily man
aged. Clearly the major problem is
that of continued hyperparathyroidism
where the risk at a subsequent opera
tion far outweighs the morbidity of
temporary postoperative hypocalcemia.
All glands that appear abnormal should
be removed and weighed by the pa
thologist after removing extracapsular
fat; there should be dialogue between
pathologist and surgeon. Glands with
a normal gross appearance do not re
quire excision.
There does appear to be an increas
ing proportion of patients with what
VOLUME 21, NO. 4, JULY 1978
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might be termed a mixed bag of one
or two grossly enlarged glands sug
gestive of adenoma, perhaps one nor
mal-sized gland that is hypercellular
on biopsy and one gland of normal
histology.32 This combination is con
sistent with the pathogenetic concepts
proposed earlier (Fig. 1). The nature
and course of these variants remain
unclarified and it seems necessary to
relate the gross and microscopic find
ings of all four glands to a definitive
approach to surgical treatment and then
to a long-term follow-up over many
years. Inclusion of electron microscopy
may further aid this process.
More pressing problems are the
course to be followed when one gland
cannot be definitely located, perhaps
even after hemithyroidectomy and
transcervical thymectomy, and the ap
proach to be taken for recurrent dis
ease. The ultimate success in the man
agement of the patient with continuing
hyperparathyroidism depends upon the
surgeon. He must know what the ab
normality is and how to correct it. In
the hands of an accomplished surgeon
with detailed knowledge of the numer
ous anatomical variations of the para
thyroid glands,33 the success rate is
high, even without sternotomy. As pre
viously noted, persistent disease usual
ly reflects some lack of competence on
the part of the surgeon at the time of
the primary operation rather than an
inability to distinguish between ade
noma and hyperplasia or to perform
routine prophylactic subtotal resection.
A density test recently described by
Wang and Rieder34 may prove valu
able in the intraoperative differentia
tion of primary parathyroid hyperplasia
from neoplasia and may call for further
modification of surgical attitudes and
approaches.
It is important to recognize that an
adenoma may be located in an ectopic
fifth parathyroid gland. It is note
worthy that of 14 patients with medi
astinal parathyroid tumours reported
by Scholz and associates,35 5 had pre
viously had four glands identified in
the neck. Others612’14,17 have reported
similar experiences. In such circum
stances, while removal of a single
“suspicious” enlarged gland or subtotal
removal of the normal four may result
in transient normocalcemia, the remain
ing tumour will surely declare itself,
perhaps to be misinterpreted as recur
rent disease. The periodicity of hyper
function must also be considered. Light
may be shed on these concepts and
controversies by more routine use of
sensitive assays for PTH. Purnell,
Scholz and Beahrs27 have measured
serum PTH values after parathyroidec
tomy and found that in some patients
these remained elevated. The impor
tance of the increased PTH concentra

tion in the presence of normal serum
calcium concentration is not certain.
This subject has been more extensively
reviewed in this issue of the Journal by
Goltzman (page 285).
Subtotal parathyroidectomy is man
datory in patients with multiple endo
crine adenomatosis, familial hyperpara
thyroidism, or secondary hyperpara
thyroidism. If a question of viability or
sufficiency of residual tissue arises, as
is often encountered in patients re
explored for recurrent disease, para
thyroid tissue should be transplanted
to the forearm where monitoring and
subsequent removal can be performed
if necessary.
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Glimpses of Surgical History:
V for
Venesection

D avid A.E. Shephard
B lood has so profound a meaning
fo r man that bleeding, both natural
and accidental or induced (as with
VENESECTION), early took on
deep significance. Menstruation sug
gested that blood could, maybe
should, be shed periodically; and,
in a strange twist o f sexual be
haviour, monkish males subjected
themselves to a regular regimen o f
blood-letting to counter the sup
posedly harmful effects o f accumu
lation of semen and to help them
battle fleshly temptation. In other
realms of Hygeia, the revulsive e f
fects o f accidental hemorrhage were
also recognized by primitive people.
So blood-letting became one o f the
earliest form s o f therapy: as an old
verse put it, “ It maketh cleane your
braine, releeves your eie, / It mends
your appetite, restoreth sleepe ” —
and evidently much else besides.
W e still practice venesection:
transfusion and autotransfusion re
quire venesection, and polycythemia,
hemosiderosis, arterial hypertension
and pulmonary congestion were
treated by venesection until quite
recently. Such treatment seems ra
tional, very different from that o f
the barbers o f two or three centuries
ago who let blood flow freely (the
red o f the barber’s pole reminds us o f
this) and from that o f the owners
o f "bleeding shops” that people,
well or ill, visited regularly to be
“ blooded” or to “ breathe a Vein” .
To be bled— without medical ad
vice— was fo r many an everyday
custom.
What we consider rational vene
section did not replace the maniacal
approach until the mid-19th century.
The practice o f barbers, bath-keep
ers and sow-gelders collapsed into
desuetude only with the rise o f ex
perimental physiologists like Magendie and Bernard and with the
scepticism o f therapeutic nihilists
like Skoda. A s today’s operators
(and their head-of-the-table col
leagues) watch for the ebb and flow
o f blood in a patient “ etherized upon
a table” , let thought be given to the
many who laboriously laid the lore
and learning o f blood over the cen
turies, so that modern “Surgeons. . .
trust to the Blooding” in rational
care o f their patients.
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CAGS PAPERS

Clinical Experience with the Newer Hepatobiliary
Radiopharmaceuticals
L. R o s e n t h a l l ,

md

ministration. The analogues of N-substituted IDA vary in their transit time
through the liver and in the degree of
renal excretion. 99mTc-dimethyl-IDA
("'"Tc-dm-IDA) has the most rapid
transit through the liver, but about
15 % is excreted by the kidneys; in
contrast, 99mTc-parabutyl-IDA (99mTcpb-IDA) has a slower hepatic transit
time and a 2% renal excretion, not
unlike 131I-rose bengal. The disparate
properties of these two radioactive
pharmaceuticals assume importance in
the presence of hyperbilirubinemia as
will be shown later.
This review relates our experience
with 99mTc-dm-IDA, and to a lesser
extent 99mTc-pb-IDA, in the diagnosis

Reprint requests to: Dr. L. Rosenthall,
Director, Division of nuclear medicine,
The Montreal General Hospital,
1650 Cedar Ave., Montreal, PQ H3G 1A4

Rose bengal labelled with iodine 131
was the standard hepatobiliary imaging
agent after its introduction in mid1950. The principal limitation of this
agent is the radionuclide 131I which
has an 8-day physical half-life, a highenergy photon emission that is ineffi
cient for gamma camera imaging and a
beta emission that does not contribute
to the imaging process but rather adds
unnecessarily to the body radiationabsorbed dose. To stay within accept
able limits of radiation burden the ad
ministered dose was kept low and this
resulted in liver and biliary tract
images of low information density and,
consequently, poor detail. Technetium
99m is a radionuclide with the desir
able physical qualities of being a pure
gamma emitter and possessing a short
(6-hour) half-life which aid in delivering
a low radiation-absorbed dose even
when
administered
in
millicurie
amounts. Unfortunately, it has not
been possible to label the hepatocyteseeking rose bengal with 99mTc. An
alternative radionuclide is 123I, which
has physical properties somewhat akin
to those of 99mTc, but is cyclotron-pro
duced, expensive and inappropriate
for general use in the form of a sim
ple kit.1 A variety of radioactive phar
maceuticals concentrated by hepatocytes have therefore been developed
employing the inexpensive and ubi
quitous 99mTc as the label in millicurie
doses to provide images of high in
formation density in short imaging
times.210 Two of these have undergone
considerable
clinical
investigation,
""Tc-pyridoxylideneglutamate11 and the
99mTc-labelled N-substituted iminodi
acetic acid (IDA) derivatives12'14 (Fig.
1), but the others are still at the ex
perimental stage. The IDA derivatives
are believed to possess some advantages
over pyridoxylideneglutamate,15 but
both are rapidly concentrated by the
hepatocytes, and subsequently excreted
into the biliary tract, gallbladder and
gut within an hour of intravenous ad
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Technetium 99m-labelled hepatobiliary
imaging agents provide high resolution
images not previously possible with
rose bengal labelled with iodine 131.
This has prompted a re-examination of
the utility of these radioactive phar
maceuticals. We have found that the
newer methodology provides a rapid,
innocuous and accurate means of
excluding acute cholecystitis from the
diagnosis in patients with symptoms
suggestive of this disease and of
assessing surgically altered biliary
anatomy. In the presence of moderate
bilirubinemia, up to about 85.5 to
103 pmol/L (5 to 6 mg/dL), a definitive
distinction can be made between
medical and surgical jaundice.
Les agents de contraste marques au
technetium 99m servant a la mise en
evidence des voies hepatobiliaires
offrent des images a contraste marque
qui n'etaient pas possibles avec le
rose bengale marque a I'iode 131.
Ceci nous a incite a re-examiner I’utilite
de ces produits pharmaceutiques
radioactifs. Nous avons trouve que la
nouvelle methodologie offre un moyen
rapide, nonenvahissant et precis
d’exclure du diagnostic la cholecystite
aigue chez les patients ayant des
symptomes suggerant cette maladie,
et d’evaluer les modifications chirurgicales de I'anatomie biliaire. En
presence d’une bilirubinemie moderee
allant jusqu'a 85.5 a 103 ^m ol/L (5 a 6
mg/dL), une distinction definitive
peut etre faite entre I'ictere medical
et I’ictere chirurgical.

From the division oj nuclear medicine,
The Montreal General Hospital,
Montreal, PQ
Presented at the 1st annual meeting of
the Canadian Association of General
Surgeons, Vancouver, BC, Jan. 27, 1978
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FIG. 1—Various acetanilide iminodr
acetic acid (IDA) derivatives.
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of acute and chronic cholecystitis, the
differential diagnosis of jaundice and
the assessment of the postsurgical by
pass pathways of the biliary system.
Technique

Gallbladder Assessment
Food is withheld for 2 hours prior
to the examination. About 5 mCi of
99n,Tc-dm-IDA or ""Tc-pb-IDA is in
jected intravenously and radionuclide
images are obtained at 15-minute in
tervals for the first hour until the gall
bladder is visualized. Nucleographs are
procured at 30-minute intervals there
after if necessary. The study is ter

minated when most of the radiotracer
is excreted into the gut if the gallblad
der cannot be visualized.
In the presence of liver disease and
jaundice the slower excretion of the
radioactive pharmaceuticals will ex
tend these temporal relations.
Differentiation of Jaundice and
Determination of Surgically
Altered Anatomy
No food restriction is necessary.
After an intravenous dose of 5 mCi of
""Tc-dm-IDA or ""Tc-pb-IDA nu
cleographs are obtained every 30 min
utes for the first 4 hours or less if the

FIG. 2— Normal gallbladder. 99mTc-pb-IDA images were obtained at 20, 30 and
60 minutes. Gallbladder is identified as early as 20 minutes but is more clearly seen at
30 and 60 minutes (single arrow). Filling of common bile duct (double arrows) and gut
entry (open arrow) are evident at 60 minutes.

FIG. 3— Acute cholecystitis. Serial
M"Tc-pb-IDA images fail to identify gall
bladder over 2-hour period of observation.
Bowel entry is observed as early as 30
minutes and common bile duct is seen at
45 minutes and later (arrow).
298

diagnosis becomes apparent. In severe
hepatobiliary disease a 24-hour image
is obtained to determine whether ex
cretion into the gut has taken place.
Results and Discussion

Normal Gallbladder
In normal subjects the gallbladder is
visualized within 30 minutes of the
intravenous injection of 99mTc-dmTDA
provided food is withheld for 2 hours
before the examination. With 99mTc-pbIDA the time to visualization may be
longer because of its slower transit
time, but does not exceed 1 hour. En
try into the gut can be appreciated
about the same time as the gallbladder
is visualized or soon after (Fig. 2).
In an earlier study all 43 patients
with a normal gallbladder as demon
strated by oral cholecystography and
the results of routine liver function
tests (total serum bilirubin, protein,
transaminase and alkaline phosphatase
values) showed gallbladder filling on
the 99mTc-dm-IDA images.16 These pa
tients did not require cholecystokinin,
as advocated by others,17 to induce
emptying of the gallbladder prior to
administration of the radioactive phar-

FIG. 4— Serial 99mTc-dm-IDA images in case of partial extrahepatic biliary ob
struction in patient with acute pancreatitis. Biliary system is dilated and can be seen
extending into branches of right and left hepatic ducts. Bowel entry is delayed as it is
only apparent at 3 hours. Gallbladder is visualized by 1V4 hours and enlarges progres
sively (arrow), thereby excluding a diagnosis of acute cholecystitis, particularly the
clinically suspected hydrops.
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maceuticals in order to facilitate vi
sualization.
Abnormal Gallbladder
Failure to visualize the gallbladder
in the presence of normal excretion
into the gut indicates either acute or
chronic cholecystitis (Fig. 3).

In one study16 of pathologically and
surgically proved cases all nine patients
with acute cholecystitis and seven pa
tients with chronic cholecystitis and
cystic duct obstruction failed to show
concentration by the gallbladder of
99mTc-dm-IDA. There were an addi
tional 11 patients with chronic chole
cystitis and patent cystic duct who did
not exhibit gallbladder filling with
99mTc-dm-IDA. The gallbladder in two
of these patients actually did fill fol
lowing a 5-minute 100-unit infusion
of cholecystokinin and a second dose
of 99n,Tc-dm-IDA. The presence of non
obstructing stones in the gallbladder
cannot generally be demonstrated by
radionuclide imaging.
The conclusions to be drawn from
our experience with the use of hepa
tobiliary imaging in patients with sus
pected disease of the gallbladder are:
(a) nonvisualization of the gallbladder
after radionuclide injection signals
either acute or chronic cholecystitis;
(b) radionuclide visualization of the
gallbladder excludes the presence of
an obstructed cystic duct. Therefore
acute cholecystitis can confidently be
ruled out in patients presenting with
symptoms suggestive of the diagnosis
if the gallbladder is visualized. The
technique is innocuous, noninvasive
and rapid.
Differentiation of Jaundice
Partial extrahepatic obstruction is
characterized by a dilated tract and

delayed emptying of the system into
the bowel (Fig. 4). Activity in the
bowel without dilatation of the biliary
tract identifies a jaundice of intrahepatic origin. Failure to detect entry
of the radionuclide into the bowel
within a 24-hour period of observation
establishes a diagnosis consistent with
complete extrahepatic obstruction pro
vided the serum bilirubin concentration
is only moderately elevated. Flowever,
when the degree of bilirubinemia is
high, lack of excretion into the gut may
also be associated with severe hepato
cellular disease and intrahepatic cho
lestatic jaundice and the result is no
longer definitive.
Experience with 99mTc-dm-IDA has
shown that for serum bilirubin con
centrations of 85.5 jjlm ol/L (5 mg/dL)
or lower, serial imaging can consistent
ly distinguish between medical and
surgical jaundice; in the presence of
higher concentrations the degree of
liver uptake of the radioactive phar
maceutical diminishes rapidly and the
results are of only qualified value. The
introduction of 99mTc-pb-IDA with its
higher degree of liver concentration
and lesser renal excretion than 99raTcdm-IDA has improved the ability to
differentiate between medical and sur
gical jaundice at more elevated values
of serum bilirubin (Fig. 5). Clinical
trials with this radioactive pharma
ceutical are still under way and the
precise limitations have not been fully
defined.

Fig. 5b
FIG. 5— Comparison between images
obtained using 99l“Tc-dm-IDA and 99mTcpb-IDA in patient with complete obstruc
tion of common bile duct secondary to
carcinoma of colon. Serum bilirubin value
was 205 |em ol/L (12 mg/dL). (a) Frontal
and lateral 99mTc-dm-IDA images at 1.5
and 24 hours, respectively. There is ex
ceedingly low liver concentration at 1.5
hours and complete absence at 24 hours.
Most is excreted through kidneys. Of in
cidental note is obstruction of right kidney
at ureteropelvic junction (arrow), (b)
Frontal 99mTc-pb-IDA images at 15 and
75 minutes and at 5 and 24 hours. Much
greater concentration is registered in liver
at 15 minutes with less renal excretion
than of " ”Tc-dm-IDA at 1.5 hours. At
24 hours liver is well demonstrated and
there is no appreciable gut entry; only
kidneys are visualized (arrows). This is
consistent with complete obstruction.
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FIG. 6— Serial frontal and lateral
" Tc-dm-IDA images in patient with hepatojejunostomy and bilirubinemia o f 34.2
y.mol/1, (2 m g/dL ). Good concentration is
registered at 15 minutes and gut entry can
be appreciated by 1 hour. There is no
evidence of dilated biliary tree, which ex
cludes obstruction as cause o f jaundice.
Single arrow = normal transient renal ex
cretion, double arrow=free end of jejunum.
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Ultrasonography generally plays a
primary role in evaluating the status
of the biliary tract. However, in a
small proportion of cases ultrasono
graphy does not clearly define the sta
tus of the biliary tract and the disclo
sure of dilatation by itself does not
necessarily imply obstruction, particu

larly if there has been previous surgical
intervention.
Radionuclide
imaging
helps by providing morphologic and
dynamic information in these cases.

Determination of Surgically
Altered Anatomy
The integrity of such operative pro
cedures as
choledochojejunostomy,
cholecystojejunostomy and hepatojejunostomy (Fig. 6) can be assessed in
the presence of moderate jaundice. In
let and outlet obstructions of gastro
enterostomies can be disclosed (Fig. 7)
and intra-abdominal bile spills are
easily detected (Fig. 8). Hepatobiliary
imaging in the presence of these con
ditions offers a unique and noninvasive
method of investigating the altered and
disordered anatomy proximal to the
gastroenterostomy.
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Tantalum Angiography in the Study of Rejection
of Pulmonary Transplants
M. Goldberg,

md , frcs [c], A. G reenaway, b sc, M.I. S teinhardt , md , frcp [c ],
S.C. L uk, md, frcp [c] and B. Pollock, b sc

The results obtained in dogs after
the use of pulmonary allografts from
donors pretreated with cyclophospha
mide were compared with those
obtained after the use of unmodified
and immunosuppressed grafts.
Tantalum angiography demonstrates
the pulmonary vasculature in detail to
precapillary levels. In normal lungs
a uniform narrowing of vessels occurs
ending in a fine precapillary rete.
In rejected lungs the finer peripheral
vessels are occluded by thrombi.
Parenchymal spaces between medium
sized vessels are enlarged owing to
expansion by hemorrhage, congestion
and mononuclear cell infiltration.
After pretreatment of the donor, the
angiogram shows a normal appearance
in the transplant up to 84 days after
transplantation. The microvasculature
demonstrates no vasoconstriction,
thrombus formation or irregularities in
vessel diameter.
Electron microscopy demonstrates
persisting vessel integrity until late
rejection when total disruption
associated with thrombosis occurs.
Immunosuppression markedly inhibits
the early rejection response and donor
pretreatment almost totally prevents
it. Tissue disruption and thrombosis
occur only at the stage of late
rejection and terminal necrosis.
Les resultats obtenus chez le chien
avec ('utilisation d’allogreffes pulmonaires provenant de donneurs trades
a la cyclophosphamide ont ete compares
avec ceux obtenus avec des greffes
nonmodifiees et traitees aux immunosuppresseurs.
L'angiographie au tantale demontre
en detail le systeme vasculaire jusqu’au
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niveau des precapillaires. Dans le
poumon normal, un retrecissement
uniforme des vaisseaux survient, se
terminant en un fin reseau de
precapillaires. Lorsqu'il y a reaction de
rejet, les vaisseaux peripheriques les
plus fins sont obstrues par des thrombi.
Les espaces parenchymateux entre les
vaisseaux de moyen calibre sont elargis
a cause de I'expansion provoquee par
I'hemorragie, la congestion et I’infiltration de cellules mononuclees. Apres
traitement du donneur, i'angiogramme
montre l’apparence normale du greffon
jusqu'a 84 jours apres la greffe. Les
vaisseaux microscopiques ne presentent
aucune vasoconstriction, formation de
thrombi ou irregularite du diametre
des vaisseaux.
L’examen au microscope electronique
demontre la persistance de I’integrite
vasculaire jusqu’au rejet retarde quand
une separation des tissus accompagnee
de thrombose survient. L'immunosuppression inhibe fortement la reponse
de rejet immediate et le traitement
du donneur la previent presque totalement. Le detachement des tissus et la
thrombose ne surviennent qu’au stade
du rejet retarde et de la necrose
terminate.

At present the outstanding problem in
any transplantation program is ade
quate abrogation of the induced rejec
tion response of the allograft. Prolonged
survival is dependent upon inherent
histocompatibility, attenuation of re
jection by selective immunosuppres
sion, and anticipation and treatment of
any postoperative complications related
to technique. Guttman1-3 prolonged
functional survival in animal and hu
man renal allografts by pretreatment
of the cadaver donor kidney with cy
clophosphamide and methylprednisolone. Cytotoxic drugs decrease the
immunogenicity of the graft by inactiv
ating the donor’s nonparenchymal pas
senger leukocytes. No agent or com
bination of agents has consistently in
hibited the rejection response, but
donor pretreatment has prolonged his
tologic integrity and functional sur
vival as assessed by ventilation and
perfusion scanning studies in canine
pulmonary allografts.4

Tantalum angiography has been used
specifically in experimental hyperacute
rejection of renal xenografts.5 This new
radiologic procedure, which uses intra
arterial injections of tantalum particles,
was compared with the standard re
placement method of microphil injec
tion. Tantalum angiograms vividly il
lustrated the subtle changes of de
creased glomerular perfusion. The
radiologic demonstration of decreased
numbers of visualized glomeruli corre
lated with the physiologic, coagulation
and pathologic studies and indicated
localized obstruction of the microcir
culation of the glomerulus by intra
vascular coagulation. The microphil
injections into hyperacutely rejected
kidneys were inferior in demonstrating
these changes because of their com
plete filling of the postglomerular vas
cular bed, including the renal veins.
With the technique of tantalum angio
graphy the progressive destruction of
the glomerular microcirculation demon
strated that this avascular bed was the
prime target in the experimental model
of hyperacute renal xenograft rejec
tion. Arterial spasm was suggested by
the segmental narrowing of the arteries
early in the process of rejection, a fea
ture that could not be demonstrated by
microphil injections.
We attempted to correlate, in detail
previously undescribed, the histologic
features of abrogation with angio
graphic changes in the central and
peripheral vascular bed of a pulmonary
allograft using the new method of
tantalum angiography.
Material and M ethods

Left lung transplantation was per
formed in 41 dogs; 14 dogs underwent
left autotransplantation and 27 under
went left allotransplantation (7 without
immunosuppression, 10 with postoper
ative recipient immunosuppression and
10 following donor pretreatment and
with postoperative recipient immuno
suppression). Immunosuppression was
induced by postoperative administra
tion of methylprednisolone (2 mg/kg
body weight) and azathioprine (1.5
mg/kg). Pretreated donors received a
continuous infusion of cyclophospha-
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mide (0.75 g) and methylprednisolone
(2.0 g) for at least 6 hours prior to
transplantation.
Lung biopsy specimens were obtained
either in vivo or after the animal’s
death. Whole lung specimens were in
flated with 10% buffered formalin by
way of the bronchus at pressures rang
ing from 20 to 30 cm HaO. After 24
hours’ fixation tissues were dehydrated
in graded alcohols, then embedded in
paraffin and sectioned for micro
scopic study. Sections were stained
with hematoxylin and eosin. When cir
cumstances warranted, special staining
procedures were also employed includ
ing trichrome, reticulin, periodic acidSchiff and Gram’s staining.
Electron microscopy was performed
when light microscopy demonstrated
an entity that warranted further in
vestigation. For fixation by immersion,
the lung tissue was cut into 1-mm
blocks and immersed in cold phos
phate-buffered 1% osmium tetroxide
for 1 hour. After dehydration in graded
alcohols and propylene oxide accord
ing to the method of Luft,6 the tissue
blocks were embedded in a mixture of
epon-araldite.7 Sections were cut with
glass knives on an ultramicrotome
(LKB Instruments, Rockville, MD);
1-/A sections were stained with toluidine blue. Thin sections for electron
microscopy were stained with uranyl
acetate and examined and photographed
in the Philips electron microscope
(model EM-301, Philips Electronic,
Mahwah, NJ).
Tantalum pulmonary angiography
was used to define minute changes in
the microvasculature not previously
identified by other angiographic tech
niques. The technique was applied to
both normal and transplanted canine
lungs. Fifteen grams of tantalum
(size, 1 jx) was suspended in 30 mL of
0.9% saline. An effective method of
obtaining a uniform suspension was
aggressive manual agitation just prior
to injection. The animal was killed,
the lung removed and inflated and the
bronchus clamped. Experience demon
strated that no matter how quickly the
hilar structures were clamped after
infusion of the pulmonary artery, tan
talum was able to enter into either an
alveolar or venous phase, thus destroy
ing arterial definition. Therefore to
ensure preferential back-up of tantalum
in the arterial side of the lung the pul
monary veins were ligated before in
jection. The pulmonary artery was
cannulated and the suspension slowly
infused until greying became notice
able over portions of the lung surface,
at which time the infusion was ter
minated and the pulmonary artery
ligated. A water manometer was at
tached to a T limb of the infusion cir
cuit to quantify injection pressures and
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to ensure that pulmonary artery pres
sures of 20 mm Hg were not ex
ceeded.
Two high resolution industrial films
(Cronex NDT, E.I. DuPont De Ne
mours Inc., Wilmington, DE), speeds
65 and 45, offering complementing
degrees of resolution and penetration
were used. Lung tissue was placed in
direct contact with the film and ex
posed in a “Faxitron” unit. An ex
posure of 30 kV for 1.5 minutes for
the canine lung tissue was adequate.
Films were then developed in the
automatic processor for 7 minutes at
31.7°C.
Results of Histologic Studies

A utotrcinsplaritation
Three hours after operation a “re
implantation response” was identifiable.
Focal areas of interstitial and alveolar
edema and a moderate degree of con
gestion were present. There was neither
a granulocytic nor a lymphocytic re
sponse and the bronchial wall distal to
the anastomosis was intact with no
ischemic change. Presumably the re
implantation response is due to oper
ative trauma, lung ischemia (increased
pulmonary capillary permeability and
pulmonary edema), or to a denervationresistance response attributed to out
flow obstruction of the small veins.810
At 21 days mild peribronchial edema
was present and fibrin deposition was
found both in alveoli and in bronchial
lumina. In both sites the fibrin was ac
companied by minimal infiltration by

nonspecific inflammatory cells. At 35
days only patchy focal areas of edema
in alveoli were present along with com
pensatory emphysema. There was no
perivascular or peribronchial lympho
cytic aggregation.
Electron microscopy beyond 30 days
demonstrated only a very few focal
areas of interstitial edema and con
gestion. Alveolar type I and type II
pneumocytes and endothelial cells with
adjacent basement membrane were all
normal. The remaining portions of
lung showed no abnormality.
Allotransplantation
Four days after unmodified allo
transplantation, light microscopy show
ed both perivascular and peribronchial
infiltration with mononuclear cells,
presumably T-lymphocytes (Fig. 1). At
times the lymphocytic infiltrate was
predominantly peribronchial with ede
ma in the perivascular space. Occa
sionally lymphocytic infiltrates were
also seen in the alveoli, the bronchi
and the interstitium. Submucosal edema,
congestion and mild infiltration by
mononuclear cells were found at the
bronchial anastomosis, but no evidence
of impaired viability or ischemic
change was demonstrated.
At 7 days the perivascular lympho
cytic infiltrate became more intense,
as did the hemorrhage into the alveoli,
bronchi and interstitium. A fibrinous
exudate into the alveoli was seen in
itially and became more pronounced
with time. There was no desquamation

FIG. 1—Photomicrograph of canine lung 4 days after allotransplantation without
immunosuppression. Bronchus (B) is cuffed by infiltrates of mononuclear cells (open
black arrow) which extend through bronchial wall into submucosa. Medium-sized artery
(A) is surrounded by edema (black arrow) and little cellular infiltrate. Mild congestion
and edema are present in alveolar septa (S) (hematoxylin and eosin, reduced by 27%
from X20).
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of any of the alveolar lining cells, nor
was there evidence of arteritis or vas
culitis. Thrombosis of vessels was a
terminal event associated with necro
sis and total disruption of lung archi
tecture. In early rejection the leukocyte
response was predominantly lympho
cytic but during the necrotic stage at
7 to 9 days cellular infiltrates were
mainly polymorphonuclear.
Electron microscopy at 4 days re
vealed lymphocytes containing active
cytoplasmic organelle systems. No ab
normalities were found in either the
endothelial cells or the adjacent base
ment membrane. Small lymphocytes
were present in the interstitial and in
travascular compartments. Occasional
ly there was focal disruption of the
endothelial basement membrane which
allowed perivascular migration of lym
phocytes with subsequent interstitial
infiltration. Lymphoblastic transforma
tion of T-lymphocytes was readily
identified in capillaries adjacent to
endothelial basement membranes. In
all instances type I and type II pneu-

mocytes remained intact; there was no
baring of the basement membranes
and no generalized disruption of the
endothelium (Fig. 2). Seven days after
operation there were more extensive
areas of intra-alveolar and interstitial
hemorrhage, severe congestion and
edema. At this stage there was dis
ruption of basement membranes and
lung architecture (hemorrhagic necro
sis). The mononuclear cell infiltration
became less conspicuous and was re
placed by an infiltrate of polymorpho
nuclear cells and macrophages that
were actively consuming debris and
erythrocytes.
In cases of allotransplantation with
postoperative immunosuppression light
microscopy suggested the entire spec
trum of acute rejection described above
but the period over which these changes
occurred was greatly prolonged. The
degree of response, as estimated by the
absolute number or volume of lym
phocytes, was depressed at any ar
bitrary time postoperatively when com
pared with the unabrogated response.

End-stage infections and sudden ter
minal venous thrombosis were com
monly seen in the immunosuppressed
animals. The rejection response identi
fied by electron microscopy was simi
lar to the unabrogated response but
the period over which these changes
occurred was prolonged. When acute
rejection was present the alveolar type
I and type II pneumocytes, endothelial
cells and basement membranes were all
intact. It was only in the end stage of
necrosis that changes in these and all
other structures were present.
In allotransplantation with postoper
ative immunosuppression and donor
pretreatment light and electron micro
scopy demonstrated an even greater
abrogation of the rejection response
than in the other two groups. Appear
ances in light and electron photomicro
graphs were entirely within normal
limits in most long-term survivors.
The findings of light and electron mi
croscopy identify neither the lung’s
antigenic stimulus, which elicits the cel
lular response, nor the target organ or
organelle to which the T-lymphocytes
react.
Results of Angiographic Studies

A normal angiographic pattern was

FIG. 2—Electron micrograph of lung 80 days after allotransplantation and post
operative immunosuppression. Capillary (C) contains single erythrocyte (R) and is
lined by normal endothelial cells (white arrow) interconnected by normal electrondense junctions. Adjacent basement membrane (black arrow) and type I pneumocytes
(open black arrow) lining alveoli (AA) are intact. Representative infiltrative T-lymphocyte (LL) is positioned in mildly edematous interstitial compartment. Architectural
integrity is present (reduced by 23% from X4500).
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FIG. 3—Tantalum angiogram of canine
lung 68 days after allotransplantation and
postoperative immunosuppression with pretreatment of donor. Normal asymmetrical
dichotomous arterial branching pattern is
illustrated to sixth generation (precapil
lary) levels with total patency and normal,
uniform tapering. N o attenuation of or en
croachment upon peripheral precapillary
branches and no intraluminal filling de
fects are present.
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identified in autografts and allografts following the destruction of nonparenwith abrogated rejection responses. An chymal cells of hemopoietic origin
asymmetrical
dichotomous
arterial (mobile passenger leukocytes), which
branching pattern was visualized to the are the stimulus of allograft immunity
sixth generation, with total patency and possibly the targets for certain ef
and normal uniform tapering and fector mechanisms.
branching patterns. No distortion of or
The pathogenesis of allograft rejec
encroachment on peripheral precapil tion of the canine lung remains con
lary branches and no intraluminal fill troversial and our results differ some
ing defects were present (Fig. 3).
what from those generally described.
With
rejection the vasculature Three phases of rejection have been
showed a loss of normal tapering of described: alveolar, vascular and ne
various arterial and arteriolar branches crotic. The alveolar phase, occurring
coupled with multiple filling defects 2 to 3 days postoperatively, is charac
representing thrombus formation. The terized by a fibrinous exudate into al
absolute number of branches also veoli, with swelling of type I pneumodiminished and there was visualization cytes followed promptly by their dis
only to the fourth generation, produc solution. The vascular or cellular phase,
ing the typical appearance of a occurring 2 to 5 days postoperatively,
“pruned tree”. These changes may be is characterized by segmental peripheral
asymmetrical since various portions of arteriolar narrowing due to perivascular
the allograft may be rejected at dif cuffing by mononuclear cells, endo
ferent rates, thus producing a range thelial swelling and intimal hyperpla
of histologic and angiographic changes sia. Platelet thrombi occur late in this
in any one allograft (Figs. 4 and 5).
phase, well after vascular obstruction
When rejection was at its end stage, is visualized angiographically. The final
multiple filling defects representing necrotic phase is a consummation of
thrombus formation occurred in all the the first two phases, with further archi
visualized branches. There was filling tectural disruption and supervening in
to second generation arteries produc fection.2*-22
ing a complete pruned tree appearance.
Our findings suggest that architec
These branches showed irregular and tural integrity of the lung persists until
ragged intimal surfaces and loss of
normal tapering. The lung parenchyma
demonstrated total consolidation with
parenchymal infiltration encroaching
on the smaller arteries and arterioles
which, together with the intraluminal
thrombus formation, prevented distal
filling of the pulmonary vascular tree
(Fig. 6).

terminal necrosis occurs irrespective of
the presence or absence of infection.
No histologic changes have been seen
on light or electron microscopy in type
I and type II pneumocytes, in endo
thelium, or in basement membranes un
til the final necrotic event produces
rapid and total parenchymal dissolu
tion. Acute and chronic rejection dif
fer only in the quantity of T-lympho-

FIG. 5— Magnification of angiogram
o f Fig. 4 in area of rejection. Thrombi
are present (white arrows) in both major
and minor arteries. Loss of regular taper
ing (open white arrow) occurs and precapillary vasculature is compromised cre
ating pruned tree appearance.

Discussion
Most methods of graft immunosup
pression inhibit the sensitization phases
of the afferent arc, or the effector
phases of the efferent arc, of the im
mune response. Results depend upon
depression or inactivation of sensitized
lymphocytes and plasma cells. The
exact mechanisms by which immuno
suppressive therapy acts upon both the
cellular and humoral phases of im
munity have not yet been determined.
In canine pulmonary allotransplant
ation, immunosuppression has been
effected by methotrexate alone,11'12
methotrexate in combination with
other agents,13,14 azathioprine alone1518
and azathioprine and methylprednisolone.14'19’20 Cyclophosphamide and actinomycin C can also markedly alter the
immune response. Pretreatment of the
donor with cyclophosphamide and
methylprednisolone has prolonged his
tologic integrity and functional survival
in canine pulmonary allografts when
compared with other immunosuppres
sive regimens.4 This effect is caused
by a reduction in graft immunogenicity
304

FIG. 4—Tantalum angiogram of lung 7
days after allotransplantation and post
operative immunosuppression in pre
treated donor. Vasculature of upper
half of the lung (black arrow) is normal.
Arteries of lower half (open white arrow)
show loss of uniform tapering, and several
filling
defects
representing thrombus
formation are present intraluminally. Ab
solute number o f branches is diminished
and filling occurs to fourth generation
branches (“pruned tree” appearance).
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FIG. 6— Tantalum angiogram of lung 9
days after allotransplantation without im
munosuppression. At final stage of rejec
tion, many filling defects representing
thrombus formation are present in all
visualized branches. Filling to only sec
ond generation branches produces comulete pruned tree appearance. Arteries
have irregular and ragged intimal surfaces
and abnormal tapering. Lung parenchyma
shows consolidation (CN) with paren
chymal infiltration encroaching upon
smaller arteries and arterioles which, to
gether with thrombus, prevents distal
perfusion.

THE CANADIAN JOURNAL OF SURGERY

cytes present in a unit of lung volume.
Tantalum, a radiopaque transitional
metal that is physiologically inert,
can be injected intravenously into labo
ratory animals and selectively depos
ited on injured vascular endothelium.23
Particles of tantalum show virtually no
tendency to attach to normal or grow
ing vessels or to leak from capillaries
or from small venules. Following in
jury, however, tantalum adheres to the
endothelial wall or to formed elements
and appears to be transported by cir
culating phagocytic cells. Tantalum
particles are easily visible in capillary
beds in vivo and in histologic sections
prepared for light or electron micro
scopy. Intravenously injected tantalum
particles are useful in identifying a
variety of vascular abnormalities in
large vessels and in the peripheral mi
crocirculation.
Conventional pulmonary angiography
using radiopaque fluids has been
performed at varying stages after lung
transplantation in order to demon
strate any abnormalities that may sug
gest the pathogenesis of rejection. Two
days after transplantation the angio
gram demonstrated a normal pattern,
that is, a venous appearance time of
less than 2 seconds, an arterial phase of
less than 3 seconds and a normal vas
cular pattern. A fter 6 days the pul
monary transit times increased during
the arterial phase (3 to 5 seconds) and
there was a delayed venous filling
time. The vascular pattern became ab
normal as evidenced by terminal arte
riolar non-filling after more than 1
minute. During chronic rejection there
occurred a retrograde progressive
obliteration of the pulmonary tree.20,24’26
Conventional angiography is useful
only in detecting the cause of impaired
perfusion in a transplanted lung but in
no way casts light on the more detailed
and intricate pathogenesis of the de
crease in perfusion.
Correlated histologic and angiogra
phic data in our study suggest several
novel concepts. Rejection may progress
at different rates in various portions of
the allograft and at any one time a
range of events can be identified.
Electron microscopy has been valuable
in showing that previously suggested
target organs (endothelium, basement
membrane, pneumocytes) remain intact
during rejection which is only identi
fied by a progressive increase in the
volume and number of infiltrative
lymphocytes. As infiltrates increase,
the interstitium becomes expanded and
encroaches upon arteries producing
progressive obliteration of the peri
pheral microcirculation. T-lymphocytes
produce thrombokinins and perhaps
when they reach a certain titre (de
pendent upon total numbers) acute
thrombosis occurs. A t this end stage
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necrosis and disruption of parenchy
mal architecture results from sudden
thrombosis in all arteries.
We thank Mrs. Cathy Bennett
typing the manuscript.

for

16.
17.

References

1. G uttman RD, Beaudoin JG, M ore
house DD: Reduction of immunogenicity of human cadaver renal allo
grafts by donor pretreatment. Trans
plant Proc 5: 663, 1973
2. G uttman RD, L indquist RR, O ck-

18.

19.

SA: Renal transplantation in the
inbred rat. IX. Hematopoietic origin
of an immunogeneic stimulus of re
jection. Transplantation 8: 472, 1969
ner

3. G uttman RD, L indquist RR: Renal

20.

transplantation in the inbred rat. XL
Reduction of allograft immunogenicity by cytotoxic drug pretreatment
of donors. Ibid, p 490
4. G oldberg M, L uk SC, G reyson
ND, et al: Canine lung allotrans
plantation: donor pretreatment. Ann
Thorac Surg 24: 462, 1977
5. N agy EJ, K olin A, D avidson JW,
et al: Tantalum angiography in ex
perimental hyperacute renal xenograft
rejection: a physiological and ra
diological study. Invest Radiol 9:
356, 1974
6. L uft JH: Improvements in epoxy
resin embedding methods. J Biophys
Biochem Cytol 9: 409, 1961
7. G ivan KF, T urnbull C, J ezequel
AM: Pepsin digestion of virus parti
cles in canine hepatitis using Eponembedded material. J Histochem Cytochem 15: 688, 1967
8. D uvoisin GE, F owler WS, E llis
FH JR, et al: Causes of depressed
pulmonary function following reim
plantation of canine lung. Chest 58:
102, 1970
9. H utchin P, F eezor MD, W alker
EL, et al: Ventilation and perfusion
after transplantation of the lung.
Studies with intravenous xenon-133.
J Thorac Cardiovasc Surg 61: 476,
1971
10. Siegelman SS, Sinha SBP, V eith FJ:
Pulmonary reimplantation response.
Ann Surg 111: 30, 1973
11. Blumenstock DA, Collins JA,
T homas ED, et al: Homotransplantation of the lung in dogs treated with
methotrexate. Surg Forum 12: 121,
1961
12. M acP hee IW, W right ES: Experi
mental lung transplantation. Lancet 1:
192, 1964
13. Blumenstock DA, G rosjean OV,
O tte HP, et al: Experimental allo

transplantation of the lung. J Thorac
Cardiovasc Surg 54: 807, 1967
14. Suzuki C, N akada T, Watanabe A,
et al: Experimental studies of canine
lung allotransplantation. The effect of
cytotoxic agents and donor spleen
cells for immunosuppressive treat
ment. J Thorac Cardiovasc Surg 55:
200, 1968
15. Barnes BA, F lax MH: Experimental
pulmonary homografts in the dog.

21.
22.

23.

24.

25.
26.

II. Modification of the homograft
response by BW 57-322. Transplanta
tion 2: 343, 1964
E llis EE, R ichards V: The fate of
homogenous lung transplants in dogs.
Surgery 36: 1109, 1954
N ettlesblad SC, Soroff HS, Sachs
BF, et al: Experimental studies of
the response of homotransplantation
of pulmonary tissue. Ann N Y Acad
Sci 120: 689, 1964
R ichards V, A swaq M, P into D:
Prolongation of canine lung homo
transplant with Imuran. Am J Surg
110: 218, 1965
K ahn DR, A bell MR, V ontz FK,
et al: Rejection response in canine
lung homotransplantation: effects of
azathioprine and steroids. Ann Thorac
Surg 1: 650, 1965
V eith FJ, Sinha SBP, Blumcke S,
et al: Nature and evolution of lung
allograft rejection with and without
immunosuppression. J Thorac Cardio
vasc Surg 63: 509, 1972
Becker NH, Sinha SBP, H agstrom
JWC, et al: Fine structure alterations
in canine lung transplants. Ibid, p 81
Siegelman SS, H agstrom JW, V eith
F J: Roentgenologic—pathologic evalu
ation of rejection in allografted lungs.
Am J Roentgenol 112: 546, 1971
G rant L, M artelli AB, D umont
AE: Selective deposition of tantalum
particles on injured vascular endo
thelium. Microvasc Res 1: 376, 1974
D ougherty JC, V eith F J : Mechan
ism of lung allograft rejection in un
treated dogs. Curr Top Surg Res 3:
301, 1971
Siegelman SS, V eith F J : Angio
graphy of the transplanted lung. Am
J Roentgenol 120: 795, 1974
W alker EL, G abriele O, H utchin
P: Pulmonary angiography—sequential
changes during acute rejection of
canine lung allografts. J Surg Res 10:
405, 1970

BOOKS RECEIVED
Advances in Obstetrics and Gynecology.

Ronald M. Caplan and William J.
Sweeney 3rd. 710 pp. Illust. The Wil
liams & Wilkins Company, Baltimore;
Burns and MacEachern Limited, Don
Mills, 1978. $59.50. ISBN 0-683-014358.

Atlas of Surgery in the First Six Months
of Life. S. Frank Redo. 188 pp. Illust.

Harper & Row, Publishers, Inc., Hagers
town, 1978. $27.50. ISBN 0-06-1422398.

Chemotherapy of Solid Tumors. Proceed

ings of the 19th Clinical Conference.
Edited by John O. Godden. 124 pp.
Illust. The Ontario Cancer Treatment
and Research Foundation, Toronto,
1977. Price not stated, paperbound. ISSN
0315-9884.
Clinical Application of Intra-Aortic Bal
loon Pump. Edited by Hooshang Bo-

looki. 500 pp. Illust. Futura Publishing
Company, Inc., Mount Kisco, 1977.
$34.50. ISBN 0-87993-10403.
continued on page 315

THE CANADIAN JOURNAL OF SURGERY

305

Recurrent Duodenal Ulcer
D a n ie l T asse , m d , f r c s [c ], L o u ise C h o in ie r e , m d ,
S t e p h e n M o r g a n , m d , f r c s [ c ] and D e n is B e r n a r d , m d , f r c s [ c ]

In the past 6 years 26 patients
underwent operation for recurrent
duodenal ulcer after what was
considered to be an “adequate" initial
operation. In such patients it is
necessary first to demonstrate the
recurrent ulcer and then to determine
its cause. Endoscopy was the best
means of confirming the diagnosis. The
cause of recurrence was determined
by tests for gastric acid secretion;
70% of patients had hyperacidity and
80% had positive results of the
Hollander test. Treatment is always
surgical but varies depending on the
type of initial surgery, the primary
cause of recurrence and the condition
of the patient. Ten patients underwent
vagotomy, 12 had vagotomy with
antrectomy and 4 had antrectomy alone.
There were no operative deaths but
nine (35%) patients experienced 11
significant postoperative complications.
Vingt-six malades ont ete reoperes
au cours des 6 dernieres annees pour
recidive d’ulcere duodenal. Chez ces
malades il faut d’abord faire la preuve
de la recidive et en etablir la cause.
L’endoscopie est le meilleur moyen
diagnostic. Par la suite la recherche
de la cause se fait a I'aide des tests
de stimulation gastrique; 70% ont
demontre une hyperacidite et 80% un
Hollander positif. Le traitement a
toujours ete chirurgical mais varia
selon le type de chirurgie initiate, la
cause premiere de recidive et I'etat
du patient. Dix malades ont subi une
vagotomie seule dont 6 par voie
thoracique, 12 une vagotomie avec
antrectomie et 4 une antrectomie.
Aucune mortality operatoire n’est
rapportee mais neuf (35%) malades
ont eprouve 11 complications postoperatoires significatives.
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Recurrent ulceration following “ade
quate” surgical treatment of duodenal
ulcer still represents a major challenge
for the surgeon. Not only does he have
to determine the cause of the recur
rence, but he must also treat each pa
tient by the means least likely to lead
to further recurrence and associated
with the least morbidity and mortality.
We report our experience in the man
agement of the condition accumulated
over a period of 6 years.
Patients and Methods

Between Apr. 1, 1971 and Mar. 31,
1977, we treated 26 consecutive pa
tients with demonstrated recurrent ulcer
following what is generally considered
“adequate” surgical treatment of duo
denal ulcer (Table I). In this retro
spective study we excluded patients
Table I—Distribution of Recurrences
According to the Type of Primary Operation

Primary operation

No. of
patients
(and % )

Truncal vagotomy and
pyloroplasty
13 (50.0)
Truncal vagotomy and
gastroduodenostomy
1 (3.8)
Truncal vagotomy and
gastrojejunostomy
1 (3.8)
Selective vagotomy and
pyloroplasty
6 (23.1)
Truncal vagotomy and antrectomy
(Billroth 1)
1 (3.8)
Partial gastrectomy (Billroth II) 4 (15.4)
Total

26 (100.0)

Table II—Time Interval between Operations
in Patients with Recurrent Ulcer

Interval, yr

No. of
patients
(and % )

< 1
1
2
3
4
5
> 5

4
5
4
3
1
2
7

Total
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who underwent simple suture and epiplooplasty for perforation or gastro
enterostomy without vagotomy, patients
with stomal ulcers that developed after
a procedure not primarily directed to
an ulcer, such as a pancreaticoduo
denectomy, and patients with recurrent
ulcer after surgery for a primary gas
tric ulcer.
Our series comprised 22 men and 4
women with an average age of 44
years (range, 23 to 69 years). Almost
two thirds belonged to type O blood
group which is similar to the usual
frequency of that blood group in pa
tients with duodenal ulcer. The dura
tion of the symptoms varied widely
from 2 months to 14 years. Symptoms
tended to reappear early following the
primary operation; more than two
thirds of the patients became symp
tomatic within 2 years. Patients gen
erally sought medical advice without
delay when their symptoms recurred.
Seventy percent underwent repeat op
erations less than 1 year after recur
rence of symptoms and altogether
61.5% of the patients underwent a
second operation within 3 years of the
first one (Table II). In only 6 of the
26 patients was the initial operation
performed as an emergency procedure,
in 2 for hemorrhage and in 4 for per
foration. The site of the recurrence
varied widely according to the type of
initial surgery (Table III). Pain was
Table III—Distribution of Recurrences
According to Anatomical Site

Site

No. of
patients

Duodenal

8

Pyloric

4*

Prepyloric

7

(15.4)
(19.2)
(15.4)
(11.5)
(3.8)
(7.7)
(26.9)

Antral

2*

Stomal
Billroth 1
Billroth II
Gastrojejunostomy

1
4
1

26 (100.0)

*1 patient had 2 ulcers.

/

Total

27
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the most frequent complaint (88%),
followed by hemorrhage (42%), ob
structive symptoms (15%) and per
foration (3.8%). Recurrent ulceration
had a deleterious effect on nutri
tional status; 10 (38%) patients lost
from 2.25 to more than 9.07 kg.
We attempted first to demonstrate
the ulcer and then to determine its
cause. Roentgenography after a barium
meal revealed an ulcer in 76% of
the cases in which it was done. En
doscopy was diagnostic in 90% of
cases. While endoscopy showed a re
current ulcer in five patients whose
roentgenogram was normal, it could
not demonstrate an ulcer in one patient
whose roentgenogram had previously
been positive and also overlooked an
ulcer on the lesser curve which had
been seen on the roentgenogram and
was confirmed at operation. The
etiology of the recurrences was deter
mined by gastric acid secretion tests:
basal acid output (BAO) and maximal
acid output (MAO) after pentagastrin
stimulation, by the Hollander test and
by the serum gastrin concentrations.
For circumstantial reasons, all these
studies were not done in every patient.
The Hollander test showed that the
vagotomy performed in 20 patients
had been incomplete in 16. The
serum gastrin concentration was nor

Table V I— Postoperative Com plications in Relation to Type of Surgery*

Gastric acid output,
innol/s (m e q /h )

Pulm onary atelectasis and pancreatitis
Gastric atony and retention

Type of surgery

Pulm onary atelectasis

Gastric hemorrhage and dysphagia
Duodenal fistula

3
11

Subphrenic abscess

Maxim al acid output
< 5.6 (20.0)
> 5.6 (20.0)

5
8

Recurrent ulceration is the most
frequent complication that requires a
second operation following surgical
treatment of duodenal ulcer. The wide
variety of procedures still used to cure
duodenal ulcer indicates that no single
operation is without failure. In a ran
domized study, Postlethwait1 deter
mined the 5-year recurrence rate fol
lowing vagotomy and drainage (6.2%),
vagotomy and antrectomy (0.7%),
vagotomy and hemigastrectomy (0.9%)
and subtotal gastrectomy (3.7%) for
treatment of duodenal ulcer. These re
sults are comparable to those reported
by Goligher and colleagues.2 The newer
procedure of highly selective vagotomy
also has a recurrence rate of 6% to
7% as the duration of follow-up in
creases.3'8
In our retrospective study, most of
the findings were comparable to those
recently reported.9'14 Recurrent ulcers
occurred more commonly in men in
a proportion of five to one. The latent
period was short (less than 2 years in
66%) and so was the symptomatic pe-

All patients with a recurrent ulcer
following adequate surgical treatment
underwent a second operation. The
type of surgery performed took into
consideration the following: (a) the
nature of the primary operation, (b)
the probable cause of recurrence, and
(c) the patient’s general condition. Ta
ble V lists the various secondary opera
tions performed in relation to the
primary procedures. Ten patients had
vagotomy alone, 12 had vagotomy and
antrectomy and 4 had antrectomy
alone. All vagotomies were of the
truncal variety; in 6 a thoracic ap
proach was used. We had no 30-day
operative mortality but morbidity was
high. Nine (35%) patients had 11 se
rious complications (Table VI); six pa

Complication

Basal acid output
< 0.8 (3.0)
> 0.8 (3.0)

Discussion

Treatment and Complications

Table IV — Distribution of Recurrences in
Relation to Gastric Acid Output (nm ol/s)
No. of
recurrences

tients had complications after antrec
tomy and three after thoracotomy.

mal in 12 of the 13 patients in whom
it was determined. One patient, after
a subtotal Billroth II gastrectomy, had
a baseline gastrin value of 442 ng/L,
leading us to suspect the presence of a
gastrinoma. No gastrinoma was found
and she was asymptomatic 18 months
following vagotomy. Results of gastric
secretion tests are shown in Table IV;
70% of patients had hypersecretion.

Antrectom y (B illro th II)
Repeat vagotomy, thoracic approach (2 p a tients)
Antrectom y (B illro th 1)
Repeat vagotomy and antrectom y
(B illro th 1) (2 patients)
Vagotomy, thoracic approach
Repeat vagotomy and antrectom y
(B illro th II )
Antrectom y (B illro th II)
(catheter duodenostomy)

*There w ere 11 complications in 9 patients.

Table V— Surgical Treatm ent in Relation to the P rim ary Procedure
Second operation

First operation, no. of patients

No. of patients

Procedure

10

ReV— thoracic approach
abdominal approach

TV + P

V— thoracic approach
abdominal approach
12

ReV - f A— B illroth 1
B illroth II
V + A— B illroth 1
B illroth II

4

A— B illroth 1
Billroth II

Total

TV + Jab

2
1

1
—

___

—
6
1

TV + GE

SV+ P

TV + A (B l)

PG ( B ll)

—

—

2
—

___

_

___

___

—

---

—

___

___

—

—

1
3

__

__

___

___

___

_

—

—

—

—

—

2
1

__

___

__

—

1

—

13

1

1

6

Total

—

5
2

—

1
2

1
2

__

___

—

—

7
4

___

1

1

0
1

___

_

—

—

2
2

1

4

26

ReV = repeat vagotomy, V = vagotomy, A = antrectom y, TV = truncal vagotomy, P = pyloroplasty, Jab = Jaboulay gastroduodenostomy, GE = gastroenterostom y, SV = selective vagotomy, Bl = B illro th 1, PG == partial gastrectomy, B ll = B illro th II.
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riod (less than 1 year in 70%). Further
more, 60% of the patients were re
operated on within 3 years of their
initial operation. Our patient popula
tion was relatively young (average age,
44 years) and 66% belonged to blood
group O. That the primary procedure
was done as an emergency does not
explain a recurrence, for 77% of our
patients had an elective primary opera
tion.
Endoscopy is the best way to dem
onstrate a recurrence. It should be
performed in any case in which recur
rence is suspected but not demon
strated by roentgenography. Interpreta
tion of the roentgenogram after a
barium meal is often misleading after
any operation for duodenal ulcer ex
cept parietal-cell vagotomy. Even when
the roentgenogram is positive, endo
scopy still provides useful information.
For instance, it is the only means of
demonstrating esophagitis or biliary
gastritis, and the finding of a con
comitant disease can change the sur
gical approach.
Most (80%) of the recurrent ulcers
occurred after vagotomy and a drain
age procedure. This is in accordance
with the findings of others.1,4 In
our series the main factor in producing
most of such recurrences was failure
to achieve a complete vagotomy14 as
shown by a positive Hollander test in
80% of the patients in which it was
done. Although a positive Hollander
test indicating incomplete vagotomy
does not mean that a duodenal ulcer
is sure to recur, we find it valuable in
determining the cause of a proven
recurrence. Four of our patients with
a negative Hollander test after vago
tomy and drainage were explored
through the abdomen for residual
vagal fibres. In one patient an intact
posterior vagal trunk was found. In all
four patients, antrectomy was per
formed. In the presence of a negative
Hollander test and high basal acid se
cretion, one should still suspect incom
plete vagotomy.
Serum gastrin was determined in
half of our patients. Fasting and 45minute postprandial concentrations
were not elevated enough to cause
suspicion of Zollinger-Ellison syndrome
or a G-cell hyperplasia in any patient.
When a high gastrin concentration is
found, investigation by secretin and
calcium perfusion tests is called for.
We have yet to discover our first gas
trinoma.
The selection of the proper proce
dure for the second operation is deter
mined by the nature of the first, the
suspected cause of recurrence and the
general condition of the patient. Other
factors can also modify surgical plan
ning, namely, several previous ab
dominal operations, obesity, advanced
308

age and concomitant abdominal dis
ease. Every patient in whom an incom
plete vagotomy is suspected should
have at least repeat vagotomy as part
of the treatment. For recurrence after
vagotomy and drainage when there is
a normal serum gastrin concentration,
transthoracic vagotomy is our proce
dure of choice when there is no ob
struction, hemorrhage, or perforation.15
It is most helpful in obese patients.
Should there be a further recurrence,
antrectomy could then be performed
and would not be as difficult as if it
were done as a tertiary abdominal
procedure. The abdominal approach is
mandatory for patients after vagotomy
and drainage when there is obstruction,
perforation or hemorrhage, marked hy
persecretion, a suspicion of G-cell hy
perplasia or concomitant abdominal
disease. In any of these circumstances
the procedure should be the most
definitive available, namely, repeat
vagotomy and antrectomy. This com
bination still offers the lowest known
rate of recurrence in most centres.
If the first operation was gastric re
section without vagotomy, then vago
tomy should be performed. If antral
exclusion and Zollinger-Ellison syn
drome are not suspected and there are
no complications of the ulcer, the
thoracic approach may be selected.
If recurrence follows vagotomy and
antrectomy, one should highly suspect
a gastrinoma or antral exclusion after
a Billroth II reconstruction. Examina
tion of a frozen section of a duodenal
biopsy specimen during the primary
operation assures prevention of the
latter. Even in the absence of hypergastrinemia, surgery should be per
formed using an abdominal approach
to explore the pancreas, liver, stomach
and duodenum. If such an exploration
discovers no abnormality repeat vago
tomy can then be performed.
We used antrectomy alone in the
patients with a negative Hollander test
and normal gastric acid secretion. In
these cases, we still dissected the eso
phageal hiatus to make sure that no
vagal fibres remained. Even though
antrectomy “protects” against incom
plete vagotomy,13 exploration of the
hiatus does not add to the morbidity,
and making sure that the vagotomy is
complete lessens the possibility of re
currence after vagotomy and antrec
tomy.
Most of our patients (21 of 26) were
reoperated on in the past 3 years. Our
follow-up is therefore short but in
cludes 24 of the 26 patients. As yet
there has been no known or suspected
recurrence. The 30-day operative mor
tality was zero.
Conclusion
If a given percentage of recurrence
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following operation for duodenal ulcer
is predictable, subsequent surgical
treatment should aim at preventing any
further recurrence while incurring the
least morbidity and mortality. Thor
ough investigation is necessary to make
an accurate diagnosis of recurrence
and to determine its cause as pre
cisely as possible. Attention should be
directed not only to the completeness
of the vagotomy but also to its efficacy.
Endocrine-secreting tumours should be
sought. The single common denomina
tor of all the recurrences is insufficient
primary treatment—gastric resection
without vagotomy, incomplete vago
tomy, overlooked endocrine-secreting
tumour, or too limited surgery (e.g.,
vagotomy and drainage) for virulent
duodenal ulcer disease.
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Immunologic Detection of Primary Carcinoma
of the Pancreas
K enneth T aguchi,

The prevalence of carcinoma of the
pancreas is increasing in North
America. Primary prevention of this
disorder is not yet possible and
secondary prevention is difficult
because most investigative procedures
are either highly invasive or not
universally available. The authors tested
the efficacy of a simple immunologic
assay, the leukocyte adherence
inhibition (LAI) assay, in the detection
of carcinoma of the pancreas. They
investigated 55 patients who were
divided into six groups— normal
(control) patients (16) and those with
carcinoma of the pancreas (9 patients),
pancreatitis (15), other intra-abdominal
carcinomas (9), obstructive jaundice (4)
and pancreatic pseudocysts (2). The
LAI assay proved highly effective in
selecting patients who, at surgery,
were shown to have carcinoma of
the pancreas, but was not as effective
in the other groups. This assay may
therefore prove valuable in the early
evaluation of patients with a suspected
pancreatic malignant condition.
La frequence des carcinomes du
pancreas est en augmentation en
Amerique du Nord. La prevention
primaire de cette affection n'est pas
encore possible et la prevention
secondaire est difficile car la piupart
des techniques exploratrices sont ou
tres envahissantes, ou pas generalement
disponibles. Les auteurs ont teste
I'efficacite d'un essai immunologique
simple, le test d'inhibition de I'adherence
des leucocytes (IAL), pour la detection
du carcinome du pancreas. Ils ont
examine 55 patients se repartissant en
six groupes: les patients normaux
(groupe temoin) (16) et ceux souffrant
d'un carcinome du pancreas (9), de
pancreatite (15), d'autres carcinomes
intra-abdominaux (9), d’ictere par
retention (4) et de pseudokystes
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pancreatiques (2). L'epreuve d'lAL s’est
averee tres efficace pour selectionner
les patients qui, a la chirurgie, ont
presente un carcinome du pancreas,
mais elle ne s’est pas montree aussi
efficace pour les autres groupes. Cette
epreuve peut done etre utile a
revaluation precoce des patients chez
qui Ton soupconne une atteinte maligne
du pancreas.

The prevalence of carcinoma of the
pancreas is reported to be increasing
in North America.1,2 This entity is now
reported to be the fourth most common
cause of death due to cancer, being
exceeded only by carcinoma of the
lung, colon and rectum, and breast.3
Most patients who suffer from carci
noma of the pancreas die within 6
months of the diagnosis having been
made. The mortality, therefore, very
closely parallels the incidence.
Improved methods for early diag
nosis of this fatal condition are clearly
required. Many of the newer tests such
as selective angiography, endoscopic
retrograde pancreatography and com
puterized tomography are either in
vasive, technically difficult or not uni
versally available. Such tests are not
indicated in the evaluation of patients
with minimal symptoms.
In 1972 Halliday and Miller4 de
scribed a simple technique for the invitro determination of cell-mediated
immunity to tumours. They demon
strated that the normal adherence of
immune leukocytes on a glass surface
could be inhibited by the presence of
the specific antigen. This means of in
vestigation was called the leukocyte
adherence inhibition (LAI) assay.
Numerous modifications have been de
scribed.5'8 In our laboratory, we have
adopted the tube LAI assay as de
scribed by Grosser and Thomson.5 The
present communication reports pre
liminary data on the diagnosis of car
cinoma of the pancreas using this assay.
Patients and Methods

Patients were referred for study if
they were suspected of having carci
noma of the pancreas on the basis of
weight loss, epigastric pain, jaundice,
or an abnormality evident in contrast
studies of the stomach and duodenum.
Patients with other pancreatic disorders

were also assessed, as were a number
of normal individuals and a few pa
tients with obstructive jaundice due to
lithiasis.
Patients were subsequently subdi
vided into six main groups:
• Patients with carcinoma of the
pancreas confirmed at operation.
• Patients with clearly demon
strated acute or chronic pancreatitis.
• Patients with other malignant tu
mours of the gastrointestinal tract.
• Patients with obstructive jaundice
due to stones, confirmed at operation.
• Patients with pancreatic pseudo
cysts confirmed at operation.
• Normal healthy persons (con
trols).
Antigen Preparation

Tumour tissue was usually obtained
at autopsy and stored at -70 °C. A
pool of tumour tissue, usually from
two to four patients, was taken from
the freezer and thawed. All excess fat
and normal tissue were scraped away.
The pooled tumour tissue was then
minced with a scalpel and with scissors.
The minced tissue was diluted with
five volumes of ice-cold phosphatebuffered saline at pH 7.3 and homo
genized for 15 minutes at 40 000 rpm
in a VirTis homogenizer (VirTis Co.
Inc., Gardiner, NY). The homogenate
was centrifuged at 20 000 g for 30
minutes. If a layer of fat was present
on the surface it was removed and
2-mL aliquots of the clear supernatant
were stored in small vials at -70°C.
Normal control antigen, usually nor
mal liver tissue, was prepared in the
same fashion and also stored in 2-mL
vials. Before use in any assay, the
protein concentration of an antigen ex
tract was determined by a Lowry as
say.9
Leukocyte Preparation

From patients selected for study 20
mL of blood was collected into vacutainer tubes containing heparin. These
tubes were then incubated vertically
at 37°C for 1 hour. The resulting
leukocyte-rich plasma fraction was
aspirated and centrifuged at 200 g for
5 minutes. The supernatant plasma
was discarded. Erythrocytes contamin
ating the cell buttons were lysed by
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adding tris-buffered ammonium chlo
ride and the tubes were left at room
temperature for 15 minutes.10 The
procedure was terminated by the addi
tion of an equal volume of Medium
199 (Grand Island Biological Co.,
Grand Island, NY). The tubes were
again centrifuged at 200 g for 5 min
utes and the supernatant was removed
and discarded. The cells were then
washed three times with approximately
10 mL of Medium 199. Before the last
wash a known volume of medium was
added and a small aliquot of this cell
suspension was withdrawn for cell
counting. Cell counts were performed
with a Coulter counter (Coulter Elec
tronics, Hialeah, FL). Following the
final wash the cells were resuspended
in Medium 199 at a concentration of
1 X 107 cells/mL.
Antigen Specificity and Titration
The specificity of all antigens pre
pared was determined by performing
a tube LAI assay with peripheral blood
leukocytes from patients with known
tumours. The appropriate protein con
centration of the antigen was deter
mined by constructing a titration curve
of protein concentrations ranging from
50 fig to 400 jxg for both test and
normal antigens. Antigens causing a
high degree of nonspecific release were
discarded. In general, the appropriate
protein concentration to yield optimal
results was approximately 200 fxgf
tube.
L A I Assay
The LAI assay was performed in
glass tubes 16 X 150 mm. All assays
were performed in triplicate. The ap
propriate antigens to be tested in the
assay were thawed and diluted to ap
propriate protein concentration, usual
ly 2 mg/mL, using Medium 199. A
0.1-mL volume of leukocyte suspen
sion (1 x 107 cells/mL) was carefully
pipetted into the bottom of the glass
tube. Then 0.1 mL of buffer, specific
antigen, or control antigen was added
to each set of triplicate tubes. Subse
quently 0.3 mL of Medium 199 was
added to bring the mixture to a final
volume of 0.5 mL. Each tube was
carefully mixed using a Pasteur pipette
and the tubes were incubated horizon
tally. This incubation process was
aided by using a styrofoam tray which
is readily available in most hospital
wards that use vacutainer tubes.
The tubes were incubated at 37 °C
in a humidified atmosphere of 5%
carbon dioxide in air for 2 hours. Fol
lowing this period of incubation the
tubes were placed vertically and the
number of nonadherent cells was
counted using a Coulter counter. The
data obtained were then converted to
314

a nonadherent index (NAI) using the
formula shown in Table I.
Results

The results of our assay are set
forth in Table I. The specificity of the
pancreatic tumour antigen is demon
strated by the fact that the NAI is sig
nificantly (P < 0.01) higher in patients
with carcinoma of the pancreas than
in those with other intra-abdominal
malignant tumours. Also, the breast
tumour antigen, which had previously
been shown to be present in patients
with breast carcinoma, was absent in
patients with carcinoma of the pan
creas and other intra-abdominal malig
nant lesions.
A positive NAI does not appear to
be due to inflammation of the pan
creas since in most patients with pan
creatitis the index was not substantially
elevated. Similarly, patients with ob
structive jaundice not due to a malig
nant condition did not have a notably
elevated NAI. These preliminary data,
although small in number, suggest that
the LAI assay may be a simple, noninvasive means of selecting patients
with a possible malignant tumour of
the pancreas who require further in
vestigative procedures.
When an NAI index of 50 or greater
was arbitrarily selected as indicating
malignancy, it was shown to be
so in eight of nine patients with
surgically proven pancreatic cancer.
The false-negative rate would there
fore seem to be acceptably low. The
false-positive rate, however, has been
disturbingly high. Five of 15 patients
with pancreatitits, 3 of 9 patients with
other gastrointestinal carcinomas and
4 of 16 normal (control) patients had a
positive index. Clearly, more patients
must be studied to determine the effi
cacy of this assay.
Discussion

The preoperative diagnosis of car

cinoma of the pancreas continues to
be difficult to establish. Laboratory in
vestigations that are said to be helpful
in making this diagnosis include pan
creatic function tests,11,12 radionuclide
scanning of the pancreas,13 ultrasono
graphy,14,15 arteriography16,17 and endo
scopic retrograde pancreatography.18'20
With the exception of ultrasonography,
which is not universally available, each
of these investigative procedures is
relatively invasive. A recent report
has suggested that the triple study
by ultrasonography, pancreatic func
tion tests and endoscopic retrograde
pancreatography has an accuracy rate
of almost 90% in either diagnosing or
excluding pancreatic malignant le
sions.21
Few immunologic tests have been
described for the detection of carci
noma of the pancreas. The measure
ment of carcinoembryonic antigen
(CEA) was once believed to be of value
in the diagnosis of this disorder.22 Un
fortunately, various nonmalignant pan
creatic disorders and other upper ab
dominal diseases produce measurable
CEA concentrations resulting in a very
high rate of false-positive results.23
More recently the amount of CEA
present in the pancreatic juice obtained
at endoscopic retrograde pancreato
graphy has been investigated. While the
results are encouraging there is no
evidence that this is of greater assist
ance in diagnosis than simple retro
grade pancreatography.12'24
In 1974 Banwo, Versey and Hobbs25
prepared an antibody to fetal antigen
from the pancreas comparable to the
CEA prepared by Gold and Freed
man.26 They called it a new oncofetal
antigen for human pancreas and found
it in the serum of 36 of 37
patients with carcinoma of the
pancreas. However, a later report
revealed that the pancreatic oncofetal
antigen was also to be found in patients

Table I— Nonadherent Index (N A I)* A ctivity to Pancreatic and
Breast Antigens of Patients w ith Pancreatic Disorders
Pancreatic antigen,
200 ij.g/tube
No. of
patients

Condition
Carcinoma of pancreas
Pancreatitis
O ther carcinomas
Obstructive jaundice
Pancreatic pseudocyst
Control

9
15
9
4
2
16

NAI ± SEM
179 ± 34
29 ± 26
29 ± 16
- 1 8 .7
-4 6 .5
24 ± 12

Breast antigen,
200 u.g/tube
No. of
patients

NAI ± SEM

7
6
11

23 ± 8.3
- 4 ± 9.9
0 ± 14
ND
ND

15

-1 .6 ± 9

SEM = standard error of mean, ND = not done.
*

No. of nonadhering cells
No. of nonadhering cells
in presence of specific
— in presence of nonspecific
antigen
antigen
No. of nonadhering cells in presence of nonspecific antigen
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with other types of abdominal carci
noma, pancreatitis and miscellaneous
disorders.27
The present communication has de
scribed another immunologic assay for
the detection of carcinoma of the pan
creas While the number of false-posi
tive results in patients with other malig
nant tumours and with benign pan
creatic disease has been disturbingly
high, the rate of false-negative results
in patients subsequently proved to have
pancreatic carcinoma has been gratifyingly low. This suggests that the LAI
assay may be of value in the early in
vestigation of patients with suspected
malignant tumours. Such, patients
whose LAI assay is positive should ob
viously be subjected to the more in
vasive tests that have been described.
Patients whose LAI assay is negative
may safely be kept under observation
without any further investigative proce
dures being carried out.
I acknowledge the technical assistance
of Mrs. Margaret Turner and Mr. Chris
Howitt.
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Reoperation Following Failure of Aortoiliofemoral
Arterial Reconstruction
J o h n A. K n u d s o n ,

Over a 19-year period, 729 primary
arterial reconstructions for aneurysmal
and occlusive disease of the aortoiliac
arterial system were performed at
the Health Sciences Centre, Winnipeg.
During the same interval 49 of these
reconstructions required reoperation
and 6 additional cases were referred
for secondary repair from other
institutions. The authors reviewed these
55 cases to determine the reasons for
reoperation and the cumulative results
of secondary repair.
Secondary arterial repair was per
formed in 11.5% of cases of occlusive
disease and in 1.2% of cases of
aneurysmal disease. The overall fre
quency of reoperation was 6.7%. The
mean interval between primary and
secondary operation was 31.5 months.
Perioperative failure, false aneurysm,
graft infection, progression of disease
and late technical problems were the
major reasons for reoperation. Of the
secondary repairs the results in 83.6%
were satisfactory at 30 days. At 5
years, 57% of secondary repairs at
risk remained satisfactory. The operative
mortality for secondary arterial repair
was 5.4%. The authors believe that
continued aggressive management of
failed primary aortoiliac reconstructions
is justified.
Au cours d'une periode de 19 ans,
729 reconstructions arterielles primaires
pour anevrisme ou obliteration du
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A lla n R. D o w n s ,

systeme arteriel aortoiliaque ont ete
effectuees au Health Sciences Centre
de Winnipeg. Durant ce meme intervalle,
49 de ces reconstructions ont exige
une reintervention et 6 autres cas ont
ete achemines pour reparation secondaire d'autres institutions. Les auteurs
ont etudie ces 55 cas dans le but
de determiner les raisons ayant entraine
une reintervention et les resultats
cumulatifs des reparations secondaires.
Une reparation arterielle secondaire
a ete effectuee dans 11.5% des cas
d'obliteration et dans 1.2% des cas
d'anevrisme. La frequence des reinter
ventions pour I'ensemble a ete de
6.7%. L’intervalle moyen entre la
premiere et la deuxieme operation a ete
de 31.5 mois. Les principales causes
d’une deuxieme intervention ont ete
I’echec peroperatoire, un faux ane
vrisme, I'infection du greffon, I’evolution
de la maladie et certains problemes
techniques tardifs. Du nombre de
reparations secondaires, des resultats
satisfaisants a 30 jours ont ete obtenus
dans 83.6% des cas. Cinquante-sept
pourcent des reparations arterielles
secondaires a risque eleve sont
demeurees satisfaisantes apres 5 ans.
La mortalite operatoire a ete de 5.4%.
Les auteurs croient que le maintien
d’un traitement agressif dans les echecs
des reconstructions aortoiliaques
primaires est justifie.

The patency rate of aortoiliac and
aortofemoral reconstructive procedures
varies between 62% and 90% over 10
years.1'7 Early and late complications
leading to reoperation are uncommon
in this form of surgery, but when they
do occur corrective procedures can be
challenging.
Between Jan. 1, 1958 and Oct. 31,
1976, 729 primary arterial reconstruc
tions for aneurysmal or occlusive dis
ease of the aortoiliac arterial system
were performed at the Health Sciences
Centre, Winnipeg. During the same
period 49 patients required reoperation.
Six additional patients were referred
for secondary repair from other insti
tutions. Seventy-nine operations were
performed in these 55 patients (Table
I). We have reviewed these secondary
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arterial reconstructions to examine the
causes of failure leading to reoperation
and to determine the cumulative re
sults of secondary repair.
We define secondary repair as re
operation because of failure of a
primary arterial reconstruction; peri
operative occlusion was included.
Early reoperation for hemorrhage,
other than that resulting from infec
tion, is excluded from the definition.
Seventeen patients required more
than one reoperation. However, all re
operations related to the same primary
reconstruction were considered as one
statistical event.
There were 46 men and 9 women.
The mean age was 59.9 years (range,
36 to 79 years). Duration of follow-up
ranged from 3 months to 9 years
(mean, 3 years). Three patients with
successful secondary repairs were lost
to follow-up at 37, 37 and 33.5 months.
Occurrence of Failure of
Primary Operation

Vascular complications requiring re
operation
occurred following 45
(11.5%) of 391 operations for occlu
sive disease and after only 4 (1.2%) of
338 operations for aneurysmal disease.
The overall incidence of reoperation
was 6.7%. The number of reopera
tions was related to the type of primary
procedure (Table II). Secondary pro
cedures were required in 3.5% of all
aortic bifurcation grafts and in 9.2%
of cases in which aortic bifurcation
grafts were introduced for the man
agement of occlusive disease. Of pa
tients who underwent unilateral pros
thetic procedures, 18.3% required
reoperation. One would expect the risk
of failure of bifurcation grafts to be
twice that of unilateral grafts. HowT a b le ^ S e c o n d a r y A rt e ria l R e p a ir s

N o. of p a tie n ts

No. of re o p e ra tio n s

38
13
3
1

1
2
3
6

55

79
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postoperatively. False aneurysm was a
late complication developing an aver
age of 56.2 months following surgery.

T a b le I I — F re q u e n c y o f S e c o n d a ry R e p a ir R e la te d to P rim a r y O p e ra tio n
N o . fa ile d
a n d r e o p e ra te d

N o . p r im a ry
o p e r a tio n s
A o r to ilio fe m o r a l p ro s th e s is
O c c lu s iv e d is e a s e
A n e u ry s m
A o r to ilia c e n d a rte re c to m y
U n ila te r a l p ro s th e s is
U n ila te r a l e n d a rte re c to m y
U n ila te r a l v e in g r a ft
C ro s s -fe m o ra l g r a ft (v e in o r p ro s th e s is )
A x ilto fe m o r a l g r a ft
T o ta l

% r e o p e r a tio n s

479
141
338
43
82
74
10
24
17

17
13
4
6
15
5
1
0
5

3 .5
9 .2
1 .2
1 3 .9
1 8 .3
6 .8
10
0
2 9 .4

729

49

6 .7

T a b le I I I — In d ic a tio n s fo r P r im a r y a n d S ec o n d a ry R e p a ir
P r im a r y r e p a ir , no.
o f p a tie n ts (a n d % )

In d ic a tio n

30 (5 4 .5 )
19 (3 4 .6 )
6 (1 0 .9 )

C la u d ic a tio n
L im b s a lv a g e
A n e u ry s m
F a ls e a n e u ry s m
G r a ft in fe c tio n

—

T o ta l

55

—

ever, in patients with occlusive disease
only 30.8% of the primary bifurcation
graft procedures were performed for
limb salvage compared with 46.7% of
the primary unilateral procedures, sug
gesting that arteriosclerosis was more
severe in the latter group. Reoperation
was necessary in 13.9% of bilateral
aortoiliac endarterectomies and in only
6.8% of unilateral iliac endarterec
tomies.
Symptoms attending failure of a
primary vascular reconstruction were
usually more severe than those in
dicating the need for initial repair. Of
the 55 patients who later required re
operation, the indication for primary
repair was claudication in 54.5% and
limb salvage in 34.6% (Table III).
Following failure of primary repair,
these figures were 25.4% and 45.4%
respectively. Graft infection and false
aneurysm were the indications for
secondary repair in the remaining pa
tients.
Causes of Failure

Eight (14.5%) patients with peri
operative occlusion required reopera
tion on the day of surgery. The higher
proportion of immediate failures in the
endarterectomy group probably reflects
the higher degree of technical skill re
quired for endarterectomy as compared
with bypass procedures.
Progression of arteriosclerosis was
responsible for 21 (38.2%) reopera
tions. Inadequate outflow from the
deep femoral artery with concomitant
chronic occlusion of the superficial
femoral artery resulted in failure of
VOLUME 21, NO. 4, JULY 1978
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S ec o n d a ry r e p a ir , n o .
o f p a tie n ts (a n d % )
14 (2 5 .4 )
25 (4 5 .4 )
—

9 (1 6 .4 )
7 (1 2 .7 )
55

13 of 16 prosthetic procedures in this
group. Only one patient had severe
arteriosclerosis of the deep femoral
artery and 12 had stenosis or occlusion
at the origin of the deep femoral artery.
These figures emphasize the importance
of adequate management of the deep
femoral artery at the primary recon
struction. In the remaining eight cases
in this category failure occurred more
than 3 years after reconstruction be
cause of recurrent arteriosclerosis at
the site of endarterectomy or the distal
anastomosis. The 10 late technical fail
ures (18.2% of the total) were in pa
tients in whom none of the other
identifiable causes of failure were ap
parent. Incomplete endarterectomy or
inadequate initial anastomoses ac
counted for the late failures in this
group.
There were seven graft infections
(12.7%) (one of which was fatal) and
two amputations. Nine patients re
quired a secondary repair for a false
aneurysm which was located in the
groin in eight. Of the nine patients
with a false aneurysm (16.4% of
the total), five had associated aneu
rysmal disease. The higher frequency
of false aneurysms in patients with
aneurysmal disease suggests that the
condition predisposes to false-aneurysm
formation, but this awaits confirmation.
If immediate failures are excluded,
the mean interval between primary and
secondary operation was 31.5 months.
Progression of disease necessitated a
second operation an average of 31.6
months after the first. Graft infections
presented an average of 9.1 months

Operative Procedures

A variety of procedures were used
for secondary operations.
False aneurysms in the groin are
usually best managed by excision of
the anastomotic site and insertion of a
longer prosthesis (Fig. 1). In the pres
ence of occlusion of the superficial
femoral artery an end-to-end anastomo
sis to the divided end of the deep
femoral artery is preferred. If the
proximal aortic anastomosis is aneurys
mal, a graft replacement is indicated
(Fig. 2). Eight of nine patients were
managed successfully by these meth
ods.
Recurrent occlusion of an endarterectomized segment is best treated by
a bypass graft. For unilateral iliac oc
clusion, a cross-femoral bypass graft
may suffice.
Occlusion of one limb of a pros
thesis is usually due to outflow ob
struction. Where there has been recent
occlusion of the prosthesis it may be
possible to remove the thrombus by

FIG. 1— Anastomotic false aneurysm,
right groin, and occlusion, left prosthetic
limb, due to anastomotic false aneurysm.
Both treated by graft extension.

FIG. 2— Aortoiliac prosthetic graft,
with false aneurysms at all three anasto
moses.
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way of the groin without exposing the
graft in the abdomen.8 A cross-femoral
graft from the patent limb of the pros
thesis may be the simplest reconstruc
tive procedure (Fig. 3). It is most im
portant to establish an adequate out
flow to avoid reocclusion. If clot is
present at the bifurcation of the graft,
proximal control will be necessary, and
thrombectomy of the occluded limb of
the prosthesis may then be carried out
(Fig. 4).
Graft infection usually necessitates
removal of the graft and an amputation
or an extra-anatomical reconstruction
such as an obturator bypass (Fig. 5) or
an axillofemoral bypass. Anastomotic
stenosis requires patch-graft angio
plasty or an extension of the prosthesis
more distally to the site of an adequate
outflow (Fig. 6). It cannot be overem
phasized that the operation must be
tailored to the individual patient.

demands careful analysis of the results
because the indications for such pro
cedures are variable. We define success
as improvement in disabling claudica
tion, limb salvage when the limb has
been at risk, management of infected
prostheses without loss of life or limb
and repair of false aneurysms without
incurring new vascular symptoms. Ex
cept in graft infections, patency of the
repair parallels a successful result.

Discussion

Results
The evaluation of secondary repair

FIG. 3— Prosthetic limb occlusion
treated by cross-femoral graft from patent
limb to deep femoral artery.

FIG. 5— Obturator vein bypass graft
in groin for infection of prosthesis.

FIG. 4— Prosthetic limb occlusion with
clot, extending into patent limb, requiring
proximal control.
318

The average duration of follow-up
in our cases of secondary repair was 3
years. We were interested in the ul
timate result in patients, hence we con
sidered more than one reoperation in
an individual patient as a single statis
tical event. To analyse success we used
the life-table method.9
Nine failures occurred within 30
days of operation. Our success rate at
30 days was 83.6%; at 2 years it had
fallen to 62.2% and at 5 years to 57%
(Fig. 7). There were three operative
deaths, giving a surgical mortality of
5.4%. Two of the deaths were in pa
tients with aortoenteric fistula and one
followed unsuccessful repair of a
ruptured iliac false aneurysm.

FIG. 6— Anastomotic iliac stenosis, re
quiring graft extension to common
femoral arteries.
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All failed reconstructions do not
necessarily lead to reoperation. Risk of
reoperation has to be weighed against
the expectation of technical success, the
severity of symptoms and the possible
mortality without operative interven
tion. Patients undergoing reoperation
often have life or limb at risk. A pa
tient may require several reoperations
before a successful result is achieved.
Improvement in prosthetic materials,
the use of synthetic sutures for anasto
moses and definition of the stress forces
on vascular anastomoses have reduced
the frequency of false aneurysm to be
tween 1.9% and 8% .1<M4 The frequency
of false aneurysm among patients in
our series was about 1.2%. With the
evolution of perioperative management
and vascular techniques, and possibly
with the prophylactic use of antibiotics,
the infection rate of prostheses varies
between 1.5% and 6% .15,16 Graft in
fection accounts for the highest mor
bidity and mortality, but aggressive
surgical management can save most of
these patients and their limbs as demon
strated by our experience. Progression
of arteriosclerotic disease was the prin
cipal reason for failure of the primary
operation.
There have been several reports on
aortoiliac secondary repairs.8,17'19 How
ever, the long-term results of aortoiliac
reoperations have not been well docu-

FIG. 7— Analysis of success of second
ary repair of aortoiliac disease by lifetable method.
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merited. Continued aggressive manage
ment of failed primary aortoiliac re
constructions is indicated.
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Role of Doppler Ultrasonography in Determining the
Hemodynamic Significance of Aortoiliac Disease
K.W . J o h n sto n , m d , fr c s [c ], facs

Doppler ultrasound recordings from
the common femoral artery were
quantified by calculation of the
pulsatility index (a number related
to the maximum oscillatory energy of
the wave). To demonstrate that the
index permits detection of hemodynamically significant aortoiliac
stenosis, studies were carried out that
led to the following conclusions:
(a) in patients with aortoiliac occlusive
disease and normal distal vessels,
the index correlates with the ankle
pressure ratio (the ratio of systolic
blood pressure at the ankle to brachial

systolic blood pressure) (r = 0.70);
(b) the index allows distinction of
subjects with significant aortoiliac
disease, demonstrated arteriographically,
from normal subjects; and (c) in
patients with pure aortoiliac occlusive
disease (no evidence of distal disease
on arteriography) there is a strong
correlation between the index and the
percentage improvement (i.e., increase)
in the ankle pressure ratio following
operation (r = 0.80). When the femoral
pulsatility index was greater than 5,
the ankle pressure ratio did not
improve following operation, but when
it was 4 or less, an objective
improvement in ankle pressure ratio
was demonstrated.

etudes ont ete menees qui ont donne
les conclusions suivantes: (a) chez les
patients souffrant d'une maladie
aortoiliaque occlusive et ayant des
vaisseaux distaux normaux, I'index a
montre une correlation avec le rapport
de pression de la cheville (le rapport
de la pression systolique a la cheville
et la tension arterielle brachiale
systolique) (r = 0.70); (b) cet index
permet de faire la distinction entre les
sujets ayant une maladie aortoiliaque
significative demontree a I'arteriographie, et les sujets normaux; et (c)
chez les patients souffrant d'une maladie
aortoiliaque occlusive pure (sans signe
d'atteinte distale a I'arteriographie),
II existe une forte correlation entre
I'index et le pourcentage d'amelioration
(d'augmentation) du rapport de pression
de la cheville apres I'operation
(r = 0.80). En presence d'un index
de pulsatilite superieur a 5, le rapport
de pression de la cheville ne s'est pas
ameliore apres I’operation, mais quand
I'index etait de 4 ou moins, une
amelioration objective du rapport de
pression de la cheville a ete demontree.

From the department of surgery,
Toronto General Hospital, and the
Institute of Biomedical Engineering,
University of Toronto, Toronto, Ont.
Les examens aux ultrasons de Doppler
Based on a paper presented at the 1st
de I'artere femorale commune ont ete
annuaI meeting of the Canadian Associa quantifies par le calcul de I'index de
tion of General Surgeons, Vancouver,
pulsatilite (une valeur reliee au maximum
BC, Jan. 26, 1978
d'energie oscillatoire de I'onde). Pour
Supported by a grant from the Medical
demontrer que le calcul de I'index
Research Council of Canada
de
pulsatilite femorale permettait la
Reprint requests to: Dr. K.W. Johnston, detection
d'une stenose aortoiliaque
Rm. 1-100, University Wing, Toronto
General Hospital, Toronto, Ont. M5G 11.7 hemedynamiquement significative, des
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A successful vascular operation de
pends primarily on good clinical judge
ment combined with technical excel
lence. In aortoiliac surgery, in spite of
careful preoperative clinical and arteriographic assessment and a technically
successful procedure, some patients
are unimproved following operation.
The failure rate of aortoiliac recon
struction can be reduced by attention
to certain technical considerations and
perhaps by more precise objective as
sessment of the hemodynamic signi
ficance of aortoiliac stenosis.
The purpose of this study is to
answer the question, Can noninvasive
Doppler ultrasound recordings from
the femoral artery determine if an
aortoiliac stenosis is hemodynamically
significant?
A New Doppler System

Before we could obtain quantitative
information about the aortoiliac seg
ment from femoral artery Doppler
recordings, we had to overcome the
inherent limitations of Doppler “flow
meters”1'3 and solve the following prob
lems: (a) to obtain meaningful direc
tional Doppler signals: (b) to process
the signals and produce a blood flow
velocity wave free of artefacts; and (c)
to quantify the Doppler wave. Our
methods for accomplishing these ob
jectives have been reported,4’5 but will
be briefly reviewed here in order to
clarify the inherent limitations of cur
rently available commercial Doppler
“flowmeters”.
Obtaining Meaningful Directional
Doppler Signals
The normal blood flow velocity
wave is triphasic with a forward flow,
a reverse flow and usually a second
forward flow component. Unless the
Doppler system is able to separate
clearly the directions of blood flow,
the resultant waveform may be in error.
Many commercial Doppler instruments
have serious limitations in their direc
tion-resolving ability. To overcome this
problem, we have designed and con
structed a heterodyne Doppler velocity
meter which has almost perfect direc
tion-resolving capabilities (Kassam M,
Johnston KW, Cobbold RSC: Unpub
lished data, 1978).

zero crossing detector to process the
Doppler signals, but unfortunately this
method produces artefactual waveforms
in many situations.1'3 We have overcome
this problem by designing a relatively
inexpensive real-time frequency analy
ser which displays the Doppler wave
form on an oscilloscope or on record
ing paper.4
Quantifying the Doppler Waveform
At present there is only one way to
quantify the Doppler waveform ac
curately and that is by calculating the
pulsatility index (a number that is
proportional to the maximum oscilla
tory energy of the wave).6'9 It would
be ideal to calibrate the Doppler wave
form and thus be able to measure ab
solute velocity, but at present this is
not possible with any degree of ac
curacy.6 The theoretical basis for the
calculation of the pulsatility index and
its in-vitro and in-vivo validation are
beyond the scope of this paper;5 suffice
it to say that the pulsatility index can
be calculated easily from the maximum
instantaneous velocity wave by using
a pencil and ruler.
Methods and Patients

In this study the hemodynamic sig
nificance of aortoiliac disease was de
termined from Doppler ultrasound
velocity recordings taken from the
femoral artery using our new Doppler
system and a real-time frequency anal
yser and display system. The pulsatility
index was calculated and was used to
quantify the wave. Normally, the
pulsatility index is high. Distal to an
arterial stenosis the waveform is dam
pened (i.e., the peak is delayed and
flattened and reverse flow is absent)
and the pulsatility index is reduced.
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Results

Correlation between Femoral
Pulsatility Index and Systolic Blood
Pressure Ratio at the Ankle
Only patients with pure aortoiliac
occlusive disease (i.e., no evidence of
distal disease on arteriography) were
studied; hence it is reasonable to as
sume that systolic blood pressure meas
ured at the ankle was directly related
to femoral artery blood pressure. Ac
cordingly it was to be predicted that
the femoral pulsatility index would also
be related to systolic blood pressure
ratio at the ankle. As illustrated in Fig.
1, for 38 points, ankle pressure ratio
and femoral pulsatility index were
related by a power equation of the
form y = axb with a correlation co
efficient of 0.70.
Relation between Femoral Pulsatility
Index and Arteriographic Grades in
the Aortoiliac Segment
Although arteriography does not pro
vide a hemodynamic measurement, the
above relation is important to establish.
When arteriography was used as a base
line for comparison, in 155 limbs
femoral pulsatility index appeared to
be as discriminating (Fig. 2). It dis
tinguished subjects with clinically and
arteriographically significant lesions
from the normal group.
Relation between Femoral Pulsatility
Index and the Objective Improvement
Following Operation

Processing the Doppler Signals and
Producing a Blood Flow Velocity
Wave Free of Artefacts
Since our aim is to obtain quanti
tative information from the Doppler
waveform, it is essential to obtain one
that is free of errors and artefacts.
Current commercial instruments use a

Doppler ultrasound velocity record
ings were made from the common
femoral artery and the femoral pulsa
tility index was calculated from these
recordings. In order to demonstrate
that the femoral pulsatility index was
actually a hemodynamic measurement
and to determine whether it could be
used to estimate the severity of aor
toiliac disease, femoral pulsatility in
dex was compared with: (a) the meas
urement of ankle pressure ratio (i.e., the
ratio of systolic blood pressure at the
ankle to brachial systolic pressure),
(b) arteriograms graded according to
the severity of the stenosis in the aor
toiliac segment, and (c) the amount of
improvement in the ankle pressure ratio
following operation.

FIG. 1—Relation between femoral pul
satility index and ankle systolic pressure
ratio (ratio of systolic blood pressure at
ankle to brachial systolic blood pressure)
in patients with aortoiliac occlusive dis
ease and normal distal vessels.
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Arteriography has serious limitations
when used for determining the signi
ficance of lesions in the aortoiliac seg
ment. Therefore in order to determine
whether the measurement of femoral
pulsatility index can detect and quan
tify the hemodynamic significance of
an aortoiliac lesion, a third relation-
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ship was assessed—that between the
femoral pulsatility index and the re
sults of operation as measured objec
tively by the increase in the pressure
ratio following operation. Forty-six
limbs of patients with pure aortoiliac
occlusive disease were studied. Preoperatively, the femoral pulsatility in
dex was measured and the ankle pres
sure ratio calculated. The ankle pres-

sure ratio was remeasured postoperatively and the percentage improvement
in the pressure ratio was calculated
(Fig. 3). As predicted, when the pre
operative femoral pulsatility index was
high, the ankle pressure ratio did not
improve. On the other hand, when the
femoral pulsatility index was low, the
pressure ratio did improve. It is ap
parent that the relation between
femoral pulsatility index and percent
age improvement in ankle pressure
ratio, as expressed in Fig. 3, is an
inverse function. Hence, if the inverse
of the femoral pulsatility index is plot
ted against the percentage improvement
in the pressure ratio, a linear relation
results as illustrated in Fig. 4. For 46
limbs, we found a linear relation be
tween inverse femoral pulsatility index
and percentage improvement in the
pressure ratio. The correlation coeffi
cient was 0.80.
Sum m ary and C onclusions

We have demonstrated that the
pulsatility index calculated from Dop
pler ultrasound recordings from the
femoral artery is a quantitative meas
ure of the hemodynamic significance
of arterial occlusive disease in the aorFIG. 2— Femoral pulsatility index plot
ted against corresponding arteriographic
grade of aortoiliac segment. Grade 0 =
normal subjects; grade 1 = patients with
intimal irregularity only; grade 2 = pa
tients with less than 50% stenosis; grade
3 = patients with greater than 50%
stenosis; grade 4 = patients with com
plete arterial occlusion.
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toiliac segment. When the femoral
pulsatility index is less than 4, a hemodynamically significant lesion is present
in the aortoiliac segment and opera
tive repair produces an objective im
provement. When the femoral pulsa
tility index is greater than 5, no hemodynamically significant lesion is pres
ent in the aortoiliac segment and
operation does not produce an objective
hemodynamic improvement.
The technical assistance of Mrs. B.
Hansen, RN is acknowledged.
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Oropharyngeal Dysphagia in Patients with
Oculopharyngeal Muscular Dystrophy
C. A ndre D uranceau, md, frcs[c], J ean L etendre , md, frcp [c],
R ichard J. C lermont , md, frcp [c], H enri-P aul L evesque, md, frcp [c]
and A ndre B arbeau, md , frcp [c], facp

Sixteen patients with an established
diagnosis of oculopharyngeal muscular
dystrophy underwent clinical, radiologic
and manometric assessment. Secondary
pharyngo-oral and pharyngonasal re
gurgitations are usually associated with
this condition and chronic aspiration
with consequent bronchorrhea is com
mon. Such patients may present with
marked oropharyngeal dysphagia.
Cineradiologic findings correlated
well with the manometric results. The
pharynx showed very weak contractions
of longer duration than those observed
in normal subjects. The proximal
esophageal sphincter had a normal
resting and closing pressure; however,
relaxation and coordination of the
sphincter were substantially different
from those in a control group.
Eleven patients underwent crico
pharyngeal myotomy. All had notable
improvement of their symptoms. Surgery
on the sphincter results in a substantial
decrease in its resting pressure;
pharyngeal contraction remains
unaltered.
Seize patients porteurs d’une dystrophie
oculopharyngee ont ete evalues. Ils
ont eu un examen clinique, radiologique
ainsi qu’une etude de la fonction
oesophagienne. Ces patients presentent
une symptomatologie typique qui est
d'apparition tardive. Une dysphagie
oropharyngee souvent severe est
observee. Secondairement, des regur
gitations pharyngo-orales et pharyngonasales surviennent. Des episodes
repetes d’aspiration entrainent une
bronchorrhee importante.
La radiologie et la manometrie

From the departments of surgery,
medicine and radiology, Universite de
Montreal, Hotel-Dieu de Montreal,
Montreal, PQ
Presented at the 1st annual meeting of
the Canadian Association of General
Surgeons, Vancouver, BC, Jan. 25, 1978
Reprint requests to: Dr Andre Duran
ceau, Departement de chirurgie,
Hotel-Dieu de Montreal, 3840 St-Urbain,
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s’accordent: le pharynx montre des
contractions faibles et prolongees. Le
sphincter pharyngo-oesophagien presente
une pression de repos et une pression
de contraction comparables au normal.
Le relachement et la coordination du
sphincter avec la contraction du
pharynx varient cependant de facon
significative d'avec les normaux.
Onze patients ont ete traites par
une myotomie du sphincter pharyngooesophagien. Tous ont ete tres ameliores
par cette intervention. Les effets
observes de la chirurgie sur la fonction
du sphincter sont une diminution
marquee de la pression de repos dans
celui-ci. La fonction du pharynx
demeure identique.

Methods
Clinical Evaluation
In 16 patients (average age, 63 years)
the diagnosis of oculopharyngeal mus
cular dystrophy was established by a
neurologist (A.B.). All were subsequent
ly examined at the surgical outpatient
clinic and underwent a full medical
assessment by a gastroenterologist and
a surgeon (J.L., R.C., A.D.).

Radiologic Investigation
Examination of the pharynx and
recording of the act of swallowing were
performed with the patient in a stand
ing or sitting position. Initially, the
cineradiographic technique was used
in the frontal and lateral projections at
Oculopharyngeal muscular dystrophy a frame rate of 30 per second. The
is a syndrome characterized by pro patient was instructed to hold a mouth
gressive palpebral ptosis and dysphagia. ful of concentrated liquid barium (MiThis condition was first described by cropaque 95 %, Nicholas Laboratories
Taylor1 in 1915; all his patients with Ltd., Slough, UK) (28 g in 30 mL
this disease who had reached the age water) until directed to swallow. The
of 50 years died of starvation resulting same procedure was repeated after the
from paralysis of the muscles of de patient was given 5 mL of paste pre
glutition.
paration (Microtrast, Nicholas Labo
Subsequently a number of case re ratories Ltd.).
ports2’4 and a genetic study5 revealed
The examination was completed by
that this syndrome afflicts mainly pa taking spot film exposures in the an
tients of French-Canadian ancestry al teroposterior and lateral projections. If
though it has been described in patients the patient had a history of trouble
of Bohemian6 and Jewish origin2 as some aspiration, the examination was
well as in people of Latin American7 performed with cineradiography only
and Italian8 descent.
using a water-soluble medium (GastroMost publications on the subject grafin, Squibb). All the radiologic ex
concentrate on the genetic and neurolo aminations were reviewed and analysed
gic aspects of the disease.1'3*4,3 Late and by the same radiologist (H-P.L.).
progressive ptosis is a more striking
Manometric Study
clinical sign than the accompanying
dysphagia. Dysphagia, however, is fre
Manometric studies were performed
quently mentioned as a symptom that in all 16 patients using a triple-lumen
precedes the ptosis and causes the pa esophageal motility tube (USCI #1100,
tient much discomfort.10’13
USCI International, Murray Hill, NJ).
It is our intention in this paper to; The body of the esophagus was per
(a) document more precisely the oro fused at a rate of 1.9 mL/min for each
pharyngeal, esophageal, laryngeal and lumen and the proximal sphincter area
tracheobronchial symptoms presented at a rate of 7.6 mL/min for each lu
by a group of patients with this disease, men. Recording was done on a four(b) assess the pharyngeal dysfunction channel physiograph (model 7754A,
through radiologic and manometric Hewlett-Packard Co., Palo Alto, CA).
studies, and (c) evaluate the results of All tracings were analysed according
treatment.
to fixed criteria and the statistical
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method used for interpretation was
Student’s t-test for paired values.

Most of the patients in this series
had voice modification. Concomitantly
with the dysphagia, episodes of airway
aspiration supervene. This happens
after every swallowing action in the
more severe cases. During sleep, pool
ing of saliva in the hypopharynx and
larynx causes the patient to aspirate
the secretion and a severe bronchorrhea results. These symptoms were ob
served in all 16 patients during their
manometric evaluation.

Treatment
Four patients were given an anti
cholinesterase medication and two
were treated by dilatation using mer
cury bougies.
Eleven patients underwent crico
pharyngeal myotomy. The indications
for surgery were severe dysphagia with
regular pharyngo-oral and pharyngonasal regurgitations as well as frequent
episodes of tracheal aspiration. Surgery
was performed under general anesthe
sia and using a left cervical approach.
When the esophagus was isolated, a
no. 42 mercury bougie was passed
through the upper esophageal sphincter
(UES) into the cervical esophagus. A
5-cm myotomy including the UES and
distal hypopharynx was carried out.
The mucosa was dissected from the
muscular layer over approximately
40% of the circumference and the
muscular layer was then fixed to the
thyroid capsule.

Table I I I — Radiologic Findings in 16 Patients
w ith Oculopharyngeal Muscular Dystrophy
No. of
patients

Finding
Pharynx
Weak or absent contractions
Hypopharyngeal stasis
Nasal regurgitation
Upper esophageal sphincter (UES)
Cricopharyngeus impression
Small
Marked
Absent
Lumen diam eter
Diminished
Adequate
Complete obstruction
Relaxation
Incomplete or late
Absent
Laryngeal aspiration
Aspiration pneumonitis on lung
roentgenography

Radiologic Findings
The radiologic findings are presented
in Table III. The pharynx showed a
weak or nonexistent contraction against
the UES which relaxed incompletely or
late in the majority of cases. The eso
phageal lumen at the UES level re
mained concentrically diminished in

14
14
3
8
4
4
10
4
2
12
4
9
2

Table II— Laryngeal, Tracheobronchial and Pulmonary Symptoms
Aspiration

Bronchorrhea

Patient Voice While
While
no. change eating sleeping Pneumonias

Results

Clinical Findings
The clinical symptoms are set forth
in detail in Tables I and II.
Generally, patients present complain
ing of marked oropharyngeal dysphagia
of long duration. Solids and eventually
liquids cause dysphagia, which is exa
cerbated by anxiety and by drinking
cold liquids. Oropharyngeal and nasal
regurgitations were experienced by near
ly all patients. Consequently, alimenta
tion time is longer and weight loss may
follow. Odynophagia was noted and
many patients reported a burning
sensation in the pharynx on swallow
ing.

i
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16

+
+
+
+
+
0
+
+
+
+
+
+
+
0
+
+

Total

14

+
+
+
+
+
+
+
+
+
+

+
+
+
+
+
+

4

+
+
+
+
+
+
+
+
+
+

+

+
+
+

+

16

4

4

-

+
+
+
+
+

0
0
+
+
0
+
0
+
0
0
0
0
0
0
0
0

+
+
+
+
+
+
-

+
+
+
+
+
+
+

+

16

W hile
During m otility
study
sleeping
+
+
+
+
+
+
+
+
+
+
+

+
+
+
+
+
+
+
+
+
+
+

+
+
+
+
+
+
+
+
+
+

0
+ +
0
0
+ +
13

A fte r
Systemic
surgery* disease

+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+

+ +

4

“

+ +
+ +
+
+
+
+

+
+
+
+

+
0
0
+
0
4

* “

+ +
—
—
—
—
—

0
+
0
0
0
0
0
0
+
0

ii

5

44
-

16

-

*11 patients.
+ = m ild; + + = severe; 0 = absent.

Table I— Oropharyngeal Symptoms
Symptoms
Dysphagia
Patient
no.
i
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16

Odynophagia

Increased Increased
Age,
yr Solids Liquids w ith cold w ith anxiety
76
61
64
68
61
74
52
74
66
69
50
57
61
62
61
56

+
+
+
+
+
+
+
+
+

+
+
+
+
+
+
+
+
+

+

-f- +

+
+
+
+
+

+ +
+ +

++
+
0
+

~h
+ +
+

4

-

+ +

0
0
0
0
0

+
+

+
+

+
+
+
+
+
+

+
+
+
+
+
+
+
+

Burning sensation in
Severe pharynx on swallowing
0
0
0
0
0
0
0
0

+

+

0
0
0
0
0

+ +
0
0

+
+

+

0

0

0
0
0
0
0
0
0

0
0
0
0
0
+
+
+

0
0
0
0
0
0
0
0

Regurgitation
Pharyngonasal
+ +
+ +

++

0
+
+
+
+
+

+
+
+
+
+

44
-

-

++
++
+

0
0

+

Pharyngooral
+ +
+ +
+ +

44
-

+ +

—

-

0

+ +
+ +
+ +

++
++

A lim entation
tim e, m in*

0
0
0
0
0

75
30
35
45
60
45
60
35
35
30
45
45
20
45
45

W eight
loss, kg f
0
0
18
9
0
0
0
0
18
13.5
6.75
13.5
0
0
0
0

*Average, 45 min.
fA verage, 13.0 kg.
+ = mild; + + = severe; 0 = absent.
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response to swallowing in eight patients.
Consequently, hypopharyngeal and
laryngeal pooling induced aspiration in
more than half the group. Repeated
swallowing was necessary to empty the
pharynx of its content.
Motility Studies
Table IV summarizes the significant
findings of pharyngeal and proximal
sphincter evaluation. The detailed study
of esophageal function will be reported
separately.
The pharynx was uniformly very
weak so that its contraction time was
significantly longer than in a control
group (Fig. 1). The UES, while regis
tering resting and contracting pressures
comparable to those found in a normal
group, showed a significant number of
inadequate and incoordinated relaxa
tions. The swallowing pattern was that
of weak and repeated pharyngeal con
tractions attempting to relax the upper
sphincter (Fig. 2).
Evaluation of Treatment
The four patients for whom anti
cholinesterase treatment was prescribed
had had early dysphagia; they were
clinically improved by the medication.
Of the two patients treated by dilata
tion, one was 50% better while the

other obtained no relief and subse
quently underwent a cricopharyngeal
myotomy.
Eleven patients underwent UES
myotomy. Clinical and manometric ef
fects of the operation are summarized
in Table V. All experienced marked
improvement of their symptoms. Eight
patients reported that swallowing was
“more than 100% better”. One patient
declared it was 75% better and two
patients admitted it was 50% better.
After surgery all patients ate faster
and stopped regurgitating either nasal
ly or orally during meals. Four out of
five patients who had lost weight re
gained it in the months following sur
gery.
All patients who underwent the op
eration experienced fewer episodes of
aspiration and much less nocturnal ac
cumulation of secretions; only one
complained of having to get up at night
as often as before to relieve his bronchorrhea.
The two patients admitted with
pneumonia showed a normal postoper
ative evolution of the disease with sig
nificant improvement of their condi
tion.
Postoperative complications occurred
in two cases. In one patient who had
a cholecystectomy as well as UES myo

Table IV—Significant Findings Resulting from Evaluation of the Pharynx and UES in Patients
with Oculopharyngeal Muscular Dystrophy
Patients with
oculopharyngeal muscular
dystrophy

Control
subjects

Finding
Pharynx
Peak contraction, mm Hg
Contraction duration, s

40.6 ± 1.8
0.37 ± 0.03

tomy, postoperative respiratory insuf
ficiency occurred, necessitating trache
ostomy, long-term respiratory support
and intravenous hyperalimentation. In
the other patient a retropharyngeal
hematoma developed and then resolved
spontaneously. There were no deaths.
D iscussion

Oculopharyngeal muscular dystrophy
is considered a rare disease. In certain
areas, however, it can be observed quite
frequently. Since the genetic basis was
established by Barbeau,5 a clear auto
somal dominant transmission in a num
ber of Quebec families has been de
scribed. Most of the cases reported
elsewhere are also of French-Canadian
origin.
Because of the rarity of the disease,
relatively little is known of the clinical
aspects and management of these pa
tients. Attention has focused mainly ort
its genetic and neurologic aspects.
As early as 1915 Taylor1 had men
tioned that with the passage of time
a degree of dysphagia develops of such
severity that these patients cannot eat
and die of starvation. This was fre
quently described by a number of our
patients who remembered a parent
dying of starvation, malnutrition or
from clinically diagnosed “laryngeal or
esophageal cancer”.
NORMAL

OPMD

P value

10.4 ± 2.2
0.73 ± 0.07

< 0.001
< 0.001

54.7
71.3
94.4
76.5

NS
NS
< 0.02
< 0.01

UES
Resting pressure, mm Hg
55.3 ± 4.1
Contraction pressure, mm Hg 81.2 ± 5.3
Relaxation, %
100
Coordination, %
100

±
±
±
±

7.9
7.3
2.7
9.5

FIG. 1— Normal pharyngeal contraction
generates peak pressure of 41 mm Hg. In
patient with oculopharyngeal muscular
dystrophy (OPMD), pharynx shows power
less contractions. These voluntary con
tractions must be repetitive since bolus
cannot easily cross proximal sphincter area.

NS = Not significant.

Table V—Results of Surgery

Patient
no.
i
2
3
4
5
6
7
8
9
10
11

UES pressure
before operation,
mm Hg

UES pressure
after operation,
mm Hg

Clinical
response

Length of
follow-up, mo

69
100
54
35
34
61
56
125
30
53
—

45
33
58
16
29
28
17
14
22
19
—

Excellent
Excellent
Excellent
Excellent
Good
Excellent
Excellent
Good
Excellent
Good
Excellent

24
14
12
8
6
5
5
4
3
1
18

61.7 ± 9.5*

28.1 ± 4.4*

*P < 0.002.
Excellent = major improvement in all symptoms; good = persistence of one or more incapa
citating symptoms
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FIG. 2— Proximal manometric reading
is in upper esophageal sphincter (UES)
area. Adequate relaxation can be observed
on swallowing but coughing from aspira
tion eventually results. Two readings in
proximal esophagus show absent peristal
sis in waves that follow sphincter closure.
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Most of the patients in our series see such an improvement in patients
had seen a number of doctors and ob with completely deficient pharyngeal
tained little improvement from symp contraction. The degree of improve
tomatic management. After clinical, ment was impressive in our patients on
radiologic and manometric evaluation, whom surgery was performed. The on
we conceived the pattern of oropharyn ly physiologic explanation for this is a
geal dysphagia to be as follows: pha lowering of the pressure barrier at the
ryngeal contractions are powerless UES level in the presence of normal
against the normal resting pressure of activity and propulsive force of the
the proximal esophageal sphincter and tongue, permitting an easier transit of
since an adequate pressure signal is food from the pharynx to the esopha
essential for proper function of the gus. The surgical treatment was re
UES, relaxation of the sphincter is late stricted to patients with severe symp
or incomplete. Oral and nasal regur toms. Lesser degrees of dysphagia ap
gitation occur with repeated episodes pear to be manageable by medication
of aspiration. These patients avoid eat or dilatation.
A word of caution is in order con
ing with their families or in public.
Whether this malfunction of the cerning dilatation. At operation, in all
UES is due to a disease or results from patients with oropharyngeal muscular
a weak signal secondary to a deficient dystrophy, a tight and localized point
pharyngeal contraction is still not clear. of constriction was observed at the
Present knowledge points to a primary junction of the pharynx and the cer
pathologic condition of the muscle,3'4'7'12 vical esophagus. Even under anesthe
but the peripheral nervous system as sia with the esophagus in hand, it may
well as neural transmission may be prove difficult to pass the bougie across
involved. Of interest is the clinical ob the UES area. With such a resistance
servation by one of us (A.B.) that in and the lateral dilatations of the pyri
the early phase of the disease dysphagia form sinuses, perforation could easily
responds to anticholinesterase medica occur.
Even if surgery does not influence
tion. This is contrary to the conclusions
of most reports published to date on the underlying pathology of the dis
the use of edrophonium chloride (Ten ease, marked symptomatic improve
silon, Roche). More studies are needed ment may result from a simple myo
to evaluate the response to this medica tomy at the proximal sphincter level.
tion. Two patients who ceased to re Long-term results need to be assessed.
spond to anticholinesterase treatment
We thank Dr. Jacques Sylvestre and
were submitted to esophageal dilatation Dr. Gilles Beauchamp for constructive
by mercury bougies. This proved very criticism and Miss Christine Holland for
helpful in one patient but brought typing the manuscript.
about no change in the other.
References
Surgical treatment by cricopharyn
geal myotomy, as reported by Mont
1. T aylor EW: Progressive vagus-glos
gomery and Lynch,10 Peterman, Lillingsopharyngeal paralysis with ptosis: a
contribution to the group of family
ton and Jamplis,11 Blakeley, Garety and
diseases. J Nerv Merit Dis 42: 129,
Smith.14 Bender15 and Mills,16 brought
1915
about clinical improvement in most of
2. V ictor M, H ayes R, A dams RD:
the reported cases. It is surprising to
Oculopharyngeal muscular dystrophy.

A familial disease of late life charac
terized by dysphagia and progressive
ptosis of the eyelids. N Eng J Med
267: 1267, 1962
3. A myot R: Ptosis hereditaire familial
et tardif des paupieres superieures.
Union Med Can 77: 1287, 1948
4. Saucier J : The clinical significance
of ptosis with special reference to
ptosis of late onset. J Nerv Merit Dis
119: 148, 1954
5. Barbeau A: La “myopathie oculaire”
au Canada frangais: etude preliminaire, in Conipte Rendu du ler Congres International de N euro-G enetique
et de Neuro-Ophtalmologie, Basel/

New York, Karger, 1968, pp 49-55
6. M yrianthopoulos NC, Brown 1A:
A genetic study of progressive spinal
muscular atrophy. Am J Hum Genet
6: 387, 1954
7. W eitzner S: Changes in the pharyn
geal and esophageal musculature in
oculopharyngeal muscular dystrophy.
Am J Dig Dis 14: 805, 1969
8. L ewis I: Late-onset muscle dystrophy:
oculopharyngoesophageal variety. Can
Med Assoc J 95: 146, 1966
9. Bray GM, K aarsoo M, Ross RT:
Ocular myopathy with dysphagia.
Neurology (Minneap) 15: 678, 1965
10. M ontgomery WW, L ynch JP: Ocu
lopharyngeal
muscular
dystrophy
treated by inferior constrictor myo
tomy. Trans Am Acad Ophthalmol
Otolaryngol 75: 986, 1971
11. P eterman AF, L illington GA,
J amplis RW: Progressive muscular
dystrophy with ptosis and dysphagia.
Arch Neurol 10: 38, 1964
12. R oberts AH, Bamforth J: The
pharynx and esophagus in ocular
muscular dystrophy. Neurology 18:
645, 1968
13. M urphy SF, D rachman DB: The
oculopharyngeal syndrome. JAMA
203: 1003, 1968
14. Blakeley WR, G arety EJ, Smith
DF: Section of the cricopharyngeus
muscle for dysphagia. Arch Surg 96:
745, 1968
15. Bender MD: Esophageal manometry
in oculopharyngeal dystrophy. Am J
Gastroenterol 65: 215, 1976
16. M ills CP: Dysphagia in pharyngeal
paralysis treated by cricopharyngeal
sphincterotomy. Lancet 1: 455, 1973

Critique of Item 20 (SESAP II)
Anemia is a common finding among postgastrectomy patients. The point at issue is whether the anemia is
related to failure to absorb iron, to iron loss, or to the deficiency of extrinsic factors. Iron deficiency might re
sult simply from inadequate intake or from inadequate absorption. Iron deficiency may also develop when rela
tive or absolute achlorhydria is present, or when the ingested iron is diverted from the normal duodenal absorptive
surface. Iron deficiency anemia would be expected in the presence of marginal ulceration and slow but chronic loss
of blood. In either instance, the anemia would be microcytic and hypochromic. Anemia secondary to loss of the extrin
sic factors B12 and folic acid is typically megaloblastic and therefore macrocytic and normochromic. Among the tests
listed, the blood indices would be the most helpful. Commonly used methods for determining B12 absorption seem
to be of little value after gastrectomy. If deficient B12 is suspected, studies of the level of serum B 12 and red
blood cell B12 are indicated.

2 0 /1 . Deller DJ, Ibbotson RN, Crompton B: Metabolic effects of partial gastrectomy with special reference to

calcium and folic acid: II. The contribution of folic aciddeficiency to the anaemia. Gut 5:225-229, 1964
2 0 /2 . Mahmud K. Ripley D, Doscherholmen A: Vitamin B)2 absorption tests: Their unreliability in postgastrectomy
states. JAMA 216:1167-1171 (May) 1971
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To lower
blood pressure
during
anesthesia

reduces excessive
blood loss

Precautions

for controlled hypotension during anesthesia
Rx Summary
‘Nipride’ is only to be used as an infusion with sterile 5% dextrose
in water without preservatives. Not for direct injection.
Indications
'Nipride' is indicated for producing controlled hypotension during
anesthesia to reduce bleeding in surgical procedures where deemed
appropriate. Benefit-risk ratio should be carefully considered on an
individual basis.
Contraindications
In the treatm ent of com pensatory hypertension, e.g. arteriovenous
shunt or coarctation of the aorta. It is also contraindicated in physically
poor-risk patients (A.S.A. Risk 5), in patients with uncorrected anemia
or hypovolemia or in those with known inadequate cerebral circulation.
In patients with liver disease, severe renal disease, Leber’s optic
atrophy and disease states associated with vitamin B12 deficiency.
Warnings
‘Nipride’ is only to be used as an infusion with sterile 5% dextrose
in water without preservatives. Not for direct injection. Infusion rates
greater than 8 /ig/kg/m inute are virtually never required. If at this
rate an adequate reduction in blood pressure is not obtained within
10 minutes, administration of ‘Nipride’ should be stopped.
Fatalities due to cyanide poisoning have occurred following sodium
nitroprusside administration. One factor is common to all known
cases, namely that large amounts of nitroprusside were infused at
high rates. Since detoxification relies upon enzymatic action, the
rare possibility of deficient or atypical enzymes occurring in humans
should always be considered. Patients most apt to run into difficul
ties are those who are resistant to the hypotensive effect or those
in whom maintenance at the selected blood pressure level is difficult
or impossible.
Constant attention to the patient’s dose-response characteristics
is mandatory, if infusion rates are in excess of 8 ^g/kg/m inute deter
mine the nature of the response (effective constant response at
higher dose; tachyphylactic; resistant - none or less than expected).
As soon as either tachyphylaxis or resistance is determined the infu
sion of ‘Nipride’ should be discontinued immediately. In abnormal
responders it has been noted that metabolic acidosis may occur
at higher doses.
Caution should be exercised in using 'Nipride' in patients with hypo
thyroidism or severe renal im pairm ent.
Blood levels of thiocyanate should be determined if treatm ent is to
be extended especially in patients with severe renal dysfunction.
As long as blood thiocyanate levels do not exceed 10 m g/100 ml, it is
probably safe to continue with the infusion. Peritoneal dialysis can
be helpful if too high levels o f thiocyanate are found.
Hypertensive patients are more sensitive to the intravenous effect
of sodium nitroprusside than are normotensive subjects. Patients
receiving concom itant antihypertensive m edications (especially
hydralazine or hexamethonium) are more sensitive to the hypotensive
effect of sodium nitroprusside and the dosage of 'N ipride' should
be adjusted downward accordingly.
The following Warnings apply to the use of 'N ipride' fo r controlled
hypotension during anesthesia:
1. Extreme caution should be exercised in patients who are especially
poor surgical risks (A.S.A. class 4 and 4E).
2. Tolerance to blood loss, anemia and hypovolemia may be dim in
ished. If possible, preexisting anemia and hypovolem ia should be
corrected prior to em ploying controlled hypotension.
3. Hypotensive anesthetic techniques may alter pulmonary ventilation
perfusion ratio. Patients intolerant of additional dead air space
at ordinary oxygen partial pressure may benefit from higher oxygen
partial pressure.
4. Resistance and tachyphylaxis o c c u r more frequently in norm oten
sive patients infused with sodium nitroprusside. Induction of delib
erate hypotension in healthy young individuals may prove to be
more d ifficu lt than in oth er segments of the population.
5. Upon discontinuance of the sodium nitroprusside infusion for the
purpose of controlled hypotension during anesthesia a rebound
hypertension has been observed on rare occasions.

Adequate facilities, equipm ent and personnel should be available
fo r frequent and vigilant m onitoring of blood pressure. W hen the in fu 
sion is slowed or stopped, blood pressure usually begins to rise imme
diately and returns to pretreatm ent levels w ith in one to ten m inutes.
It should be used with caution and initially in low doses in elderly
patients, since they may be more sensitive to the hypotensive effects
of the drug.
If, in the clin ica l situation, stress induced by pain or m anipulation
is reduced o r elim inated during 'N ip ride ' infusion, the patient could
experience a greater than expected red u ctio n in blood pressure
unless the rate of infusion is adjusted dow nw ard as required.
'Nipride' te n ds to deteriorate in th e presence of light. Therefore, the
infusion bo ttle should be w rapped w ith alum inum foil or oth er opaque
material. Solutions of ‘N ipride’ should not be kept or used longer
than four hours. 'Nipride' in aqueous solution yields the nitroprusside
ion, which reacts with even m inute q u a ntitie s of a wide variety of
organic and inorganic substances to form usually highly coloured
reaction pro d u cts (blue, green or dark red). If this occurs, the infusion
should be replaced as quickly as possible.
Adverse reactions
Nausea, retching, emesis, diaphoresis, apprehension, headache,
restlessness, agitation, muscle tw itch in g , retrosternal disco m fo rt and
chest pain, palpitations, dizziness, faintness, weakness, rash, abdo
minal pain, confusion and som nolence have been noted w ith too
rapid reduction in blood pressure. These sym ptom s rapidly disap
peared with slowing of the rate of infusion o r tem porary d isco n tin ua 
tion of infusion and did not reappear with co n tin ue d slow er rate
of adm inistration.
Irritation o f the injection site may o ccu r. M ethem oglobinem ia and
one case o f hypothyroidism fo llow ing p rolonged therapy have been
reported.
Dosage and administration (for controlled hypotension)
Use of ‘Nipride’ in anesthetized normotensive patients undergoing
deliberate hypotensive surgery must be restricted to carefully
selected cases. There is a possibility of an abnormal response
occurring in normotensive patients. In this event, the infusion of
‘Nipride’ should be discontinued immediately. (See Warnings).
The contents of a 50 mg ‘N ipride’ vial should be dissolved in 3 ml
of sterile dextrose in w ater w ith o u t preservatives. No other diluent
should be used. Depending on the desired co n ce n tra tio n , all of the
prepared sto ck solution should be diluted in 500 or 1000 ml o f 5 per
cent sterile dextrose in water and prom ptly w rapped in alum inum
fo il or other opaque material. Both sto ck so lution and infusion solu
tion should be freshly prepared and any unused portion discarded.
The freshly prepared solution fo r infusion has a very fa in t brownish
tint. If it is highly coloured, it should be discarded. (See Precautions).
The solution should not be kept or used longer than fo u r hours from
initial reconstitution. The infusion fluid used fo r the adm inistration
of 'Nipride' should not be em ployed as a vehicle fo r sim ultaneous
adm inistration of any other drug.
'Nipride' dosage varies considerably from pa tie nt to patient, hence
the need fo r individual titration. The infusion should be started at
the lower dosage range, 0.5 ,u g /kg /m in u te and increased by
0.2 fjg /k g /m in u te every 5 m inutes until the desired red u ctio n in
blood pressure is obtained. The blood pressure usually starts to drop
immediately o r at least w ithin a few m inutes. C on tin u ou s m onitoring
of the blood pressure is necessary. Blood pressure should not be
allowed to d ro p at too rapid a rate and systolic pressure should not
be lowered below 60 mm Hg.
Infusion rates greater than 8 jig /k g /m in u te should rarely be used.
The maximum recom m ended dose is 800 m g/m inute.
‘Nipride’ should be adm inistered by an infusion pump, m icro -d rip
regulator o r any similar device th a t will allow precise m easurem ent
of the flow rate. Avoid extravasation. The rate should be adjusted
to maintain the desired hypotensive effe ct, as determ ined by freq u e n t
blood pressure determ inations.
For the use o f 'N ipride' in the trea tm e nt o f hypertensive crises please
refer to the Product M onograph.
Supply
'Nipride' is supplied in 5 ml am ber-coloured vials co n ta in in g the
equivalent o f 50 mg sodium nitroprusside fo r dilu tio n with 5 percent
sterile dextrose in water (available in packages o f 10).
Product M onograph available on request.
* Reg. Trade Mark for sodium nitro p ru ssid e 'R oche'
® Reg. Trade Mark

Can. 8042

(sodium nitroprusside)

Usage in pregnancy
The safety of 'Nipride' in women who are or who may become preg
nant has not been established; hence, it should be given only when
the potential benefits have been weighed against possible hazard
to mother and fetus.
Usage in children
The safety of 'Nipride' in children has not been established. Clinical
experience is limited.

Hoffmann-La Roche Limited
Vaudreuil, Quebec
J7V6B3
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Cholestatic Jaundice
During Total Parenteral Nutrition
D.B. A llardyce ,

md , fr c s [c ],

Because of the frequent occurrence
of cholestasis in patients receiving
total parenteral nutrition (TPN), the
authors reviewed 32 cases in which
the patient had been so supported
for over 30 days. The indications for
this form of management were
complications of gastrointestinal surgery
or inflammatory bowel disease.
The initial protocol for administering
TPN provided a total of 45 C al/kg
(188 kJ/kg). Sixty percent of the
energy requirement was supplied as
Intralipid 10% (Pharmacia), 3 g /k g
daily, and 40% as hypertonic dextrose.
Amino acids were supplied by Travasol
(Baxter Laboratories), 100 g or
2 g/kg of protein daily.
Twenty-four of the 32 patients treated
according to this protocol showed
elevated serum alkaline phosphatase
values by 19 ± 2 .9 days. An increase
in the concentration of serum bilirubin
was evident at 30 ± 1.5 days; in 19
of the 32 individuals the increase was
progressive to above 2.5 m g/dL
(43 jj.mol/L). Liver biopsy specimens from
eight patients showed well-preserved
hepatocytes, but bile-duct proliferation,
periportal bile plugs and inflammatory
infiltrates in portal areas.
The cholestasis was corrected and
liver function returned to normal in
all surviving patients when TPN was
discontinued. Substantial reduction in
the Intralipid component resulted in
reversal of cholestasis in three patients.
The authors conclude that TPN
supplies a high total and percentage
of energy requirements in the form of
lipid emulsion when combined with
hypertonic dextrose and that a high
protein intake (2 g /k g daily) will induce
progressive cholestatic jaundice in a
high percentage of patients if
administered for more than 30 days.

From the departments of surgery and
pathology, University o f British Columbia,
Vancouver, BC
Presented at the 1st annual meeting o f the
Canadian Association o f General
Surgeons, Vancouver, BC, Jan. 25, 1978
Reprint requests to: Dr. D.B. Allardyce,
Department o f surgery, University o f
British Columbia, 700 W 10th Ave.,
Vancouver, BC V5Z 1L5
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A.J. S alvian ,

m d and

N.F. Q u e n v il l e ,

A cause de I'apparition frequente d'une
cholostase chez les patients recevant
une alimentation parenterale complete
(APC) les auteurs ont etudie 32 cas
ou les patients ont ete maintenus de
cette facon pendant plus de 30 jours.
Les indications de ce mode de traitement
ont ete les complications de la chirurgie
gastrointestinale ou une maladie
inflammatoire de I’intestin.
Le protocole original d’APC assurait
un total de 45 C al/kg (188 kJ/kg).
Soixante pourcent des besoins
energetiques ont ete assures par de
I'lntralipid 10% (Pharmacia), 3 g/kg
par jour, et 40% sous forme de dextrose
hypertonique. Les acides amines ont
ete procures par le Travasol (des
Laboratoires Baxter), 100 g ou 2 g /kg
de proteine quotidiennement.
Vingt-quatre des 32 patients traites
selon ce protocole ont presente une
augmentation de la phosphatase alcaline
serique a compter du jour 19 ± 2.9.
Une augmentation de la concentration
serique de bilirubine a ete observee
au jour 30 ± 1.5; chez 19 des 32
sujets, (’augmentation a ete progressive
jusqu'a plus de 2.5 m g/dL (43 um ol/L).
Chez huit patients, une biopsie du
foie a revele une bonne conservation
des hepatocytes, mais aussi une
proliferation du canal biliaire, des
bouchons biliaires peri-portes et des
infiltrats inflammatoires de la region
porte.
La cholostase s'est corrigee et la
fonction hepatique est revenue a la
normale chez tous les patients qui ont
survecu, lorsque I'APC a ete interrompue.
Une reduction substantielle de la
partie Intralipid a amene une inversion
de la cholostase chez trois patients.
Les auteurs concluent que I'APC
procure un total eleve et un fort
pourcentage des besoins energetiques
sous la forme d’une emulsion de lipides
quand elle est associee a une solution
hypertonique de dextrose et qu'un
apport proteinique eleve (2 g /kg par
jour) provoque progressivement un
ictere cholostatique chez un fort
pourcentage des patients lorsqu'il est
administre pendant plus de 30 jours.

m d , f r c p [c ]

tal parenteral nutrition (TPN). Since
1975 more than 150 patients under our
care have been supported with TPN.
In 37 of them this form of manage
ment was continued for over 30 days
but we omit from this review five cases
in which the course of the illness was
complicated by severe sepsis and re
peated operations. In the remaining 32,
enterocutaneous fistulas and inflam
matory bowel disease were the com
monest indications for instituting TPN
(Table I). Cholestatic jaundice de
veloped in 19 patients and the serum
alkaline phosphatase concentration was
elevated in 24.
We have examined the records of
these patients with particular attention
to the composition of the solutions
administered, the monitoring of vari
ous clinical and laboratory values and
the effect of TPN on hepatic function.

Composition of Solutions
Parenteral nutrition was initiated
using a mixture comprising 1500 mL
of Intralipid 10% (Pharmacia, Dorval,
PQ) (3 g/kg), 1100 mL of Travasol
(Baxter Laboratories of Canada Ltd.,
Malton, Ont.) and 400 mL of 50% dex
trose. The total nonprotein energy sup
ply was 2300 Cal (9.63 x 103 kJ)
(45 Cal/kg [188 kJ/kg]). Solutions
were generally administered through
centrally placed catheters, but through
peripheral veins for short periods in
some patients. Because of the develop
ment of jaundice in a few patients,
Ta b le
1— U n d e r ly in g
C o n d itio n s
of
32
P a tie n ts W ho R eceive d TPN fo r Lo n g e r th a n
30 D ays D u rin g 1976 and 1977

C o n d itio n
In fla m m a to ry b o w e l dise a se
Esophageal d is e a s e
D uod ena l fis tu la
In te s tin a l fis tu la
C o lo n ic fis tu la
O th e r
T o ta l
‘ M o re th a n o n e c o n d itio n w as

No. o f
p a tie n ts
10
3
5
5
8
4
35*
p re s e n t in

Progressive cholestatic jaundice may som e p a tie n ts .
develop in adult patients receiving to
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acetic transaminase (SGOT), bilirubin
(total and indirect), cholesterol, trigly
cerides and proteins and the prothrom
bin time were measured weekly. The
bromsulfalein test was performed in
three patients before the start of TPN.
Oral feeding was withheld in most
patients. Access to water was permit
ted for those able to take fluids. Two
patients were able to take a fluid diet,
and one patient was advanced to full
diet while on TPN in order to observe
the effect on cholestasis.

mined twice weekly; values of serum
alkaline phosphatase, glutamic oxalo

20% dextrose or a protein hydrolysate
(Amigen 5% or Amigen 800 [Baxter
Laboratories]) was substituted as the
energy or protein source.
The major components and additives
of the TPN solution are shown in Ta
ble II. Folic acid (10 mg), vitamin
B 12 (100 jug) and phytonadione (10
mg) were given intramuscularly once
a week. Zinc sulfate and other trace
metals were given if the course of TPN
extended beyond 3 weeks.

Table II— Major Components and Additives
of TPN Solution

Monitoring
Patients receiving TPN had close
monitoring of pulse rate, temperature
and fluid balance. Values of serum
electrolytes, blood urea nitrogen and
creatinine, hemoglobin, and leuko
cyte count and differential were deter

Travasol (Baxter Laboratories),
mL
Intralipid 10% (Pharmacia), mL
Dextrose 50%, mL
Protein, g
Nitrogen, g
Nonprotein energy, Cal

1050
1500
450
105
17.5
2650

Additives
MVI (Arlington Laboratories),
mL
Calcium gluconate, meq/d
Magnesium sulfate, meq/d
Vitamin K, mg/wk
Vitamin B 12, [xg/wk
Folic acid, mg/wk

10
4.7-9.4
4.0-8.0
20
100
10

Liver Function during TPN
Table III sets forth, for the 32 pa
tients studied, the composition of the
TPN mixture infused, the duration of
TPN when elevation of serum bilirubin
first became apparent, and the peak

Table III — 32 Patients on TPN Classified According to the Presence of: Progressive Cholestasis (19), Minimal Changes (5),
or No Change in Liver Function (8)
Serum alkaline
phosphatase
Serum bilirubin
Composition of TPN
solution, mL
Patient
no.

Sex

i
2
3

M
F
F

4
5
6

M
F
M

7
8

F
F

9
10
11
12
13
14
15
16
17
18
19

M
M
M
F
F
F
M
M
F
M
M

20

F

21
22
23

F
F
M

24

M

25
26

M
F

27
28

M
F

29

M

30
31

M
M

32

F

Age,
yr

Diagnosis

Travasol

45 Crohn’s disease (ileum)
34 Crohn’s disease (colon)
64 Ovarian carcinoma,
rectovaginal fistula
66 Esophageal necrosis
26 Crohn’s disease
37 Crohn's disease, gastric
outlet obstruction
58 Perforation of esophagus
69 Duodenal fistula, pancreatitis
61 Pancreatitis
35 Crohn’s disease (ileum)
73 Postgastrectomy
62 Small-bowel fistula
38 Perforated gastric ulcer
66 Ulcerative colitis
52 Diverticulitis
64 Subphrenic abscess
61 Crohn’s disease
28 Appendectomy, fistula
40 Duodenal fistula
78 Irradiation for carcinoma
of esophagus
50 Colonic carcinoma
52 Crohn’s disease
73 Abdominal wall sepsis,
fistula
61 Hypernephroma, mesenteric thrombosis
17 Crohn’s disease
22 Crohn’s disease (rectovaginal fistula)
50 Small-bowel fistula
18 Crohn’s disease, total
colectomy
70 Small-bowel fistula,
necrotizing fasciitis
45 Duodenal fistula
Bladder
carcinoma, bowel
64
obstruction
54 Pancreatitis

Days of
TPN

Days of TPN

Intralipid Dextrose
50%
10%

Peak
value, Elevated Peak at
day
mg/dL at day

Base
value,
IU

Peak
value, Elevated
IU
at day

SGOT Duration
peak
of
value, therapy,
IU
d

1050
1600

1500
2000

450
400

8.8
9.6

24
20

38
37

73
158

750
735

—
—

—
230

35
39

1050
1050
1600

1500
1500
2000

450
450
400

11.2
3.4
4.7

33
25
30

48
32
60

77
46
—

349
420
700

28
—
24

107
170
—

116
60
52

1200
1100

2000
1500

600
400

4.5
4.0

27
38

40
—

68
—

655
1150

15
10

152
58

52
62

1050
1050
1150
1100
1100
1050
1050
1500
1100*
1700
1100
1000

1500
1620
1500
1500
1500
1500
1500
200
1500
2000
1500
1000

450
450
450
450
400
450
450
500
400
300
400
—

4.6
24.5
13.2
4.9
6.4
4.0
3.6
6.2
3.6
9.8
3.0
2.5

30
31
30
42
35
36
32
25
30
63
26

37
—
46
51
67
45
52
60
31
54
—
28

—
—
—
91
—
50
65
120
44
—
—
30

520
400
800
1800
480
722
1000
750
313
758
767
—

20
—
10
10
15
—
24
20
40
20
—
—

50
—
200
200
85
—
90
210
85
202
—
—

41
31
49
45
64
42
46
109
42
64
60
33

1000
1050
1100

1500
1500
1500

400
450
400

1.3
1.3
1.6

28
24
45

—
—
50

—
—
—

—
580
275

—
24
—

30
29
52

—
80
—

1100

1500

400

1.3

27

—

—

—

—

106

—

203

—

38

56

1400

1500

1500

___

—

600

1.4

30

34

39

1500

N

—

—

—

N

—

N

35

1500f
1500t

1500
2000

400
600

N
N

—
—

—
—

—
—

340
N

10
—

N
N

38
54

1100

1500

400

N

—

—

—

—

—

N

38

1100
1400

1500
2000

400
600

N
N

—
—

—
—

—
—

506
N

30
—

N
N

49
77

750
750

1500
1500

750
—

N

—

1 .0

—

—
—

—
—

—
449

—
—

—
N

—
38

*Freamine (McGaw Laboratories, Santa Ana, CA).
tAmigen 800 (Baxter Laboratories).
N = normal.
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IU

IU

mg/dL

bilirubin and alkaline phosphatase con
centrations reached.
The patients were divided into three
groups—those demonstrating progres
sive elevation of serum bilirubin and
alkaline phosphatase (19 patients),
those with bilirubin values between 1.0
and 2.5 mg/dL (17.1 and 42.7 /zmol/L)
associated with elevated serum alkaline
phosphatase values (5), and those who
maintained normal serum bilirubin
concentrations (8). Two of the lastnamed group had elevated serum alka
line phosphatase concentrations.
All patients who eventually exhibited
progressive cholestasis had normal se
rum bilirubin values when TPN was
started. In three individuals tested, the
bromsulfalein test also gave a normal
result.
The earliest time at which the serum
bilirubin concentration became elevated
was on day 20 after starting TPN. By
day 42, 18 of 32 patients were jaun
diced. One individual received treat
ment with TPN for 63 days before

a Aik. Phos.
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FIG. 1— Case 1. Values of serum glutamic oxaloacetic transaminase (SGOT, IU),
alkaline phosphatase (Aik. Phos., IU) and bilirubin (Bil., mg/dL) during this patient’s
hospital course (days).
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FIG . 2— Case 2. Values of SGOT, serum alkaline phos
phatase and bilirubin during hospitalization.
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FIG. 4— Case 4. Values of SGOT, serum alkaline phos
phatase and bilirubin during hospitalization.
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FIG. 3— Case 3. Values of SGOT, serum alkaline phos
phatase and bilirubin during hospitalization.
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FIG. 5— Case 5. Values of SGOT, serum alkaline phos
phatase and bilirubin during hospitalization.
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elevation of the serum bilirubin value
was noted.
Elevation of serum alkaline phospha
tase was apparent before elevation in
serum bilirubin; the average time at
which it was first noted was on day
19 ± 2.9 days. Peak values of 748 ±
89 IU were reached. M oderate eleva
tion of the SGOT concentration de
veloped and stabilized at 100 to 200
IU (normal, to 37 IU). The prothrom 
bin time and serum albumin value
were normal or improved while the
patient received TPN.
The course of bilirubin, alkaline
phosphatase and SGOT values in six
patients is illustrated by the cases re
ported below (Figs. 1 to 7). Generally
the first abnormality to appear is a
progressive rise in the serum alkaline
phosphatase value, followed by an in
crease in SGOT and bilirubin con
centrations. The bilirubinemia is large
ly direct-reacting. Withdrawal of TPN
resulted in prompt reversal of these
trends in most patients, although “over
shoot” and slow recovery were noted in
four individuals (Figs. 2 to 5). The re
sults of all liver function tests showed
a return to normal in all surviving pa
tients. Three deaths occurred in the
group of jaundiced patients and two
of these individuals were still jaun
diced at the time of death. Deaths were
due to cardiorespiratory complications
or to an advanced malignant condi
tion and did not appear to be related
to cholestasis.
Case Reports

Case 1.—A diagnosis of Crohn’s dis
ease with predominantly colonic involve
ment had been made in a 34-year-old
woman (patient 2, Table III) 2 years be
fore admission and she was taking sul
fasalazine (Salazopyrin, Pharmacia) and
prednisone 20 mg/d. Exacerbation of her
disease had developed and she was daily
passing 10 to 20 liquid stools containing

blood. She was admitted for a period of
intestinal rest. This patient had a slightly
Cushingoid appearance and was mildly
obese (weight, 58 kg). Her temperature
was normal and her pulse rate was 90
beats/min. She was allowed clear fluids
by mouth up to 1000 mL/d. TPN was in
stituted; the solution provided 1600 mL
of Travasol and 2000 mL of Intralipid
10% per day (3 g/kg of protein and 3.4
g/kg of fat daily). Total intake was 2800
Cal (11.72 X 103 kJ) daily or 50 Cal
(209 kJ)/kg. The patient was managed
on a medical service apart from the sur
gical parenteral nutrition program and it
is our belief that the protein and fat in
take and total energy intake for a 58-kg
patient, requiring maintenance only, was
in excess of the requirements. The effects
on her liver function are shown in Fig. 1.
No manifestations of sepsis appeared dur
ing her illness. Her tachycardia (between
90 and
100 beats/min)
persisted
throughout her hospitalization. Leukocyte
and differential counts were normal. Her
gastrointestinal symptoms were much re
lieved when she was discharged on the
45th hospital day, although her SGOT
and serum alkaline phosphatase and bili
rubin values were still elevated. When
she returned 5 months later for hemor
rhoidectomy, all indices of liver function
were within normal limits.
Case 2.—A 26-year-old woman (pa
tient 5, Table III) had Crohn’s disease of
the terminal ileum and cecum and com
plained of persistent obstructive symp
toms. She was admitted for intestinal rest.
She was taking prednisone 50 mg/d and
Salazopyrin 0.5 g six times daily. The
same TPN protocol was observed as for
the patient in case 1 for 52 days with
similar effects upon liver function (Fig.
2). Her pulse rate fluctuated between 90
and 110 beats/min. Throughout her hos
pitalization she remained afebrile, and the
leukocyte and differential counts were
normal. She was ambulatory and symp
tomatically greatly improved. On admis
sion she weighed 51 kg so that calculated
amounts of Travasol and Intralipid 10%
and her total energy supply were clearly
excessive. After 75 days in hospital her
symptoms were considerably relieved and

FIG. 6— Case 6. Values o f SGOT, serum alkaline phos
phatase and bilirubin during hospitalization.
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her weight had increased to 67 kg. Re
sults of tests for liver function were still
abnormal when she was discharged. She
was kept under surveillance as an out
patient and indices of liver function
showed improvement. Approximately 150
days later she was readmitted for intes
tinal resection because of increasing ob
struction. Liver function was normal at
that time.
Case 3.—A 37-year-old man (patient
6, Table III) was transferred to Vancou
ver General Hospital because of recent
perforation of a stomal ulcer at a gastro
enterostomy site; the operation had been
performed for obstruction of the duodenum
caused by Crohn’s disease. Gastric outlet
obstruction persisted with daily loss of
large volumes of fluid. On admission he
weighed 53 kg, his temperature was 38 "C
and his pulse rate 100 beats/min; the
leukocyte and differential counts were
normal. Initially he was treated by naso
gastric decompression and parenteral
feeding. Calculated amounts of Travasol
and Intralipid 10% administered were
more modest than in cases 1 and 2 but
were still excessive. On this regimen his
weight increased to 60 kg and his strength
and mobility greatly improved. However,
the SGOT value showed a mild increase
and the serum bilirubin concentration was
elevated above 2 mg/dL (34.2 pmol/L) by
hospital day 35 (Fig. 3). A repeat gastro
jejunostomy was performed on day 36 to
permit gastric drainage. Postoperatively
he continued to show an upward trend of
serum bilirubin, alkaline phosphatase and
SGOT values. TPN was discontinued on
hospital day 55, and after a short in
terval and overshoot of serum alkaline
phosphatase concentration, his liver func
tion returned to normal. Intravenous
cholangiography at this time showed nor
mal-sized extrahepatic ducts.
Case 4.—This 62-year-old woman
(patient 12, Table III) originally under
went laparotomy for a pelvic mass. She
was found to have ovarian metastases
from a previous primary growth of the
colon. As there was no evidence of spread
elsewhere, the ovarian tumour was ex
tirpated. A small-bowel fistula developed
on the 10th postoperative day so TPN

FIG. 7— Case 7. Values of SGOT, serum alkaline phos
phatase and bilirubin during hospitalization.
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was instituted. Initially there was per
sistent tachycardia and leukocytosis but
these manifestations of sepsis regressed.
After 40 days of TPN, however, th;
fistula had not closed, so a small-bowel
resection was performed. TPN was con
tinued and an increase in concentrations
of serum bilirubin and alkaline phospha
tase was detected (Fig. 4). After 60 days
of TPN the regimen was changed to
Amigen with a partial reversal of cholesta
sis. The patient was discharged after 95
days in hospital. She returned 3 months
later with evidence of further intra-ab
dominal neoplasia; her condition deteri
orated progressively and she died. At the
time of death, liver function was normal.
Case 5.—A 35-year-old man (patient
10, Table III) had recurrent Crohn’s dis
ease of the ileum and left colon following
previous resection of the terminal ileum
and right colon. He had severe perianal
complications with abscesses and fistulas.
Following evacuation of a perianal abscess
TPN was instituted to ensure intestinal
rest and to improve his nutritional status
prior to further surgery. Serum alkaline
phosphatase concentration increased early
and rapidly after the institution of TPN
(Fig. 5). The serum bilirubin value was
elevated after 38 days of TPN. Resection
of the left colon and rectum was per
formed on day 24 of TPN. At operation,
calculi were found in the gallbladder,
which was removed. An operative cholangiogram showed a normal extrahepatic
biliary tree without evidence of obstruc
tion. Following surgery he exhibited no
manifestations of bacterial infection. His
pulse rate never rose above 100 beats/
min, he was afebrile and the band cells
were never in excess of 10%. He received
no medications commonly recognized as
causing cholestasis. Because of progressive
cholestasis, Travasol was deleted from his
program on about day 40. He was sup
ported on dextrose and lipid alone for 10
days but cholestasis progressed neverthe
less. During hospitalization he gained 5.4
kg and was discharged on about hospital
day 55, still icteric and with an elevated
alkaline phosphatase concentration but
feeling well and eating a full diet. On
follow-up within 30 days of discharge,
serum bilirubin, alkaline phosphatase and
SGOT values had all returned to normal.
Case 6.—Cholestasis developed in a
66-year-old woman (patient 14, Table III)
who was receiving TPN and intestinal rest
for severe ulcerative colitis. Because of
progressive cholestasis (Fig. 6) her nutri
tional support was changed from lipid,
dextrose and Travasol to Amigen 800 on
day 50 of her TPN program. Amigen
800 supplies energy requirements as
fructose and as a small quantity of ethanol.
Cholestasis was reversed promptly on this
regimen. Colectomy was performed on
day 57. Liver function tests 117 days after
TPN was instituted revealed normal serum
bilirubin and SGOT values.
Case 7.—Six months before admission,
this 73-year-old man (patient 11, Table
III) had had a total gastrectomy for ade
nocarcinoma of the stomach with a Rouxen-Y esophagojejunostomy. Partial ob
struction appeared to have developed at
the anastomotic site. Weight loss ensued
and he was readmitted for intravenous
336

feeding and investigation. Early in the
course of TPN, rapid elevation of alka
line phosphatase and SGOT concentrations
was noted (Fig. 7). The patient had no
abdominal pain and was afebrile with a
pulse rate of 80 beats/min. Leukocyte
count was normal. He had received no
icterogenic drugs. He was allowed clear
fluids and took up to 1000 mL/d. Eleva
tion of serum alkaline phosphatase values
was suspected to be caused by recurrent
tumour. Because of cholestasis, Travasol
was deleted on day 23 of TPN. On lipid
and 20% dextrose alone the patient re
mained jaundiced with greatly elevated
serum alkaline phosphatase values. All

parenteral feeding was discontinued on
day 40 and he was supported on a mixture
of 10% dextrose and water, Vivonex
(Eaton Laboratories) and other fluids. A
liver biopsy showed periportal inflamma
tion and bile-duct proliferation. After dis
continuance of TPN the results of all
liver function tests returned to normal.
At the same time the patient’s nutritional
status was deteriorating. Terminally, pneu
monia and ureteral obstruction developed.
Autopsy showed recurrent tumour in the
retroperitoneal tissues obstructing the
ureter. No hepatic metastases were pre
sent. The extrahepatic biliary tree was
patent and of normal calibre.
~~
Other Causes of Cholestasis

Table IV— Evidence for Bacterial Sepsis in 19
Cases of Progressive Cholestasis
No. of
patients
Febrile (over 37°C orally) for more
than 5 of first 30 days on TPN
Pulse rate over 90 beats/min for
m orethan5offirst30days
Total leukocyte count over 12.0 X
109/L in first 30days
Band forms over 20% in first 30
days
Positive blood culture
Severe sepsis:
T emperature over 38°C
Pulse rate over 120
beats/min
Leukocytes over 20.0 X
109/L , or
Band forms over 30%

0
5
5
2
2

0

Table V—Operation Prior to Onset of
Progressive Cholestasis
No. of
patients
No operation prior to elevation of
serum bilirubin concentration
Operation (no halothane) prior to
elevation of serum bilirubin
concentration
Operation with halothane
anesthesia

7
2
10

Table VI—Prior Use of Drugs in Cases of
Progressive Cholestasis

Drug

No. of
patients

Phenothiazines
Androgenic steroids
Erythromycin
Chloral hydrate
Barbiturates
Flurazepam HCI
Sulfasalazine (Salazopyrin)
Steroids
Antibiotics
Chloramphenicol
Gentamycin
Ampicillin
Clindamycin
Cephalothin
Cloxaci Min
Tobramycin
Digoxin
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0
0
0
2
2
3
1
2
2
4
2
2
3
3
1
2
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A relationship of the course of
cholestasis to coexisting sepsis, prior
operation and anesthesia or to medica
tion seemed unlikely (Tables IV to VI).
Six patients did not have an anesthetic
or operation. In three individuals their
operation was performed 1 month be
fore the onset of jaundice. None re
ceived any medication commonly asso
ciated with cholestasis. None of the
32 patients suffered from severe bac
terial sepsis, defined as pyrexia over
38°C, pulse rate over 120 beats/min,
leukocyte count over 20 X 109/L or
band forms in excess of 30% (Table
IV).
The absence of a relation to bac
terial sepsis is further illustrated by
the case of a 66-year old man (patient
4, Table III) who underwent resection
of the thoracic esophagus as a result
of strangulation of a paraesophageal
hernia with mediastinitis. This was re
constructed with left colon. Postoperatively a leak developed from the prox
imal coloesophageal anastomosis so
TPN was begun. On the TPN regimen
serum alkaline phosphatase and bili
rubin concentrations became elevated
(Fig. 8a). Travasol and dextrose were
continued but the lipid was reduced to
1000 mL weekly to avoid deficiency
of essential fatty acids. On markedly
reduced lipid intake serum bilirubin
and alkaline phosphatase values re
turned to normal. His temperature and
pulse rate remained normal throughout,
except on one occasion (Fig. 8b). Al
though the percentage of band cells in
the differential leukocyte count was in
creased initially, it was below 10%
throughout the period in which chole
stasis was evident.
Patency of the biliary system was
demonstrated by cholangiography, Bscanning, or at autopsy in seven of the
jaundiced patients. Eight others were
operated on before or during their
course of TPN and the liver and biliary
system were found to be normal (Table
VII). No operative or radiologic evalu
ation of the bile ducts was made in
four patients, but their liver function
returned to normal and remained so
after TPN was discontinued.
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Liver Biopsy

Liver biopsy specimens were ob
tained from eight patients and demon
strated a consistent lesion typified by

portal areas expanded by inflammatory
cell infiltrates and bile-duct prolifera
tion. Bile plugs were present in peri
portal canaliculi. The liver cells were
well preserved (Figs. 9 to 11).

IU mg/dL mg/dL

beats/m in

°C

Discussion

The development of abnormalities of
liver function has not been detected
by close observation of adults who have
been maintained on long-term parent
eral nutrition.1 Furthermore, it has
usually been possible to ascribe hyper
bilirubinemia in surgical patients receiv
ing parenteral nutrition to sepsis, drugs,
tissue trauma, resolving hematomas,
anesthetic agents, hemolysis, hypoxia,
shock, or extrahepatic ductal obstruc
tion. Because these septic and metabolic
insults have been identified in many of
our patients, one might question
whether the cholestatic jaundice we re
port here was related to TPN.
The early phase of our patients’ ill
ness often involved major trauma, op
erative procedures and bacterial sepsis.
The cholestasis seen later bore no rela
tion to the earlier catabolic illness. In
contrast, cholestasis appeared to de
velop when patients were in a phase
of rapid anabolism without manifesta
tions of sepsis. Although some patients
did demonstrate moderate tachycardia
(pulse rate, 90 to 100 beats/min) and
leukocytosis for extended periods,
cholestasis supervened on an unchang
ing pattern of pulse rate and leukocyte
count.
Two patients with Crohn’s disease
were receiving TPN to ensure a period
of intestinal rest and to improve their
nutritional status. No operation was
performed and the only medications
prescribed were prednisone and sulfa
salazine (Salazopyrin, Pharmacia). Nei
ther patient was febrile and the pulse
rate was elevated only minimally
throughout. Both individuals demon
strated progressive elevation of serum
alkaline phosphatase and SGOT con
centrations and later a direct hyper
bilirubinemia (Figs. 1 and 2).
Biochemical evidence of cholestasis
appeared consistently within 2 to 3
weeks of starting TPN, which strongly
suggests an association.
Table V II—-Patency of Biliary System in 19
Cases of Progressive Cholestasis on TPN
No. of
patients

1

D ays

TPN Begun

Fig. 8b
FIG. 8— Absence of relation between cholestasis and bacterial sepsis, (a) Values
of SGOT, serum alkaline phosphatase and bilirubin, (b) Pulse rate, temperature, leuko
cyte count and band cells during hospital course of 66-year-old man who received TPN
when leak developed at anastomosis after resection of thoracic esophagus.
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Liver and gallbladder described as
normal at operation
Intravenous cholangiogram
normal
T tube in place, cholangiogram
normal. No obstruction found
at autopsy
No obstruction found at autopsy
B scan showed normal ducts and
gallbladder
Operative cholangiogram showed
patent ducts
Sinogram to common bile duct
normal
No information on biliary system
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2
1
1
1
1
1
4
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Although halothane was administered
to 10 of the 19 patients in the pro
gressively jaundiced group, 2 of the
10 patients were given the general
anesthetic more than 30 days before
the onset of cholestasis. Moreover, the
pathologic features were not similar to
those seen in previously described cases
of halothane hepatitis. Therefore to in-

FIG. 9— Gastric outlet obstruction (pa
tient 13, Table III). Expanded portal triad
shows mixed inflammatory infiltrate, in
cluding numerous polymorphonuclear leu
kocytes, moderate numbers of eosinophils
and lymphocytes, and proliferation of bile
ducts (hematoxylin and eosin, reduced by
50% from X160).

FIG. 10—Same patient as in Fig. 9.
Larger portal zone with interlobular ductal
proliferation with associated mixed in
flammation around margin of portal area.
Limiting plate is intact (hematoxylin and
eosin, reduced by 50% from x400).
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fer that this agent contributed to the as lipid, 40% as dextrose and 18 g of
disturbed liver function would be to nitrogen daily.
presume an extraordinary incidence of
It is possible that reducing the lipid
halothane hepatitis.1
contribution radically, supplying only
Because there was no anemia, mor 1000 mL weekly to prevent essential
phologic abnormalities of erythrocytes, fatty acid deficiency, resulted in re
or indirect-reacting hyperbilirubinemia, versal of cholestasis in the two cases
hemolysis cannot have been a factor where this was tried (Fig. 8).
contributing to the occurrence of
The mechanism of this cholestasis
cholestasis.
remains to be elucidated, but it seems
If the cholestatic jaundice is due to apparent that lipid/dextrose ratios ap
the TPN regimen, it is difficult to iden proximating 3:2 combined with a high
tify the component of TPN that causes amino acid intake of 2 g/kg will cause
it. None of the routine additives (min cholestatic jaundice in 50% to 75% of
erals, vitamins, trace elements) would, patients who are given the solutions for
either by reason of their deficiency or 30 days. Suggested mechanisms are de
excess, be responsible. However, there fective hydroxylation of bile acids and
are identifiable differences between the intrahepatic accumulation of lithocolic
composition of the solution we used acid,3 or a direct toxic effect of a com
and other TPN solutions that have not ponent of the amino acid solution
caused disturbance of liver function or (methionine).4 Antioxidants added to
histology when employed over extended amino acid solutions have been sug
periods. For long-term parenteral feed gested as causative agents of changes
ing Jeejeebhoy and his colleagues2 used in liver function in patients receiving
a solution supplying 25% of nonprotein TPN.5
energy requirements as Intralipid 10%
The absence of oral intake and the
and 65% as dextrose. Only three of resulting absence of gastroduodenal
their patients received Travasol as a stimulation of the water and electrolyte
source of amino acid, and no change components of bile flow have been sug
was noted in measurements of liver gested as contributory factors.6 How
function in these individuals. The ever, two individuals in our series took
amount of nitrogen supplied in their a clear fluid diet throughout their
program was more modest than in ours course of TPN and this did not prevent
(13 g/d or 1 g/kg). Our TPN program the development of cholestasis (Figs. 1
supplied 60% of energy requirements and 2). Full diet was introduced for
one patient (patient 1, Table III) and
failed to reverse the course of hyper
bilirubinemia.
Abnormalities of liver function and
histology that have developed in pa
tients on other TPN regimens should
not be confused with the condition en
countered in the patients in this series.
Infusion of a solution that will supply
all nonprotein energy requirements as
dextrose, as described by Grant,5 will
lead to acute fatty infiltration of the
liver which may be associated with
elevated SGOT, serum alkaline phos
phatase and serum bilirubin values.
This lesion is preventable or can be
reversed by addition of Intralipid 10%
to supply 20% to 40% of energy re
quirements.7 Cholestatic jaundice sub
siding after discontinuation of TPN has
been described in premature infants8
and the histologic appearance of liver
biopsy specimens from them is similar
to what was observed among the adult
cases in our program.
FIG. 11—Pancreatitis, T tube in com
mon bile duct (patient 9, Table III). Ex
panded portal triad with ductal prolifera
tion and heavy mixed inflammatory in
filtrate consisting chiefly of polymorpho
nuclear leukocytes and lymphocytes. In
flammation extends into adjacent liver
parenchyma but there is no piecemeal
necrosis. Cholestasis is severe, bile thrombi
being most prominent in periportal zone.
Within lobule hepatocytes show degenera
tion (hematoxylin and eosin, reduced by
50% from x400).
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Summary

A TPN mixture supplying a lipid
emulsion in a dose of 3 g/kg, supple
mented by 900 Cal (3.8 x 103kJ) as 50%
dextrose and with a protein intake of
2 g/kg led to development of progres
sive cholestasis in 19 of 32 patients
receiving long-term TPN. Elevated
serum alkaline phosphatase concentra-
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tions appeared consistently around day
20, and by day 42 jaundice was ap
parent in 18 of the 32 patients. Serum
proteins and prothrombin time were
not appreciably affected, and serum
bilirubin, serum alkaline phosphatase
and SGOT values returned to normal
when TPN was discontinued.
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Antibiotics in Surgery of the Colon
R.T. L ewis , mb , frcs [c], facs,* with C.M. A llan , md , frcs[c], facs,*
R.G. G oodall, md, frcs [c], FACs,f W.C. L loyd-Sm ith , md , frcs[c], facs,*
B. M arien, md , frcs [c]* and F. Wiegand, md , frcs [c], facs*

In a randomized prospective study of
patients undergoing elective colonic
surgery the postoperative wound
infection rate was 13% (early, 10%)
in patients receiving systemic
cephaloridine perioperatively and 12%
(early, 7.3%) in those given oral
neomycin and erythromycin base
preoperatively. Wound infections were
more frequent in patients with severe
lymphopenia or hypoalbuminemia pre
operatively, but the potential degree of
wound contamination was the main
determinant of postoperative infection.

precoces) chez les patients recevant
un traitement peroperatoire a la
cephaloridine systemique, et de 12%
(7.3% pour les infections precoces)
chez ceux qui ont recu de la neomycine
et de I'erythromycine par voie orale
dans la periode preoperatoire. Les
infections de la plaie ont ete plus
frequentes chez les patients ayant une
lymphopenie ou une hypoalbuminemie
severes avant I’operation, mais le
potentiel de contamination de la plaie
a ete le principal determinant des
infections postoperatoires.

Dans une etude prospective randomisee
chez des patients subissant une
operation non urgente du colon, le
taux d’infection postoperatoire a ete
de 13% (10% pour les infections

The determinants of bacterial surgical
infection are well known:1 (a) con
tamination by an inoculum of bacteria,
(b) lodgement of bacteria in a favour
able local environment, and (c) bac
terial propagation unhindered by host
resistance. Recent studies have at
tempted to describe finite dimensions
for these determinants, which may per
mit their manipulation to minimize the
risk of postoperative infection. Thus
Robson, Krisek and Heggers2 have
designated quantitatively the critical
extent of bacterial contamination nor
mally associated with bacterial wound
infection. MacLean and his colleagues3,4
have demonstrated that impaired nu
trition may be an important determinant
of diminished host resistance associated
with surgical sepsis. Burke,5 Polk and
Lopez-Mayor6 and Waterman and
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Kastan7 have shown that the timing
and dosage of antibiotics are critical
to their successful use in preventing
lodgement in potentially contaminated,
contaminated and dirty wounds. Con
troversy remains, however, as to the
optimal route and antibacterial spec
trum of antibiotics indicated in surgery
of the colon. Polk8 administered peri
operatively a systemic antibiotic that
was effective mainly against aerobic
bacteria. Nichols and associates9 pre
ferred preoperative administration of
an enteral antibiotic combination ef
fective against both aerobic bacteria
and the main colon anaerobes.
Starting in November 1975 a pro
spective randomized study of patients
undergoing elective colonic surgery
was undertaken at the Queen Elizabeth
Hospital of Montreal Centre to com
pare these two modes of antibiotic
prophylaxis and to examine the deter
minants of wound sepsis in these pa
tients.
Patients and Methods

Patients undergoing elective surgery
of the colon were randomly assigned
to two groups. All patients received a
standardized mechanical bowel prepara
tion as indicated in Table I. Group 1
patients received cephaloridine, 2 g
intravenously or intramuscularly, 2
hours preoperatively and again 5 hours
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Table 1- Mechanical Bowel Preparation
P reoperative
day

Procedure

3

1 tab bisacodyl (Dulcolax) at
1800 h

2

Low-residue diet
Magnesium citrate, 56.7 g, at
1000,1400 and 1800 h
Saline enemas to clear at
1800 h

1

Clear fluids only, orally
Magnesium citrate, 56.7 g, at
1000 h
Saline enema at 1400 h

later. Group 2 patients received neo
mycin and erythromycin base, 1 g of
each orally, on the final preoperative
day at 1300, 1400 and 1800 hours. At
operation smears were obtained for
culture from the open colon and from
the subcutaneous tissues of the wound
before closure; the degree of wound
contamination was noted. Wounds
were inspected for signs of infection
on the fifth and seventh postoperative
days and thereafter as required.
Wounds showing tenderness, erythema,
or induration were closely observed to
resolution or discharge of pus. Wounds
that discharged pus were regarded as
infected (early wound infection) and
the discharge was cultured. A follow
up report was requested from each
surgeon on wound infections not diag
nosed until after the patient left hos
pital but within the first month after
operation (late wound infection). Pa
tient records were reviewed to ascer
tain lymphocyte counts and serum al
bumin concentrations determined preoperatively and prior to any transfusion
of blood or blood products. Concentra
tions were defined for severe hypoproteinemia and lymphocytopenia accord
ing to criteria suggested by Blackburn
and associates10 and Lee and col
leagues.11 Patients who underwent sur
gery on a segment of colon previously
defunctioned by proximal colostomy
were excluded from the study. The age
of the patients, the duration of pre
operative hospitalization, the identity
of the operating surgeon, diagnosis
and the type of operation performed
and its duration “from skin to skin”
were noted. A risk index of postoper
ative wound infection for each proce
dure was calculated as recommended
by Davidson, Clark and Smith.12 Statis
tical analysis was performed where in
dicated by the y1 test and by Student’s
/-test.
Results

Seventy-nine patients were included
in the study; 38 were allocated to group
340

1 and 41 to group 2. A comparison of
the groups reveals that they were rea
sonably well matched with respect to
age and risk index (Table II). The
groups were also matched with respect
to the number of cases and frequency
of wound infections for each operating
surgeon. When wounds were classified
according to the potential degree of
contamination,13 5 of 13 contaminated
or dirty wounds became infected, while
in 5 of 66 clean-contaminated wounds
infection developed (P < 0.002). A
similar preponderance of infections in
contaminated and dirty cases was seen
within each group.
The overall rate of wound infection
was 12.6% and of early wound infec
tion, 8.8%. There were no significant
differences in the frequency of wound
infections between group 1 and group
2 (Table III). Anaerobic bacteria were
cultured from 2 of 15 specimens taken
from the colon in group 1 and from 4
of 17 such specimens from group 2;
anaerobes were isolated from one in
fected wound in each group.
Table IV shows the relation between
postoperative wound infections and

host resistance as indicated by absolute
peripheral lymphocyte counts and se
rum albumin concentrations measured
before operation. The mean lympho
cyte count before operation in the pa
tients who had sepsis after operation,
1.095 ± 0.498 x 107L, was signifi
cantly lower than the 1.683 ± 0.706 X
109/L in those without postoperative
sepsis (P < 0.03).
Discussion

This study confirms that, of the
established determinants of wound in
fection, the degree of wound con
tamination is the pre-eminent factor.
This appears to be true whether one
assesses the potential degree of conta
mination by classification of wounds,13,14
as in the present study, or the actual
degree of wound contamination as de
termined by culture of the subcutaneous
tissues after the fascia is closed.12,15
Effective aseptic technique and anti
sepsis to prevent contamination should
therefore remain the primary approach
to minimizing the frequency of wound
infection.

Table II— Comparison of Patient Groups
Factor

Group 1

Age, yr
< 60
60-80
> 80
Risk index
Diagnosis and operative site,
no. of wound infections/no. of cases
Carcinoma
Inflam m ation
Operation in true pelvis
Operation outside true pelvis

Group 2

13
20
5

11
25
5

27.9

28.7

2/25
3/13
2/24
3/14

3/28
2/13
1/17
4/24

Table I I I — Incidence of Wound Infections
No. of wound infections/total no. of cases
Wound______________________________
A.
B.
C.
D.

Clean-contam inated wounds
Contaminated and dirty wounds
Total wound infections
Early wound infections

Group 1
(n = 38)

Group 2
(n = 41)

3/31
2/7
5/38
4/38

2/35
3/6
5/41
3/41

Total wound
infections (and %
5

n

)

6)

5 (38 6)
10 (12 6)
7 (8.8)

The difference between A and B is statistically significant (P < 0.002).
Differences between groups 1 and 2 are not statistically significant.

Table IV — Host Resistance and Wound Infections
No. of wound infections/
total no. of cases

Laboratory measurement

P value

Lymphocytes, X 10°/L
< 1.0
> 1.0

2/6
3/24

> 0.05

Serum albumin concentration, g /L
< 22.5
> 2 2 .5

3/6
0/23

< 0.005
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Antibiotic therapy is, however, an
important adjunct in patients at risk
of sepsis. Polk8 has demonstrated con
sistently the diminished frequency of
surgical infection brought about by
administration of systemic cephaloridine
perioperatively, but others16,17 have ex
pressed dissatisfaction with this regi
men, and have attributed its failures
to its inability to deal with the bowel
anaerobes. Since the completion of the
present study Clarke and colleagues18
have shown convincingly that oral ad
ministration of neomycin and erythro
mycin before operation reduces the fre
quency of septic complications of colon
operations.
Our investigation showed no differ
ence in frequency of wound infection
when systemic cephaloridine and orally
administered neomycin-erythromycin
were compared. The cephaloridine
regimen employed was slightly differ
ent from that used in Polk’s original
study, in keeping with Waterman’s
recommendations7 and Polk’s subse
quent practice. We did not include a
no-antibiotic group because we be
lieved that the excellent studies of Polk
and Lopez-Mayor6 and Washington and
associates19 had already clearly demon
strated the advantage of the use of
antibiotic regimens in colon surgery.
The wound infection rates in both our
groups were somewhat • higher than
those reported by Polk and LopezMayor6 and Clarke and colleagues.18
However, neither of these groups speci
fically mentioned the inclusion of late
wound infections diagnosed up to 1
month postoperatively. Their total
wound infection rates were approx
imately the same as the early wound
infection rates found in our study.
Our data do not explain why the
differences in route of administration
and spectrum of the antibiotics used
in the two treatment groups were not
associated with different infection
rates. Moore, Cato and Holdeman20
noted that the redox potential of the
colon, which is the primary site of
action of the neomycin-erythromycin
combination, is -250 mV, in contrast
to that of +120 mV of the normal
wound, which is the primary site of
action of cephaloridine. Stone, Kolb
and Geheber21 indicated that in normal
tissues elimination of the aerobic part
ner of the usual aerobe-anaerobe sym
biosis automatically increases redox po
tential of the environment so that it
becomes hostile to anaerobes. Thus,
antibiotics acting on the wound and
effective primarily against aerobes may
afford adequate prophylactic therapy.
In the colon the low redox potential
allows anaerobes to thrive even when
aerobic bacteria have been eliminated;
hence for preoperative bowel prepara
tion an antibiotic combination effective
VOLUME 21, NO. 4, JULY 1978
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against anaerobic as well as aerobic
bacteria is required.
The association we discovered be
tween lymphocytopenia, hypoproteinemia and postoperative infection has
not previously been reported. It is,
however, in keeping with the established
close correlation between peripheral
lymphocyte counts and cell-mediated
immunity (CMI)11 and the observed
interaction of impaired CMI, impaired
nutrition and postoperative sepsis.22,23
Lee and coworkers11 noted a close rela
tion between lymphocytopenia and
anergy to 2,4-dinitrochlorobenzene skin
testing in cancer patients; Pietsch and
Meakins22 were able to identify surgical
patients at increased risk of sepsis by
preoperative anergy; and Law, Dudrick
and Abdou23 as well as Spanier and
associates4 have related diminished immunocompetence in surgical patients
to impaired surgical nutrition and hypoproteinemia. Since the number of
patients in the present report in whom
lymphocytopenia and hypoproteinemia
were studied is small, further investiga
tion is required to corroborate these
findings.
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To control upper
gastrointestinal bleeding
due to stress ulcer,
hemorrhagic gastritis, stress
gastritis, bleeding gastric
erosions, duodenal and
gastric ulcers...

The 'Tagamet'effect
The precise mechanism by which 'Tagamet1controls upper g.i. bleeding is not
understood, although several theories exist, of which these seem the most likely.

Significantly Inhibits Gastric Acid Secretion,
raising the pH of the stomach to inactivate pepsinogen (thereby decreasing pepsin which is
known to digest protein in an acidic environment) and possibly promoting clot formation.

May Decrease Gastric Mucosal Blood Flow
due to inhibition of acid secretion, allowing the body's hemostatic mechanism
to control bleeding.

May Prevent Further Damage to the Mucosa
by acid through blockade of histamine H2receptors, thereby encouraging
healing of the mucosal injury.

6 5 patients in whom other nonsurgical measures had failed, or
for whom surgical intervention
was considered impossible or
unduly hazardous, were
evaluated; the results are
reported in the adjacent table.1

Heavy
Moderate
Subacute/recurrent

C o m p le te
Su ccess

P a r tia l
Su ccess

C o m p le te
& P a r tia l
Su ccess

F a ilu re

65%
52%
45%

15%
22%
25%

80%
74%
70%

20 %
26%
30%

1. Data on file, SK&F M edical Department

The H2Receptor Antagonist-A major clinical
advance for uncontrolled g.i. bleeding
SMITH KLINE &FRENCH CANADA LTD.
Montreal, Quebec H4M 2L6

Tagamet®

DUODENAL ULCER. NON-MALIGNANT
GASTRIC ULCER, AND G A S T R O 
ESOPHAGEAL REFLUX DISEASE

(cim etidine SK&F)
Tablets
Injection

The recommended adult oral dosage for duodenal ulcer,
non malignant gastric ulcer and gastroesophageal reflux
disease is 300 mg four times a day, with meals and at
bedtime.
While healing with 'Tagamet' often occurs during the first
week or two, treatment should be continued for at least
four weeks unless healing has been demonstrated by
endoscopic examination.
Some patients may require concomitant antacids until
symptoms disappear.

P rescrib in g Inform ation
(Product Monograph available to practitioners on request)

ACTION
Cimetidine competitively inhibits the action of histamine
at the histamine Ho receptor, and thus represents a new
class of pharmacological agents, the histamine
^ -r e c e p to r antagonists.
Cimetidine is not an anticholinergic agent. Studies have
shown that cimetidine inhibits both daytime and nocturnal
basal gastric acid secretion. Cimetidine also inhibits
gastric acid secretion stimulated by food, histamine,
pentagastrin, caffeine and insulin. Its ability to inhibit
gastric acid secretion via this unique mechanism of action
permits a new approach to the treatment of acid-related
gastrointestinal disorders.
Cimetidine is absorbed rapidly after oral administration.
The plasma half-life is approximately two hours. The
principal route of excretion is the urine.
The degree and duration of inhibition of basal and
stimulated gastric acid secretion are dose-related; the
data suggest that 80% or higher inhibition throughout a
24 hour period can be achieved by a dosage regimen of
3 0 0 mg four times daily given with meals and at bedtime.
Cimetidine 3 0 0 mg reduced total pepsin output as a result
of the decrease in volume of gastric juice. The drug had no
effect on the rate of gastric emptying or lower esophageal
sphincter (LES) pressure.

INDICATIONS AND CLINICAL USE
Tagamet® (cimetidine) is primary therapy for conditions
where the inhibition of gastric acid secretion is likely to be
beneficial, such as:
□
□
□
□
□

Duodenal ulcer
Non-malignant gastric ulcer
Gastroesophageal reflux disease
Management of upper gastrointestinal hemorrhage
Pathological hypersecretion associated with ZollingerEllison Syndrome, systemic mastocytosis and multiple
endocrine adenomas.

CONTRAINDICATIONS
There are no known contraindications to the use of
'Tagamet' (cimetidine).

PRECAUTIONS
Use in Pregnancy: Nursing Mothers:
There has been no experience, to date, with use of
'Tagamet' (cimetidine) in pregnant patients. Reproduction
studies performed in rats, mice and rabbits have revealed
no evidence of impaired fertility or harm to the fetus due to
'Tagamet'. Studies have demonstrated that 'Tagamet'
crosses the placental barrier. It is also secreted in the milk
of animals. 'Tagamet' should be used in pregnant or
lactating patients or women of child-bearing potential only
when, in the judgement of the physician, the anticipated
benefits outweigh the potential risks.
Use in Children
Clinical experience in children is limited. Therefore,
'Tagamet' (cimetidine) therapy cannot be recommended
for children unless, in the judgement of the physician,
anticipated benefits outweigh the potential risks. In very
limited experience, 20-40 mg kg per day has been
administered in divided doses by mouth or intravenously.
Use in Impaired Renal Function
Because 'Tagamet' (cimetidine) is excreted by the kidney,
a reduced dosage should normally be administered to
patients with impaired renal function. (See DOSAGE AND
ADMINISTRATION)
Drug Interactions
Studies in animals revealed no pharmacological inter
action between 'Tagamet' and commonly used drugs. No
significant interactions have been observed in man.

In patients with upper gastrointestinal bleeding of
sufficient magnitude as to require blood transfusions,
'Tagamet' should be administered parenterally,
preferably by intravenous injection or intermittent
infusion or, if necessary, by constant intravenous infusion
until 48 hours after active bleeding has stopped. At this
time an oral dosage regimen may be instituted and should
be continued for at least 7-10 days.
Recommended dosage for oral administration:
3 0 0 mg every 6 hours.
Recommended dosage for intramuscular injection
administration:
3 0 0 mg every 6 hours. Inject the entire contents of a 2 ml
ampul.
Recommended dosage for intravenous injection
administration:
3 0 0 mg every 6 hours. Dilute 'Tagamet' in Sodium
Chloride Injection (0.9%) (or other compatible i.v.
solution) to a total volume of 20 ml and inject over 1-2
minutes.
Recommended dosage for intermittent intravenous
infusion administration:
3 0 0 mg every 6 hours. Dilute ’Tagamet' 3 0 0 mg in 100 ml
of Dextrose Injection (5%) (or other compatible i.v.
solution) and infuse over 15-20 minutes.
In some patients it may be necessary to increase dosage.
When this is necessary, the increases should be made by
more frequent administration of a 30 0 mg dose, but total
daily dosage should not exceed 24 0 0 mg.
Recommended dosage for constant intravenous
infusion administration:
2 mg/kg. hour. Dilute 'Tagamet' for injection in a
compatible i.v. solution, such as Sodium Chloride Injection
(0.9% ) or Dextrose Injection (5% or 10%). In some patients
it may be necessary to increase dosage. Dosage should
usually not exceed 4 mg/kg/hour.

D O SA G E ADJUSTMENT FO R PATIENTS WITH
IMPAIRED RENAL FUNCTION
Patients with severely impaired renal function have been
treated with 'Tagamet'. However, such usage has been
very limited. On the basis of this experience the
recommended dosage is 300 mg every 12 hours orally or
by intravenous or intramuscular injection. Should the
patient's condition require, the frequency of dosing may be
increased to every 8 hours or even further with caution. In
severe renal failure accumulation may occur and the
lowest frequency of dosing compatible with an adequate
patient response should be used. Hemodialysis removes
circulating cimetidine, therefore, the timing of dosage
should be adjusted to the dialysis schedule.

PATHOLOGICAL HYPERSECRETORY
CONDITIONS
(e.g., Zollinger-Ellison Syndrome)
Recommended adult oral dosage:
3 0 0 mg four times a day with meals and at bedtime. In
some patients it may be necessary to administer 30 0 mg
doses more frequently to control symptoms. Dosage should
be adjusted to individual patient needs, but usually should
not exceed 2400 mg per day. If intravenous administration
is required, the dosage schedule should be the same as
that recommended for control of upper gastrointestinal
bleeding.

SPECIAL CASES

ADVERSE REACTIONS
Mild and transient diarrhea, muscular pain, dizziness and
rash have been reported in a small number of patients
during treatment with 'Tagamet' (cimetidine). There have
been reports that a few patients have developed mild
nonprogressive gynecomastia during prolonged treatment.
No evidence of induced endocrine dysfunction was found,
and the condition remained unchanged with continuing
'Tagamet' treatment. Some increases in plasma creatinine
and serum transaminase have been reported.

O V E R D O SA G E
In cases reported to date, involving oral ingestion of up to
10 grams of 'Tagamet' (cimetidine), no untoward effects
have been noted, and recovery has been uneventful.
Treatment
The usual measures to remove unabsorbed material from
the gastrointestinal tract, clinical monitoring and
supportive therapy should be employed. Studies in animals
indicate that assisted respiration may be of value and that
any tachycardia may be controlled by administration of a
B-blocker.

D O S A G E AND ADMINISTRATION
ADULTS:
(Experience with 'Tagamet' in children is limited and it has
not been evaluated in clinical studies—see PRECAUTIONS)
In clinical studies Tagamet' (cimetidine) has been used in
divided doses of up to 2400 mg/day.
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MANAGEMENT O F UPPER
GASTROINTESTINAL HEMORRHAGE

In patients in whom control of gastric acid secretion is
desirable, the recommended oral dosage of 'Tagamet' is
3 0 0 mg four times a day, with meals and at bedtime. If
intravenous administration is required, the dosage
schedule should be the same as that recommended for
control of upper gastrointestinal bleeding.

BOOK REVIEWS
V

INFECTION IN THE FEMALE. William
J. Ledger. 240 pp. Illust. Lea & Febiger,
Philadelphia; The Macmillan Company
of Canada Limited, Toronto, 1977. Price
not stated. ISBN 0-8121-0560-5.

This monograph offers a well-organized
approach to its subject. The first half deals
mostly with bacteriology and is up-to-date.
It includes a description of the latest
information on etiologic agents such as
mycoplasma and Bacteroides fragilis. The
problems associated with specimen collec
tions are detailed, and specific reference
is made to anaerobic and aerobic infec
tions. Ledger has also provided the reader
with an excellent discussion on urinary
specimens and their collection.
The second half of the book deals with
clinical problems. Separate chapters are
included on community and hospitalacquired gynecologic and obstetric infec
tions. The investigation and treatment of
postpartum infections is specifically dealt
with. The author has not considered the
use of IgM testing and gamma globulin
therapy in rubella contacts. However, there
is a good chart on what to do for the
woman exposed to rubella during preg
nancy and how to interpret rubella anti
body titres. Included also is an excellent
chart on vaccination during pregnancy
and the effects of certain diseases such as
measles, mumps, thyroid, polio, cholera,
plague and rabies on mother and child.
While postoperative management of the
gynecologic patient is carefully discussed,
the description of some of the common
office gynecologic problems is less than
adequate. One of the most vexing prob
lems for the office practitioner is treat
ment of the patient with a persistent
vaginal discharge; unfortunately a discus
sion of this subject is not included. Can
didal and trichomonal infections are only
discussed in generalities. A more detailed
account of how to handle acute herpes
genitalis would have been welcome. This
problem is mentioned in several areas of
the book, but it is not all brought together
in one place. What should the physician
do when he or she sees the vesicles? How
do you make the patient comfortable and
what bath solutions can be recommended?
This book offers a good, although at
times superficial, review of the subject;
for this limited purpose, it can be rec
ommended.
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STABILITY O F INJECTABLE FORM
'Tagamet' injection, when added to or diluted with most
intravenous solutions, such as Sodium Chloride injection
(0.9% ) or Dextrose injection (5% or 10%), is stable for 48
hours at normal room temperature 'Tagamet' Injection
should not be refrigerated.

AVAILABILITY
Tablets:
Pale green circular biconvex film coated tablets, each
containing cimetidine 300 mg (monogrammed SKF T13).
Bottles of 100 tablets.
Injection:
Each 2 ml dose contains cimetidine HC1 equivalent to 300
mg of cimetidine, in Sterile Water for Injection. Preserved
with phenol, 0.5% . Ampuls of 2 ml, packaged in 10's.
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Ir v in g S o l o w a y

Department of obstetrics and gynecology,
Ottawa Civic Hospital,
Ottawa, Ont.
LYMPHEDEMA. Supplement to “L y m phology”. Edited by Leo Clodius. 192
pp. Illust. Georg Thieme Verlag, Stutt
gart; Stratton Intercontinental Medical
Book Corporation, New York, 1977.
Price not stated. ISBN 3-13-544901-7.

Lymphedema is a concise readable text;
its value far exceeds its modest format.
For years clinicians of all specialties have
continued on page 366
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ORIGINAL CONTRIBUTIONS

Hypothermic Coronary Perfusion for Myocardial Protection
During Aortocoronary Bypass
M ant H araphongse, md, frcp [c ], R. L eighton F isk, md, frcs [c ], R ichard E. R ossall, md, frcp [c],
C arlos A.E. Basualdo, md, frcp [c], R obert S. F raser, md, frcp [c ], E lliott T. G elfand , md, frcs [c ]
and J ohn C. Callaghan, md , frcs [c ]

aortic occlusion and myocardial hypo
thermia induced by perfusion with cold
lactated Ringer’s solution. A reversed
saphenous vein was used for the graft
on each occasion. Cannulation for ex
tracorporeal circulation was carried out
in a standard manner using transatrial
vena caval catheters and arterial return
from the extracorporeal circuit to the
ascending aorta. A left atrial, left ven
tricular or pulmonary arterial vent
catheter was placed. In most instances
both the distal and the proximal anas
Anoxic cardiac arrest is necessary for tomoses were done during a single aortic
the adequate performance of cardiac occlusion. Hypothermic cardioplegia
surgery. It has been very useful in was induced by perfusion with 5 %
aortocoronary bypass surgery (ACBS) glucose and lactated Ringer’s solution,
because it provides a dry, immobile to which was added potassium chloride
operative field which is necessary for (40 mmol/L) and sodium bicarbonate
an accurate anastomosis. To avoid (44.6 mmol/L). This solution at 5°C
anoxic injury to an already ischemic was introduced into the aortic root
myocardium is one of the most im after the start of cardiopulmonary by
Plusieurs methodes ont ete utilisees
portant goals in ACBS. Many methods pass. Once the patient was on total by
dans I'intention de prevenir les lesions
have been used in an attempt to pass, an aortic cross-clamp was placed
myocardiques qui resultent de ('interrup
minimize the myocardial damage that and 500 to 700 mL of solution was
tion du debit aortique durant une
results from the interruption of aortic introduced into the aorta proximal to
operation du coeur. On decrit un moyen
flow during cardiac operations. A rela the clamp through a small catheter
relativement simple de provoquer une
tively simple means of inducing car placed through a purse-string suture in
cardioplegie par perfusion coronarienne
dioplegia by coronary perfusion with the aorta. Once the desired amount of
d'une solution de Ringer refroidie
cold lactated Ringer’s solution through solution had been introduced, the can
dans le tronc aortique; celui-ci a ete
the aortic root has been used at the nula was withdrawn and the purse
utilise au University of Alberta Hospital
University of Alberta Hospital, Ed string suture tightened. This site could
monton, for both valve replacement later be used for an aortic vent or
From the departments of medicine and
coronary bypass surgery. The re aortotomy for proximal coronary graft
surgery, University of Alberta Hospital, and
sults
appear to be better following this anastomosis. Cardiac arrest occurred
Edmonton, Alta.
procedure and the incidence of myo after 200 mL of cold solution was in
Presented in part at the annual meeting cardial injury and intraoperative mor jected. Additional hypothermic solution
of the Canadian Cardiovascular Society,
was placed initially in the pericardial
tality have been reduced.
Edmonton, Alta., Oct. 18-23, 1976
well around the heart, but usually was
Patients and Method
Reprint requests to: Dr. M. Haraphongse,
aspirated before dissection of the ves
Director, Hemodynamic laboratory,
Between May 1, 1975 and Apr. 30, sels. If the period of aortic cross-clamp
University Hospital, Edmonton, Alta.
1976, 159 patients had ACBS with ing needed to complete the procedure
T6G 2B7
345
VOLUME 21, NO. 4, JULY 1978 / THE CANADIAN JOURNAL OF SURGERY

Numerous methods have been used in
an attempt to prevent myocardial
injury that results from the interruption
of aortic flow during cardiac operations.
The authors describe a relatively
simple means of inducing cardioplegia
during coronary bypass surgery by
coronary perfusion with cold lactated
Ringer's solution through the aortic
root. When the results following the
eqjployment of hypothermic coronary
perfusion for intraoperative cardioplegia
were compared with those obtained
without its use, the procedure was
found to confer a degree of intraopera
tive myocardial protection and ap
peared to lead to a decrease in intra
operative myocardial infarction,
subendocardial ischemia and intraopera
tive mortality.

pour les interventions de pontage
coronarien.
Comparativement aux resultats
anterieurs, la perfusion coronarienne
hypothermique employee pour provoquer
une cardioplegie durant I'operation a
confere un degre de protection myocardique et semble avoir entraine une
diminution des infarctus myocardiques
durant I'operation, de I'ischemie sousendocardique et de la mortality
peroperatoire.

was long, additional cold solution was
introduced through the aortic root and
into the pericardial well. Upon release
of the aortic cross-clamp and re-estab
lishment of coronary arterial flow, re
warming of the heart took place within
minutes.
Results
There were six operative deaths. No
patient died in the operating room.
Three patients died of myocardial in
farction postoperatively. Two patients
were doing well after the operation but
were found dead in the washroom, one
on day 6 and the other on day 9 after
operation, probably owing to cardiac
arrhythmias. One death was attributed
to septicemia.
Six percent of the patients experi
enced subendocardial ischemia which

was diagnosed if symmetrical T-wave
inversion was noted on the electrocar
diogram within the first 24 hours fol
lowing surgery. Eight percent of the
patients had postoperative myocardial
infarction which was diagnosed if new
Q waves appeared. Supraventricular
and ventricular arrythmias developed
in 19% and 2% of patients, respective
ly. Ten percent of the patients had
heart failure postoperatively.
We compared the results of ACBS
under hypothermic coronary perfusion
for myocardial protection (group 1)
with the results obtained from 185 pa
tients who had similar preoperative
characteristics (Table I) and who had
undergone ACBS without hypothermia
between. Jan. 1, 1974 and Apr. 30,
1975 (group 2). The incidence of sub
endocardial ischemia, postoperative
myocardial infarction and intraopera

tive mortality was significantly reduced
in group 1 patients (Table II).
Postoperative serum concentrations
of creatine phosphokinase, glutamic
oxaloacetic transaminase and lactic
dehydrogenase (CPK, SGOT and LDH)
were analysed (Fig. 1) in all patients
with a normal postoperative course.
The values increased with the pro
longation of anoxic arrest extended
beyond 60 minutes in group 1 and 40
minutes in group 2. Maximal values
of enzymes in the patients with hypo
thermia were significantly lower than
in normothermic patients who had been
exposed to the same durations of
anoxia.
Discussion

4

A motionless heart and a dry opera-

T a b le 1 - P r e o p e r a t iv e C h a r a c t e r is t ic s in H y p o th e rm ic (G ro u p 1 ) an d N o rm o th e rm ic (G ro u p 2 )
P a t ie n t s

N o .o f p a tie n ts ( a n d % )
C h a r a c t e r is t ic
M ean a g e , y r
M en
A n g in a a lo n e
A n g in a + p r e v io u s m y o c a rd ia l in fa rc tio n
A n g in a + p r e v io u s m y o c a rd ia l in fa rc tio n + h e a r t f a ilu r e
A n g in a + h e a r t f a ilu r e
H e a r t f a il u r e a lo n e
E le v a t e d le f t v e n t r ic u la r e n d -d ia s to lic p r e s s u r e
N e w Y o r k H e a r t A s s o c ia tio n fu n c tio n a l c la s s
II
III
IV
E x t e n t o f a r t e r ia l d is e a s e
1 a rte ry
2 a r t e r ie s
3 a r t e r ie s

G roup 1
(n = 159)

G ro up 2
(n = 185)

54
140 (8 8 )
105 (6 5 )
49 (3 1 )
2 (1 )
3 (3 )

52
149 (8 0 )
160 (8 7 )
75 (4 1 )
2 (1 )

78 (4 9 )

2 (1 )
95 (5 1 )

19 (1 2 )
121 (7 6 )
19 (1 2 )

17 (9 )
133 (7 2 )
35 (1 9 )

15 (9 )
66 (4 2 )
78 (4 9 )

25 (1 3 )
81 (4 4 )
79 (4 3 )

1

1

10H l IU/1 )
NORMOTHERMIC

HYPOTHERMIC

T a b le II - C a r d i a c C o m p lic a tio n s in H y p o th e rm ic (G ro u p 1 ) and N o rm o th e rm ic (G ro u p 2 ) P a tie n ts
N o. of p a tie n ts (an d
C o m p lic a tio n
D e te c te d by e le c tro c a rd io g ra p h y
S u b e n d o c a rd ia l is c h e m ia
M y o c a rd ia l in fa rc tio n
A r r h y t h m ia s
S u p r a v e n t r ic u la r
V e n t r ic u la r
N o n fa ta l
L o w c a r d ia c ou tpu t
L o w c a r d ia c o u tp u t + m y o ca rd ia l in fa r c t io n
H e a r t f a ilu r e

% )

G ro u p 1
(n = 159)

G roup 2
(n = 185)

P v a lu e

9 (6 )
12 (8 )

29 (1 6 )
35 (1 9 )

< 0.005
< 0.005

31 (1 9 )
3 (2 )

34 (1 8 )
8 (4 )

16 (1 0 )

1 (0 .5 )
3 (2 )
9 (5 )
ANOXIC ARREST ( MIN )

F a ta l
In t r a o p e r a t iv e
P e r io p e r a t iv e
M y o c a rd ia l in fa rc tio n
S u d d e n death
L o w c a r d ia c o u tp u t
+ m y o c a rd ia l in fa rc tio n
S e p tic e m ia
E m b o lis m
P u lm o n a ry
C e re b ra l
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6 (3 .6 )

3 (2 )
2 (1 )

1 (0 .6 )

14 (8 )
5 (3 )

< 0.05

5 (3 )

1 (0 .5 )
1 (0 .5 )
1 (0 .5 )
1 (0 .5 )
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FIG. I—Mean serum enzyme values
following surgery in patients with normal
postoperative course. Values of enzymes in
patients with hypothermia were significant
ly lower than in normothermic patients
who had been exposed to same duration
of anoxia (▲ = P < 0.05, A = P <
0.025, ■ = P < 0.01, O = P < 0.005
and □ = P < 0.001). CPK = creatine
phosphokinase, SGOT = serum glutamic
oxaloacetic transaminase, LDH = lactic
dehydrogenase.
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tive field permit a rapid and precise
anastomosis in ACBS. Cardiac arrest
reduces metabolic requirements of the
heart,1 thereby prolonging myocardial
tolerance to ischemia. Improved meth
ods for cardioplegia and myocardial
protection during cardiac arrest have
been developed recently. Early tech
niques of cardioplegia using potassium
citrate or acetylcholine were abandoned
because they produced severe, some
times irreversible, myocardial damage.2
Iced saline (slush)3 for topical hypo
thermia was introduced both to protect
the myocardium and to provide a
quiescent heart. The popularity of this
technique declined because atrial fibril
lation, epicardial reaction and phrenic
nerve paralysis were associated with its
use.4
Although coronary artery perfusion5
gained wide acceptance for valvular
surgery,6 it, too, appeared to be asso
ciated with a number of complica
tions.7'9 Bloodwell and associates10
popularized the technique of normothermic anoxic arrest. Ischemic cardiac
arrest under normothermic anoxic con
ditions is a safe method for open-heart
correction of congenital defects, valve
replacement10 and ACBS.11 It has been
shown that normothermic anoxic arrest
is moderately well tolerated for 30 min
utes.12'13 Beyond that time biochemical
changes,14 subendocardial hemorrhage15
and generalized myocardial damage are
progressive and probably irreversible.13
Topical cardiac hypothermia extended
the safe period of ischemic arrest.16
Various methods of producing myo
cardial hypothermia topically are in
use,17,18 but have been associated with
a number of problems. Homogeneous
reduction of myocardial temperature
cannot be achieved rapidly by surface
cooling of the heart particularly when
severe left ventricular hypertrophy is
present. Irrigation of the pericardial
well requires the management of cold
fluid supply and drainage. Blood is lost
from the circulation to the wash solu
tion in variable amounts. The use of
selective cardiac hypothermia induced
by perfusion of the coronary arteries
with cold lactated Ringer’s solution
through the aortic root19,20 avoids many
disadvantages of topically induced hy
pothermia. This method produces rapid
cardioplegia and better myocardial
preservation.13
Iyengar and associates15 related nor
mothermic ischemic arrest directly to
the production of subendocardial
hemorrhagic necrosis. This damage has
been attributed to stasis, sludging and
thrombosis in the myocardial microcir
culation.21 Deterioration of myocardial
function and myocardial infarction fol
lowing ACBS have been observed de
spite the presence of a patent graft.22,23
Hypothermic coronary perfusion for
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intraoperative cardioplegia in ACBS has
significantly reduced the incidence of
subendocardial ischemia and myocar
dial infarction in our series as assessed
by electrocardiographic change.
Hypothermia has the advantage of
conferring considerable protection on
the myocardium by reducing the meta
bolic rate24 and extending the safe pe
riod of ischemic arrest.16 The functional
recovery of the heart following the
termination of arrest is related to the
concentration of ATP and creatine
phosphate in the myocardium at the
end of the period of arrest.25 Hypo
thermic coronary perfusion for intra
operative cardioplegia provides rapid
cardiac arrest and uniform cooling of
the heart. Thus, the myocardium sus
tains minimal hypoxia. Under these
conditions the concentration of cellu
lar high-energy phosphates is main
tained and complete recovery is pos
sible.25,26
The patients in the two groups had
ACBS performed in two successive
periods of time. Greater surgical ex
perience, better selection of patients
and more extensive revascularization
may have been contributing factors in
producing more favourable results in
group 1. Nevertheless, the changes in
serum enzyme values following opera
tion indicated that more effective myo
cardial protection during aortic cross
clamping was provided in patients with
hypothermic coronary perfusion than
in patients operated on under nor
mothermic conditions. Hypothermic
coronary perfusion appeared to result
in a decrease in the number of myo
cardial complications and intraopera
tive mortality.
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an urgent problem
postoperative anaerobic

in gynecological
infections

.. clindamycin is an important antibiotic in the
therapy of such [gynecological] infections.”
Swenson, R.M., et al. (1974). Obstet. & Gynecol., 44:699.

in abdominal
infections

This study suggests “ ...clindamycin is an excellent
and relatively safe antibiotic for treatment of
[abdominal] infection caused by anaerobes when
combined with surgery (when indicated) or other
antibiotics active against aerobic gram-negative
bacilli, if present."

s

Levison, M.E., et al. (Mar., 1974).
Antimicrob. Agents & Chemother., p. 276-280.

an a cce p te d solution
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m eans of removing the com pound from the blood. P e riodic serum levels o f c lindam ycin should be determ ined in p a tie n ts w ith severe rena
in sufficiency.
Adverse Reactions: Local.
(a) Intram uscular Inje ctio n s: Of 404 patie nts treated w ith c lin d a m y c in pho sphate intram uscularly (w ith a s o lu tio n co n ta in in g 150 m g /m l)
six (1.5%) dem onstrated local reactions as follows: Two c o m pla ined o f pain at the injection site, tw o d e m onstrated in d u ra tio n at the injec
tio n s ite and tw o developed sterile abscesses.
(b) Intravenous Infusion: O f 192 patie nts treated w ith c lin d a m y c in pho sphate by intravenous in fu s io n , 14 (7.3% ) d e m o n stra te d loca
reactions. Eleven p atie nts developed superficial th ro m b o p h le b itis and one p atie nt developed both s u p e rfic ia l and deep th ro m b o p h le b itis
The m ajority o f these cases developed in conjunction w ith the use o f in d w e llin g IV catheters and it is d iffic u lt to know how m uch th e drug
c o n trib u te d to the irrita tio n . Two patients developed lo c a lis e d erythem a, s w e llin g and pain at the s ite o f the in fu s io n .
Systemic Side Effects: Tw enty-eight patie nts of 596 trea ted w ith c lin d a m y c in phosphate by e ith e r th e in tra m u s cu la r or in tra ve n o u s routes
developed system ic side e ffe c ts as follow s:
N u m b e r o f Patients
N um ber o f P a tients
H y p o te n s io n ...........................
..................................7
R a s h ..............................................................
H
y
p
e
rte
n
s
io
n
.........................
U rtic a ria ........................................................
S h ortness of B reath..............
P ru ritis ..........................................................
S u p e rin fe c tio n *......................
Fever, L e u c o c y to s is ...................................
C ardiac a r r e s t* ......................
Nausea, w ith or w ith o u t v o m itin g ............
Bad or b itte r taste in m outh .
Diarrhoea (See also under “ W a rn in g s ").
*S up erinfection is a co m plication o f an tib io tic therapy in general and is not necessarily a true side e ffe c t o f c lin d a m y c in phosphate.
* * Due to underlying m yocarditis in this patient.
Clinical and Laboratory Findings: Patients treated d u rin g c lin ic a l tria ls o f c lindam ycin phosphate were fo llo w e d w ith c lin ic a l laboratory
tests, in cluding com plete haematology, urinalysis and liver and kidney fu n c tio n tests. Some o f these te s ts w ere abn orm al in itia lly anc
returned to normal during therapy w ith clindam ycin pho sphate, w h ile oth e rs were norm al in itia lly and becam e abn orm al durin g therapy
O verall evaluation o f clin ic a l laboratory values in these p a tie n ts does not in d ic a te that clindam ycin phosphate therapy has a to x ic e ffe c t or
the haem atopoietic, hepatic or renal system s. Transient elev a tio n s o f serum transam inases have occurred in som e p a tie n ts, bu t o th e r live
fu n c tio n te s ts (alkaline phosphatase, serum bilirubin) have not show n any tendency to increase and there have been no c lin ic a l sig n s o
drug-induced hepatic toxicity.
Symptoms and Treatment of Oversoage: No cases o f overdosage have been reported. No s p e c ific a n tid o te is know n. Doses as high a:
1200 mg every six hours (4800 m g/day) by in fusion fo r fiv e days have been given w ith out adverse effect.
DOSAGE AND ADMINISTRATION
Adults
In tram uscular Injectio n: 600 m g /d a y in tw o equal doses.

clindamycin has been reported to be the most
actfce antimicrobial agent tested in vitro against
apaerobic bacteria; [in the pulmonary tract]
concentrations of 3.1 pg/ml or less inhibited 96%
of strains tested...”
Fass, R.J., et al. (1973). Annals Intern. Med., 78:853.

M oderately severe in fe c tio n s : 600 to 1200 m g/day in tw o o r three equal doses.
Severe in fe c tio n s : 1200 to 2400 m g/d ay in two, three or fo u r equal doses. Intram uscular in je c tio n s o f m ore than 600 m g in to £ sin g le site
are not recom m ended
Intravenous A d m inistra tion: Dalacin C Phosphate m u s t be d ilu te d p rio r to IV a dm in istratio n to a d ilu tio n o f 300 mg in 50 ml o f diluen
(6 m g /m l) or more, and infused in not less than 10 m in u te s . A d m in is tra tio n o f m ore than 1200 mg in a s in g le one -ho ur in fu s io n is not recom
m ended. Dalacin C Phosphate should not be injected in tra v e n o u s ly u n d ilu te d as a bolus.
M oderately severe in fe c tio n s : 900 to 1800 m g/day by c o n tin u o u s drip or in tw o or three equal doses, each in fu se d over 20 m in u te s or longer
Severe in fe c tio n s : 1800 to 2700 m g /d a y by c ontin uous d rip or in three or fo u r equal doses, each in fuse d over 20 m in u te s or longer. In life
threatening in fectio ns, doses o f 2700 to 4800 m g /d a y by c o n tin u o u s d rip or in three or four equal doses each in fu se d over 20 m in u te s o
longer may be given.
Children: (Over one m onth of age)
In tram uscular Injectio n: 10 to 1 5 m g /k g /d a y in two, thre e o r fo u r equal doses.
M oderately severe in fe c tio n s : 15 to 20 m g /k g /d a y in thre e or fo u r equal doses.
Severe-infections: 20 to 30 m g /k g /d a y in three or fo u r equal doses.

PAAB
CCPP
PRODUCT OF
7710

llpjohn

REGISTERED TRADEMARK; DALACIN

TRADEMARK: DALACIN C

C E 9430.2

j P M A C I
ANTIBIOTIC
RESEARCH

Intravenous Administration:
M oderately severe in fe c tio n s : 15 to 25 m g /k g /d a y by c o n tin u o u s drip or in three or four equal doses, each in fu se d over 20 m in u te s o
longer. In severe in fe ctio n s, it is recommended that c h ild re n be given not le ss than 300 m g /d a y regardless of body w e ig h t. (D ilu te D alacin C
Phosphate Sterile Solution in the same manner as fo r adu lts.)
AVAILABILITY:
Dalacin C Phosphate Sterile Solution - Each ml c o n ta in s c lin d a m y c in pho sphate equivalent to clin d a m y c in base 150 m g in 2 m l am poules

| TH E UPJOHN COMPANY OF CANADA
1
865 YORK MILLS RO AD/DON MILLS, ONTARIO

Product M onograph available upon request.

VOLUME 21, NO. 4, JULY 1978

/

T H E C A N A D IA N JO U R N A L O F S U R G E R Y

349

Importance of a Fifth Parathyroid Gland in the Surgical
Treatment of Hyperparathyroidism
J ohn A . P a l m e r , m d , fr c s [c ], fa c s * and F rank R . Su t t o n , m d |

Of 365 patients surgically treated for
hyperparathyroidism at the University
of Toronto hospitals, 3 had hyper
calcemia due to an abnormal and ectopic
fifth parathyroid gland.
Autopsy studies have shown that a
fifth gland may be present in 3% to
5% of patients with hyperparathyroidism.
The possibility of an abnormal fifth
gland as the cause of primary hyper
parathyroidism should be considered
when four glands of normal size and
histology have been found in the neck,
and such a gland should be sought in
all patients with the diffuse hyperplasia
of secondary hyperparathyroidism. The
fifth gland is usually in the lower
neck or upper mediastinum, frequently
within the thymus. If present, it can
usually be recognized and excised.
Sur 365 patients ayant recu un traitement
chirurgical pour hyperparathyroi'die
aux hopitaux de I'Universite de Toronto,
3 avaient une hypercalcemie due a
une cinquieme glande parathyroide
anormale e t ectopique.
Des etudes des resultats d'autopsie
ont montre qu’une cinquieme glande
peut etre presente chez 3% a 5% des
patients souffrant d'hyperparathyroi'die.
La possibility d'une cinquieme glande
anormale causant une hyperparathyroi'die
primaire devrait etre envisagee quand
quatre glandes de grosseur et
d’histologie normales sont retrouvees
dans le cou, et une telle glande devrait
etre recherchee chez tous les patients
presentant I’hyperplasie diffuse caracteristique de I’hyperparathyro'idie
secondaire. La cinquieme glande est
habituellement retrouvee dans la partie
inferieure du cou ou au dessus du
mediastin, frequemment a I’interieur
du thymus. Lorsqu’elle est presente,
elle peut habituellement etre identifiee
et excisee.

From the department of surgery,
University of Toronto and the Toronto
General Hospital, Toronto, Ont.
*Associate professor, department of
surgery, University of Toronto
t Department of surgery, St. Michael's
Hospital, Toronto
Reprint requests to: Dr. J.A. Palmer,
4 University Wing, Toronto General
Hospital, Toronto, Ont. M5G 1L7
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In 1925 M andl1 successfully excised a
parathyroid adenoma that had caused
osteitis fibrosa cystica. For many years
thereafter the identification and re
moval of a single adenoma was con
sidered to be the optimal treatment for
hyperparathyroidism. However, as ex
perience increased it was realized that
abnormalities of more than one gland
occurred in approximately 15% of pa
tients,2 in the form of either diffuse
hyperplasia or multiple adenomas, and
it was considered advisable to identify
four parathyroid glands and to remove
those that were abnormal on visual
examination or hypercellular on biop
sy. In a further attempt to reduce the
incidence of persistent or recurrent
hypercalcemia, Paloyan and colleagues3
recommended subtotal parathyroidec
tomy for all patients with hyperpara
thyroidism. We do not believe that this
is necessary for patients with a single
adenoma provided the remaining glands
are normal in size and on biopsy, but
we agree that subtotal parathyroidec
tomy is advisable for patients with an
abnormality of two or more glands.
This form of treatment has given
excellent long-term results. However,
approximately 5% of patients remain
hypercalcemie
postoperatively.
The
usual reason for persistent hypercal
cemia is failure either to find an ade
noma or to recognize and properly
manage an abnormality of more than
one gland.4 A hyperfunctioning fifth
gland unrecognized at operation may,
on occasion, be responsible for an un
satisfactory result. In a University of
Toronto hospital study of 365 patients,
3 patients with primary hyperpara
thyroidism, whose cases are reported
herein, had a fifth gland that was of
critical importance in surgical manage
ment. A fourth patient with secondary
hyperparathyroidism associated with
chronic renal failure requiring dialysis,
had persistent hypercalcemia following
radical subtotal parathyroidectomy and
is awaiting exploration for a fifth gland
in the mediastinum.
Case Reports

Case 1.—A 50-year-old woman had
recurrent renal calculi and hypercalcemia.
The serum concentrations of calcium
varied from 3.12 to 3.42 mmol/L (12.5
to 13.7 mg/dL) and of phosphate from
VOLUME 21, NO. 4, JULY 1978
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0.613 to 0.839 mmol/L (1.9 to 2.6 mg/dL).
A diagnosis of primary hyperparathyroid
ism was made.
At operation, four parathyroid glands
of normal size were indentified and
examination of frozen sections of each
revealed no abnormality. The left upper
gland, the largest of the four, was re
moved and on subsequent examination of
paraffin sections was described as hyper
plastic. Serum calcium concentrations
remained unchanged after operation.
It was assumed that this patient had
diffuse hyperplasia of all four glands, de
spite their relatively normal size, and
that subtotal parathyroidectomy should
have been done at the original operation.
On re-exploration of the neck 10 months
later, the right lobe of the thyroid gland
and the right upper and lower parathyroid
glands were removed; from the remain
ing normal-sized left lower parathyroid
gland a biopsy only was taken. Postopera
tively the serum calcium concentration
increased to 3.74 mmol/L (15 mg/dL).
Five months later the mediastinum was
explored through a sternal-splitting inci
sion. An adenoma measuring 3 x 3 cm
was found in the left inferior pole of the
thymus and removed. Serum calcium con
centrations have since remained within
normal range (2.24 to 2.32 mmol/L
[9.0 to 9.3 mg/dL]). Thus in this patient
three glands were removed from the neck,
a fourth gland was biopsied and an ade
noma of a fifth gland was removed from
the mediastinum.
Case 2.—A 38-year-old woman had
recurrent upper abdominal pain associated
with diarrhea. On investigation she was
found to have recurrent subacute pan
creatic calcification, mild nephrocalcinosis
and hypercalcemia (2.87 to 3.37 mmol/L
[11.5 to 13.5 mg/dL]). There was no
history of alcohol ingestion and her
biliary system was normal.
Primary hyperparathyroidism with as
sociated pancreatic and renal calcinosis
was diagnosed. Venography and sampling
of multiple veins in the neck and medi
astinum for parathormone (PTH) revealed
values in the high-normal range without
a gradient in either the neck or medi
astinal veins.5,6
On exploratory surgery of the neck
four parathyroid glands were found in
their usual positions; they appeared nor
mal in size and colour. Subtotal para
thyroidectomy was done, removing three
glands; a biopsy was taken from the right
lower gland and the remnant was marked
with a silver clip. On examination of
frozen sections the glands were considered
normal. At this stage we decided that the
diagnosis of hyperparathyroidism was
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Autopsy studies, in which the neck
is carefully examined for parathyroid
glands and their presence and number
are proved by microscopic examination,
have shown that more than four para
thyroid glands may be present.

been identified but appear to be of
In a detailed study of 428 cases,
normal size. There is a correlation be
Gilm our7 found six parathyroid glands
tween the size of an adenom a and the
in 2 cases (a frequency of 0.5% ), five
in 25 cases (6%), four in 374 cases
serum calcium value; in general, pa
tients with serum calcium values above
(87% ), three in 26 cases (6.1%) and
2.87 m m ol/L (11.5 m g/dL ) will have
only two glands in 1 case (0.2%).
an adenoma measuring 1.5 cm in
Vail and Coller8 in a similar autopsy
diameter, or larger. If such values are
study found five glands in 10 of 202
due to diffuse hyperplasia, the glands
cases. None had more than five glands
will appear enlarged. Thus, as in case
and all glands appeared normal on
3, the possibility of a fifth gland in the
both gross and histologic examination.
Alveryd9 in 352 autopsies found five upper mediastinum or elsewhere should
be considered if the four glands in the
glands in 13 cases (3.7%), four glands
neck are normal or only slightly en
in 319 cases (90.6%), three glands in
18 cases (5.1%) and two glands in 2 larged.
The role of venography and selec
cases (0.6%).
It is difficult to evaluate the re tive radioimmunoassay for P T H in the
diagnosis of a fifth gland has not been
ported occurrence of fewer than four
clarified (M urray TM: Personal com 
glands because it is doubtful whether
munication, 1977). These m ethods are
all glands were identified.
A fifth parathyroid gland is believed of questionable value in m easuring
concentrations of PTH in the large
to be of surgical importance but its
veins of the mediastinum. Of interest
presence has been difficult to verify.
is the patient in our case 2 who had
By the time the presence of a fifth
normal PTH values in the neck and
gland is suspected, the patient usually
has had a number of operations be mediastinum without gradients and
who subsequently was found to have
cause of persistent hypercalcemia and
a fifth gland in the mediastinum . Fail
often the number of glands has not
been verified by biopsy and m icro ure to demonstrate a localizing gra
scopic examination. In the past sur dient in P T H concentrations in the
geons have been reluctant to do biop neck (provided the blood sampling
sies of parathyroid glands because of from the neck veins has been m eticu
lous and complete) suggests th at the
the possibility of interference with the
blood supply. This need not be of con hyperfunctioning gland is ectopic and
cern, although if a subtotal parathyroid is probably in the mediastinum.
ectomy is done, the surgeon must take
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probably in error, so the operation was
terminated. Postoperatively serum calcium
concentrations remained elevated.
Further assessment included repeat
venography and radioimmunoassay for
PTH; as before there was no PTH gradient
in any vein. The concentration of urinary
cyclic AMP was elevated to 8.7 [janol/24
h. There was no evidence of other causes
of hypercalcemia and the cortisone sup
pression test gave a negative result. We
concluded that the diagnosis of primary
hyperparathyroidism was correct and that
the condition was caused by an adenoma
of a fifth gland, probably in the medi
astinum.
Five months later the previous neck
incision was reopened. The recurrent
laryngeal nerves were identified and the
tissues inferior to the thyroid were dis
sected to allow examination of the thymus
and surrounding tissues. An abnormality
was noted at the inferior aspect of the
right lobe of the thymus; the gland could
not safely be mobilized into the neck. A
short sternotomy to the third interspace
allowed excision of a parathyroid adeno
ma, measuring 2 X 1.2 X 1 cm, situated
within the thymus. Serum calcium values
have remained normal since operation.
Case 3.—A 75-year-old woman with a
20-year history of recurrent renal calculi
was found to have serum concentrations
of calcium ranging from 2.87 to 3.24
mmol/L (11.5 to 13.0 mg/dL) and of
phosphate ranging from 0.517 to 0.904
mmol/L (1.6 to 2.8 mg/dL). Primary hy
perparathyroidism was diagnosed. Veno
graphy and radioimmunoassay for PTH
were not considered necessary.
At operation four parathyroid glands of
normal size were found in their usual
positions. Biopsy specimens of all four
glands were considered to be normal his
tologically although there was a possibility
that the right lower gland was mildly hypercellular. We now believe that normal
sized glands, even if hyperplastic, will not
produce serum calcium concentrations of
2.87 mmol/L (11.5 mg/dL) or higher.
Therefore we decided to search for a
fifth gland.
The fibrofatty tissues inferior to the
thyroid lobes and the thymus were dis
played and an adenoma measuring 1.5 x
2 cm was identified in the midportion of
the right lobe of the thymus. The adenoma
and the right lobe of the thymus were
removed through the cervical incision;
quick section confirmed the diagnosis of
a parathyroid adenoma. Because of the
possibility of diffuse hyperplasia, we de
cided to do a subtotal parathyroidectomy.
Hence, both right glands, the left upper
gland and the mediastinal adenoma were
all removed; a biopsy of the left lower
gland was done so that only a remnant of
this gland remained.
Discussion
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Aspiration and Gastroesophageal Reflux
R o bert D. H en d e r so n , m b , fr c s [c ]* and C olin R. W o o l f e , m d , FRCP[c]f

T
v
Gastroesophageal reflux is the com
monest esophageal cause of chronic
interm ittent aspiration. The authors
investigated 1000 consecutive patients
with reflux with reference to their
medical history, and by barium
esophagography, esophageal manometry
and pH studies. In patients with
respiratory complications, chest ro
entgenography and pulmonary function
tests w ere also performed.
Of the total number, 279 patients
aspirated either by coughing and choking
during swallowing or as a result of
night reflux; of these, 159 had
associated respiratory symptoms, which
included cough, voice change, recurrent
respiratory infection, bronchiectasis
and asthma.
Of the patients with aspiration, 120
had surgical correction of reflux
because conservative management
failed. This form of reflux control
improved the symptoms of cough and
voice change and the condition of
patients with recurrent infections or
bronchiectasis, but alleviated the
symptoms in only 8 of 28 asthmatic
persons.
Le reflux gastro-oesophagien est la
cause d'origine oesophagienne la plus
frequente d’aspiration intermittente
chronique. Les auteurs ont etudie 1000
patients consecutifs souffrant de reflux,
pour leur anamnese et par oesophagographie au barium, manometrie
oesophagienne et etudes du pH. Chez
les patients ayant des complications
respiratoires, une radiographie
pulmonaire et des tests de la fonction
pulmonaire ont aussi ete effectues.
Du total, 279 patients aspiraient soit
par acces de toux, soit en s’etouffant

durant la deglutition, ou encore comme
resultat du reflux durant le sommeil;
de ceux-ci, 159 presentaient des symptomes respiratoires associes, incluant
toux, changements de la voix, infections
respiratoires recidivantes, bronchiectasie et asthme.
Des patients souffrant d’aspiration,
120 ont subit une correction chirurgicale
apres echec d'un traitement conservateur du reflux. Cette forme de
controle du reflux a permis d'ameliorer
la toux, les changements de voix et
I’etat des patients souffrant d'infections
recidivantes ou de bronchiectasie,
mais n'a soulage les symptdmes que
de 8 personnes asthmatiques sur 28.

Aspiration of food or gastric content
into the respiratory tract can occur as
an acute condition or as an intermittent,
chronic phenomenon. Acute aspiration
is usually secondary to diminished
consciousness such as occurs with
anesthesia, cerebral injury, or inebria
tion.1'2 Chronic aspiration is most com
monly caused by esophageal disease,
and gastroesophageal reflux, the most
common esophageal disorder, is most
frequently responsible.
The reported frequency of hiatal
hernia in patients with chronic aspira
tion varies between 1.3%3 and 45% .4
The frequency of aspiration in patients
with reflux has not been adequately
documented. Previous reports have
indicated the potential severity of lung
damage from aspiration and also the
effectiveness of surgery in controlling
reflux.5,6 The present study documents
the frequency of reflux aspiration and
the development of respiratory symp
toms.
Patients and Methods

From the departments of surgery and
medicine, Women’s College Hospital,
Toronto General Hospital and the
University of Toronto, Toronto, Ont.
*Surgeon-in-chief, Women’s College
Hospital; associate professor of surgery,
University of Toronto

+Physician-in-charge, respiratory research
laboratory, Toronto General Hospital;
professor, department of medicine,
University of Toronto
Reprint requests to: Dr. R.D. Henderson,
Surgeon-in-chief, Women’s College
Hospital, 76 Grenville St., Toronto, Ont.
MSS 1B2
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We investigated 1000 consecutive
patients with gastroesophageal reflux
who were admitted for a variety of
reasons, including the investigation of
chest pain and the assessment of the
severity of reflux symptoms. In all pa
tients a history of the esophageal and
respiratory complaints was obtained
and barium esophagography, esopha
geal manometry and pH studies were
carried out. In patients with symptoms
of asthma or respiratory infection chest
roentgenography and pulmonary func
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tion tests were also performed. The
radiologic studies were done by several
different radiologists and were not
standardized in technique.
The history provided the most im
portant diagnostic information. Besides
documenting symptoms of reflux, we
paid particular attention to symptoma
tic aspiration. Aspiration can occur at
night, when gastroesophageal reflux to
the pharynx spills forward to the
larynx and results in coughing and
choking. Aspiration may also occur
during the day when food sticks at the
cricopharyngeus; forward spillage of
food to the vocal cords results in chok
ing.
The patient’s history was also used
to determine the frequency of aspira
tion and to indicate the type of aspirate
(of oral or gastric content). The aspirate
was considered to be of oral content
when aspiration was associated with
pharyngoesophageal dysphagia in which
coughing and choking with swallowing
allow aspiration of food and saliva.
The aspirate was considered to be of
gastric content when aspiration oc
curred with night reflux; in these cir
cumstances gastric content spills into
the tracheobronchial tree and the
aspirate may contain food, gastric se
cretion and duodenal content. Fre
quency of aspiration was categorized
as mild (less than once per week),
moderate (more than once per week,
but less than once per day) and severe
(at least once per day).
In the respiratory history attention
was paid to cough and voice change
and to symptoms of recurrent respira
tory infection, chronic bronchitis, bron
chiectasis and asthma.
Barium esophagography confirmed
(he presence of a hiatal hernia or gas
troesophageal reflux in all patients in
cluded in the study. Reflux can be
demonstrated radiologically, but in the
conscious patient tracheal aspiration of
reflux barium is rare and was not seen
in this study. During deglutition barium
may spill into the tracheobronchial tree
owing to pharyngoesophageal obstruc
tion. This is an intermittent phenome
non and is difficult to demonstrate ra
diologically,
Esophageal manometrie and pH
studies were performed in the same
unit on all patients to exclude other
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esophageal motor disorders and to
identify reflux. Such studies may occa
sionally be of value in the investigation
of aspiration. They may demonstrate
an abrupt decrease in pH in the body
of the esophagus owing to reflux. At
the time of reflux the patient may
cough and choke and consequently
aspirate, but, since this type of aspira
tion is intermittent, the phenomenon
cannot be reliably reproduced. When
it does occur it is in the conscious pa
tient and may be altered by the pres
ence of tubes in the esophagus. This
finding was recognized only late in the
study and its frequency cannot be do
cumented.
Results

The frequency of reflux and aspira
tion as well as of pharyngoesophageal
dysphagia and aspiration is shown in
Table I.
Respiratory problems were associated
with aspiration in 159 patients: 90 of
the 279 patients with aspiration had
chronic cough or voice change, or
both, as the only symptoms; 27 patients
had recurrent respiratory infection, 2
had bronchiectasis and 40 patients
were asthmatic.
No relation could be found between
the frequency or quality of the aspirate
and the development of respiratory
symptoms. In patients who had pharyn
goesophageal dysphagia and aspiration
combined with night reflux and aspira
tion, respiratory symptoms occurred
more frequently.
Surgical Correction of Reflux
Of the 279 patients with aspiration
120 were treated surgically for control
of reflux. Surgery was indicated when
medical management failed and severe
esophageal symptoms persisted. Seven
(5.8%) of the 120 patients had recur
rent hiatus hernia demonstrated radiologically and 4 of these required
further surgical correction. Following
surgery all four patients had persistent
pharyngoesophageal dysphagia and re
quired a cricopharyngeal myotomy.
Follow-up ranged from 3 to 5 years
(average, 3.6 years).
Of the 90 patients with cough or

Table 1— Aspiration Associated w ith Gastro
esophageal Reflux in 1000 Patients
No. of
patients
Reflux to throat and aspiration
Pharyngoesophageal dysphagia
and aspiration
Combined reflux and dysphagia
and aspiration

110

Total no. of patients w ith
aspiration

279

115
54
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voice change, or both, 31 patients
whose only symptom was cough at the
time of aspiration were treated surgical
ly. All became asymptomatic. Of 46
patients with chronic cough or voice
change who underwent surgery, 44
were greatly improved. One patient had
a persistent cough, but his spasms of
coughing were fewer and less severe.
One other patient, whose cough was
not severe, was unimproved.
In the group of 27 patients with in
termittent respiratory tract infection 13
underwent surgery and none have had
recurrent infections since the opera
tion.
The two patients with bronchiectasis
were markedly improved following sur
gical control of aspiration. In both, less
sputum was produced and the condi
tion has been well controlled with con
servative therapy.
In the group of 40 patients with asth
ma 28 were treated surgically. Four
showed marked improvement, 4 moder
ate improvement, 9 slight improvement
and 11 were not improved.
Discussion

Aspiration of esophageal or gastric
content into the lungs has frequently
been shown to be associated with second
ary respiratory infection, but the fre
quency and severity of respiratory
symptoms have not been documented.5'6
In evaluating esophageal disease, the
history alone provides an accurate diag
nosis in 80% of patients.7 Roentgeno
graphy, manometry, pH studies and
acid perfusion measurements increase
the diagnostic accuracy and allow clear
distinction between the types of eso
phageal disorder.8 For the diagnosis of
aspiration a history of night reflux or
of pharyngoesophageal dysphagia, re
sulting in coughing and choking on
food and saliva, must be obtained.
The quality, frequency and quantity
of the aspirate, together with the re
sponse of the lungs to the aspiration,
are variables that are difficult to as
sess. While the circumstances of aspira
tion indicate the type of material
aspirated, they do not provide an evalu
ation of the gastric content, which may
be acidic from gastric secretions or
alkaline from duodenogastric bile re
flux. Both bile and acid present in the
stomach have been shown experiment
ally to produce severe damage to the
lung when aspirated.910 Pharyngoeso
phageal dysphagia and aspiration of
solid particles may produce bronchial
obstruction.11,12 It is not possible to
evaluate all of the factors from history
alone and, in particular, the quantity
of material aspirated at any one time
cannot be determined.
In this study we have documented
the presence of respiratory complica

tions attributable to aspiration. To
establish the relationship it is necessary
first to control the aspiration and then
to evaluate the resolution of the res
piratory problems. In 120 patients with
aspiration the reflux was corrected
surgically and the condition of the pa
tients evaluated at follow-up. Cough
or voice change were effectively cor
rected in 44 of 46 patients, indicating
that this syndrome responds well to
surgical correction. However, other
causes of cough must first be excluded.
The cough due to aspiration is second
ary to laryngeal irritation and is often
severe; it tends to be unproductive and
minor inflammation of the vocal cords
may be present.
Recurrent respiratory infections were
also effectively controlled by surgical
correction of reflux. Only two patients
with bronchiectasis were included in the
series and, although both were im
proved, no conclusions can be drawn.
The association of asthma with
aspiration is well recognized.13 In our
experience surgical correction of aspira
tion does not always confer benefit in
this condition. Also, chest discomfort
associated with reflux is often described
as causing dyspnea, although some pa
tients do recognize that this feeling of
tightness differs from that induced by
exercise. Chest discomfort causing
dyspnea in the asthmatic person is very
difficult to distinguish from that due
to bronchospasm, so that the patient
may mistake relief of the discomfort by
correction of reflux for improvement
of the asthma. Only 8 of 28 patients
with asthma were notably improved by
surgery and none were totally relieved
of their symptoms. In some the symp
tomatic relief may have been second
ary to control of the chest tightness
associated with heartburn and may not
have been related to any change in
respiratory function.
It seems that asthma is irritated by
aspiration but is not caused by it. In
some patients a major association can
be demonstrated between episodes of
aspiration and subsequent broncho
spasm. The group of patients treated
surgically were reviewed to see if this
association could be substantiated. Of
20 asthmatic patients who showed no
improvement or only slight improve
ment following reflux correction only
1 described a clear association between
reflux and asthmatic episodes. In con
trast all eight patients who were great
ly improved described such an associa
tion. In asthmatic patients with reflux
the decision to operate should be based
on the need to control the symptoms
attributable to reflux. The patient
should be told that there may be a
relation between the reflux and the
asthma, but that improvement in the
asthma after operation is unpredictable.
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The Anterior Interosseous Nerve Syndrome
E. W ie n s ,

A review of the literature pertaining
to the anterior interosseous nerve
(AIN) syndrome revealed that the
diagnostic criteria for this syndrome
need to be defined.
The authors describe the etiology of
the AIN syndrome and use two cases
of their own and 52 cases reported in
the English literature to draw up a
definition of the diagnostic criteria.
The recommended criteria are: (a)
demonstrable weakness of muscles
innervated by the anterior interosseous
nerve; (b) electromyographic findings of
marked denervation potentials and
decreased or absent voluntary motor
unit potentials of these muscles;
(c) operative evidence of entrapment
of, or injury to, the anterior interosseous
nerve; and (d) improved power in the
muscles and reversal of the electro
myographic changes on follow-up after
operation.

From the department of surgical
education, Royal Alexandra Hospital,
Edmonton, Alta.
* Teaching fellow, Royal Alexandra
Hospital, Edmonton
Reprint requests to: Dr. E. Wiens,
Department of surgery, Rm. 1240,
Royal Alexandra Hospital, Edmonton,
Alta. T5H 3V9
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m d , f r c s [c ] and

S.C.K. L au ,

Une revue de la litterature consacree
au syndrome du nerf interosseux
anterieur (NIA) a revele que les criteres
de diagnostic de ce syndrome doivent
etre definis.
Les auteurs decrivent I'etiologie du
syndrome du NIA, et emploient
deux de leurs propres cas et 52
cas decrits dans la litterature de
langue anglaise pour arriver a une
definition des criteres de diagnostic.
Les criteres recommandes sont: (a) une
faiblesse demontree des muscles
innerves par le nerf interosseux
anterieur; (b) des resultats electromyographiques de potentiels de
denervation marques et une diminution
ou I’absence de potentiels d'unite
motrice de ces muscles; (c) a ['opera
tion, des signe de coincement ou de
blessure du nerf interosseux anterieur;
et (d) une amelioration de la puissance
musculaire et une inversion des
changements electromyographiques en
post-observation.

The anterior interosseous nerve (AIN)
syndrome is characterized by functional
impairment of those muscles supplied
by this nerve, namely the flexor pollicis
longus, the radial aspect of the flexor
digitorum profundus and the pronator
VOLUME 21, NO. 4, JULY 1978
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quadratus.1 Its terminal branches me
diate sensation from the radiocarpal,
intercarpal, carpometacarpal and distal
radioulnar joints.2
Anatom y and Etiology

The anterior interosseous nerve
arises from the posterior portion of the
median nerve as its largest branch and
runs as a separate bundle within that
nerve for approximately 2.5 cm.3 The
exit from the median nerve is 2 to 6
cm below the medial epicondyle or 5
to 8 cm distal to the lateral epicondyle
of the humerus.
Injury to the anterior interosseous
nerve is rare because of its well-pro
tected course. However, it is vulnerable
at several points.
Fibrous Arch of the Pronator
Teres Muscle

In 30 dissected limbs, Spinner and
Schreiber4 found that the anterior in
terosseous nerve passed through a con
nective tissue arch (Fig. 1), usually
composed of loose areolar tissue, aris
ing from the deep head of the pronator
teres muscle. In seven limbs this arch
consisted of tough fibrous tissue. Com-
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pression of the nerve by a fibrous
arch or band or, alternatively, by a
tendinous insertion of the deep head
of the p ronator teres muscle may re
sult in the A IN syndrome.
Close P roxim ity to the Ulna
Spinner and Schreiber4 also pointed
out that when a fibrous arch or band
is present, the nerve is tightly held
against the ulna (Fig. 2). T hey cited

six cases in children of supracondylar
fracture resulting in the AIN syndrom e.
T hey suggested that the m echanism is
traction applied by the proximal frag 
ment of the hum erus to cause a te th e r
ing action of a fibrous arch or b and at
the level of the p ronator teres muscle.
Com pression o f the Anterior
Interosseous A rtery
N ear its origin the anterior interos
seous nerve is crossed by an terio r in
terosseous vessels (Fig. 3). It has been
postulated that thrombosis of these
vessels can result in the A IN syn
drom e.4,5

Tendinous Origin o f F lexo r
D igitorum Superficialis
A pproxim ately 4 cm distal to its
origin the an terio r interosseous nerve
gives off a m o to r b ran ch to the flexor
pollicis longus m uscle (Fig. 4). A t this
point it is crossed by the flex o r digi
to ru m superficialis to the long finger.
A tendinous origin o f this m uscle has
been im plicated in p roducing th e A IN
syndrom e.6'8
Close P roxim ity to the R a d iu s
W arren 9 has draw n atten tio n to the
close proxim ity of the an terio r in te ro s
seous nerve to the radius m o re distally
in the forearm (Fig. 5). H e cited tw o
cases of fo rearm fra ctu re associated
w ith the A IN syndrom e. D irect trau m a,
tractio n , or fo rm atio n of a h em ato m a
at this site could acco u n t fo r the palsy.

F IG . 3— A nterior interosseous artery
causing compression of anterior interos
seous nerve.

F IG . 5— Close proxim ity of an terio r
interosseous nerve to radius and injury
to nerve caused by fractu re of fo rearm .

FIG . 1— Fibrous arch of pronator teres
muscle over anterior interosseous nerve.

FIG . 2— Close proximity of anterior
interosseous nerve to ulna.
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F IG . 4— Tendinous origin of flexor
digitorum superficialis muscle affecting
anterior interosseous nerve.

F IG . 6— Penetrating injury of an terio r
interosseous nerve.
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P en etratin g Injury

Direct trauma to the anterior interos
seous nerve at the time of a penetrating
injury (Fig. 6)4 and during open reduc
tion of a forearm fracture4 have both
caused the AIN syndrome.
Iso lated Neuritis

As well as resulting from trauma or
pressure at various locations along the
course of the nerve, the AIN syndrome
has been attributed to an “isolated
neuritis”,10'11 or associated with the
“shoulder-girdle syndrome”.12 Parson
age and Turner12 suggested that a case
of paralysis of the flexor pollicis longus
and flexor digitorum profundus muscles
of the index finger with no other in
volvement may have been due to polio
myelitis. They stated: “This localized
paralysis cannot anatomically be of
peripheral nerve or nerve root distribu
tion and is only explicable by an an
terior horn cell lesion.” In the light
of more recent reports,313 the above
diagnosis should be discarded in fa
vour of distinct anatomical lesions of
the anterior interosseous nerve.
Clinical Diagnosis

The diagnosis of the AIN syndrome

is suspected if there is demonstrable joint and increased flexion of the prox
weakness or paralysis of one or more imal interphalangeal joint of the index
of the flexor pollicis longus, radial por finger. The metacarpal joint of the
tion of the flexor digitorum profundus, thumb is hyperflexed while the inter
phalangeal joint is hyperextended.
or the pronator quadratus muscles.
The function of the pronator quad
The weakness of the long flexors of
the thumb and the index finger can be ratus muscle should be assessed with
elicited by the pinch-grip test. As the elbow flexed at a right angle to
pointed out by Spinner,1 the pinch- minimize the action of the pronator
grip sign is characteristic of the AIN teres muscle.4-7 This maneuver will per
syndrome (Fig. 7). There is hyperex mit demonstration of weak resistance
tension of the distal interphalangeal to forced supination of the hand with
out interference from the pronator
teres.
Pain is frequently mentioned as a
presenting complaint. When present,
pain is always poorly localized. It is
most often referred to the forearm but
may be felt in front of the elbow or
rarely in the upper arm.
Electromyography

FIG. 7—Characteristic pinch-grip with
anterior interosseous nerve paralysis.

Electromyographic studies will con
firm the diagnosis of the AIN syndrome
by showing a marked denervation of
the muscles supplied by the nerve.
Voluntary motor unit potentials will
be decreased or absent. The flexor
digitorum profundus muscle will be
variably involved depending on the ex
tent of its innervation from the an
terior interosseous nerve.

Table I— Data of Cases of A nterior Interosseous Nerve Syndrome
Treatm ent
Authors

No. of
cases

Conservative Surgical

Parsonage and Turner, 194812

6

6

—

Kiloh and Nevin, 195210
Thom as, 196211
W arren, 1963»
Fearn and Goodfellow, 196515
Stern, Rosner and Blinderman, 19676
Sharrard, 1968'®
V ichare, 1968-

2
2
2
1
1
1
4

2
2
2

—

—

Farber and Bryan, 196817
M ills, M ukherjee and Bassett, 196913
Spinner and Schreiber, 19694

2
1
6

—

Spinner, 19702

10

—
—

1
1
1
4

—
—

2

—

6

1
—

—

3

5
2
Schmidt and Eiken, 1971s

2

O 'B rien and Upton, 1972'8
Gutm ann, Hobbs and W iley, 19733
Smith and Herbst, 1974'9
Lake,197 42»

1
1
1
3

Gardner-Thorpe, 197421
Krag, 197422

2
4

Wiens

2

Total

54

356

—

2

—
1

—

1

—

1
2

—

2
—

—

1
4
2

33

Proposed etiology
5 associated w ith shoulder-girdle syndrome
1 anterior horn lesion
Isolated neuritis
Compared to neuritis or neuralgic amyotrophy
Associated w ith forearm fracture
Fibrous band
Fibrous band
Fibrous band
2 intram uscular band
1 fibrous band
1 no cause found
No etiology proposed
Musculofibrous band
Associated with supracondylar fractures
Proposed traction of anterior interosseous
nerve
1 tendinous band
1 neuroma
1 thrombosed vessels w ith scar tissue
Etiology not clear
Associated w ith open reduction of forearm
fracture
Fibrous bands
Segmental demyelination
Fibrous band
Unknown
1 fascial bands
2 unknown
Unknown
1 fibrous band
3 neurogenic atrophy
Fibrous bands

Final result
Not recorded
Delayed partial recovery
Full recovery
Full recovery
Full recovery
Full recovery
Full recovery
Full recovery
Partial recovery
Full recovery
Full recovery
Full recovery
Tendon transfer
Full recovery
3 full recovery
1 partial recovery
1 tendon transfer
Both had tendon transfer
1 full recovery
1 nearly fu ll recovery
Partial recovery
Good recovery
Full recovery
Satisfactory recovery
Full recovery
Satisfactory recovery
1 satisfactory recovery
1 lost to follow-up

21
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Anatomical Variations
The clinical picture of the AIN syn
drome can be quite variable because
of differences in innervation of the
muscles concerned. In fact, the flexor
pollicis longus is the only muscle that
is always innervated by the anterior
interosseous nerve. Sunderland14 has
reported a case in which the entire
flexor digitorum profundus muscle
was innervated by the ulnar nerve. In
the “all median hand” the anterior in
terosseous nerve supplies all of the
flexor digitorum profundus. When a
communication exists between ulnar
and anterior interosseous nerves, the
communication carries motor fibres to
the first, second and third dorsal interossei and the adductor pollicis
muscles.
We have recently treated two patients
with the A IN syndrome and our ex
perience is summarized below.

the flexor pollicis longus muscles; there
was no voluntary activity in these muscles.
Sensory potentials and motor conduction
along the left median, ulnar and radial
nerves were normal.
The left antecubital fossa and forearm
were explored through an S-incision. The
median and anterior interosseous nerves
were identified proximal to the pronator
teres muscle and were followed into the
lower third of the forearm. Where the an
terior interosseous nerve passed under the
arch of the flexor superficialis it was
compressed by a tight tendinous band.
The nerve was attenuated and edematous
but there was no neuroma. The tendinous
band was excised and the compression of
the anterior interosseous nerve was re
lieved.
Unfortunately, repeated attempts to
contact the patient for follow-up examina
tion have failed.
Discussion

should be performed; the results are
gratifying. Prolonged conservative man
agement appears unwarranted.
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Case 2.—A 54-year-old carpenter had
experienced weakness of the left thumb
and index finger for 2 months. He com
plained of difficulty in holding nails while
hammering and also in buttoning his shirts.
There were also areas of numbness over
the flexor aspect of the left forearm. Ex
amination showed weakness of flexion of
the distal phalanx of the left thumb and
index finger. There was deep tenderness in
the left forearm between the brachioradialis
and the pronator teres muscles. Electro
myography demonstrated denervation po
tentials in the left pronator quadratus and

Fifty two cases of the AIN syndrome
have been reported in the English
literature. These cases and our two are
summarized in Table I.2*4'”'13’15'22 The
A IN syndrome and its diagnostic cri
teria have hitherto been only vaguely
described. We believe that this condi
tion needs to be defined. The A IN syn
drome is characterized by weakness of
flexion at the distal interphalangeal
joint of the index finger and at the
interphalangeal joint of the thumb; in
addition there is weakness in pronation
of the hand. The syndrome is caused by
entrapm ent of or injury to the an
terior interosseous nerve, with subse
quent denervation of the flexor pollicis
longus, radial portion of the flexor
digitorum profundus and the pronator
quadratus muscles. Clinically, the m o
tor weakness can be demonstrated by
the characteristic pinch-grip sign, and
by impaired resistance to forced supina
tion of the hand with the elbow flexed
at a right angle. The criteria for diag
nosis include: (a) demonstrable weak
ness of one or more of the three mus
cles innervated by the anterior interos
seous nerve; (b) electromyographic
findings of marked denervation poten
tials and decreased or absent voluntary
motor unit potentials of the correspond
ing muscles; (c) operative evidence of
isolated entrapment of or injury to the
anterior interosseous nerve; and (d) in
creased power in the affected muscles
and reversal of electromyographic
changes when the nerve is released.
O f 52 cases meeting the criteria for
the A IN syndrome compiled from the
English literature, the majority were
due to pressure applied by a fibrous or
tendinous band, or were associated with
traum a. It seems clear from the litera
ture that palsy associated with closed
fractures should be treated in the ex
pectation of good results. In cases not
associated with fracture, exploration
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Case Reports
Case 1.—A 26-year-old man complained
of aching pain, poorly localized in the
right forearm and antecubital fossa. He
was treated conservatively and the pain
was relieved. The pain returned several
months later and was accompanied by
weakness of flexion at the interphalangeal
joint of the right thumb. Examination re
vealed the characteristic pinch-grip sign
associated with the AIN syndrome. He
also had demonstrable weakness of prona
tion of the right hand. Sensory apprecia
tion was intact over the entire right arm.
On electromyography, denervation poten
tials were demonstrated in the right flexor
pollicis longus and pronator quadratus
muscles which also indicated reduced
voluntary motor activity.
The median nerve was explored in front
of the elbow. The anterior interosseous
nerve was identified posteriorly at its site
of origin and was followed distally. It
was found to be stretched over a tendinous
insertion of the deep head of the pronator
teres muscle The nerve was attenuated
but there was no true neuroma. The
tendinous insertion of the pronator teres
muscle was transected allowing the nerve
to fall into its normal position without
tension.
Two weeks later muscle power in the
flexor pollicis muscle was much improved
and 8 weeks later recovery was complete.
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fo r general surgery

fo r general surgery

sp e cia lly p re p a red fo r d ry
a p p lic a tio n and e m e rg e ncy
haem ostasis

I
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Sterile Sponge, size 100
80 x 125 x 10 mm
box of six sponges, No. 7859

S te rile Sponge, size 50
80 x 62.5 x 10 mm
box of fo u r sponges, No. 7858

S te rile C om pressed S p onge
size 100
12.5 x 8 cm
box o f six sponges, No. 7865

fo r general and n e u ro lo g ica l
surgery

fo r general and neu ro lo g ica l
surgery

prom ote healing in c h ro n ic
leg u lc e r

S terile Sponge, size 1 2 -3 mm
20 x 60 x 3 mm
box of fo u r sponges, No. 7852

S te rile Sponge, size 1 2 -7 mm
20 x 60 x 7 mm
b o x o f fo u r sponges, No. 7853
ja r of fo u r sponges, No. 7854

S te rile P ow der
ja r co n ta in in g 1 g, No. 7876

non-haem ostatic
fo r o cu la r surgery

TX.
O phthalm ic S terile G elfilm
25 x 50 mm
box o f 6, No, 7844

j

Precautions
Gelfoam and G elfilm are sim ple to use, and w ith conscientious observance o f ce rta in
precautions satisfactory results may g e nerally be expected where th e ir use is in d ica te d .
1. Gelfoam should be used d iscrim in a te ly in arterial bleeding because of th e in tra 
arterial pressure. It is advisable to suture and reinforce where possible.
2. Although Gelfoam generally serves its purpose well in the presence of h a e m o rrh a g ic
blood dyscrasias, it should not be relied upon as the sole method of haem ostasis in
such conditions.
3. Gelfoam should not be used to stop m enstrual bleeding. In postpartum and m enorrhagic bleeding it serves only as a tem porary vaginal tampon.
4. Gelfoam must be in snug co n ta ct w ith the bleeding surface in o rd e r to be e ffe c tiv e .
5. Use Gelfoam as sparingly as possible in o rd e r to m inim ise the am ount of im pla n te d
foreign material.
6. Do not ove rfill cavities with G elfoam .

CE 7 7 3 4 .3

Upjohn

7. Do not use Gelfoam in grossly contam inated wounds which are so deep th a t d ra in 
age is interfered with. However, it may be used fo r temporary haem ostasis in m ore
superficial contam inated wounds, provided it is removed after it has served its haem o
static purpose.
8. Avoid prolonged exposure o f G elfoam to contam inated air.
Detailed information available on request.

Congenital Syndactyly: A Reappraisal
M a r t in A . E n t i n ,

Digital syndactyly is a common con
genital anomaly and is associated with
other anomalies affecting the digits,
the hand, the arm or even the entire
body.
In the past it has been considered
a single entity. However, recent
information provided by experimental
embryology, studies of morphogenesis
and other sources, suggests that there
are at least two distinct entities:
primary syndactyly due to interference
with the sequence of events that
normally culminate in the division of
digits into discrete parts and secondary
syndactyly due to readhesion of
adjacent digits as a result of close
contact between raw surfaces.
Primary syndactyly may arise de novo,
or it may occur as a manifestation
of a mutation phenomenon or as a
genetically controlled syndrome.
Secondary syndactyly is the result of
mechanical adhesion of adjacent parts
involved in a general reparative or
healing process. The initial insult leading
to amputation of a portion of the
digits may or may not be genetically
controlled; adhesion is fortuitous.
Management of syndactyly is deter
mined by the complexity of the
malformation. For simple cutaneous
syndactyly the surgeon should make
a zigzag incision and provide a rec
tangular, proximally based flap for the
floor of the web, usually before the
child is 2 years of age. A full- or
split-thickness skin graft should be
applied to the defects. For complex
deformities involving several digits
and associated with postural or osseous
malformation, several operative
procedures may be required. The
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surgeon must be vigilant to note and
correct the sequelae resulting from
recurrent contractures and imbalances
associated with growth.
La syndactylie est une malformation
congenitale frequente qui est associee
a d’autres anomalies des doigts,
de la main, du bras ou meme du corps
tout entier.
On I'a consideree dans le passe
comme une entite simple. Toutefois,
■’information recente issue de I'embryologie experimental, des etudes
de morphogenese et d'autres sources
indiquent qu’il y a au moins deux
entites distinctes: une syndactylie
primaire due a une interference dans
la sequence des evenements qui
culmine normalement par la division
des doigts en parties separees, et une
syndactylie secondaire due a un
recollement des doigts adjacents,
resultant d'un contact etroit entre deux
surfaces vives.
La syndactylie primaire peut survenir
de novo, ou elle peut etre la mani
festation d’un phenomene de mutation
ou representer un syndrome controle
genetiquement. La syndactylie
secondaire resulte de I'adhesion mecanique de parties adjacentes impliquees
dans un processus de reparation
generale ou de cicatrisation. L’agression initiate conduisant a I’amputation
d'une partie des doigts peut etre
ou ne pas etre sous dependance
genetique; I’adhesion est fortuite.
Le traitement de la syndactylie est
determine par la complexity de la
malformation. Dans le cas d’une
syndactylie cutanee simple, le chirurgien
devrait faire un incision en zigzag et
preparer un lambeau rectangulaire
rattache a la partie proximale et
destine a servir de membrane interdigitale; I’operation devrait habituellement etre pratiquee avant Page de
2 ans. Une greffe cutanee pleine
epaisseur ou demi-epaisseur devrait
etre appliquee sur les defauts. Pour
les difformites complexes impliquant
plusieurs doigts et associees a des
malformations de la posture ou des os,
plusieurs interventions chirurgicales
peuvent etre necessaires. Le chirurgien
devrait etre pret a noter et corriger
les sequelles resultant des contrac
tures recurrentes et des desequilibres
associes a la croissance.
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Digital webbing is a common conge
nital anomaly. It accounted for about
20% of 350 cases of congenital digital
malformation recently reviewed at the
Royal Victoria Hospital and Shriners
Hospital for Crippled Children in
Montreal.1 Webbing of the digits may
be an isolated entity or may be asso
ciated with other anomalies of the
hand, the arm, or the entire body. In
the past, syndactyly was considered to
be a single entity. Recent studies of
morphogenesis2-6 suggest that there are
at least two distinct forms of syndac
tyly: primary syndactyly, which results
from interference in the normal sequen
tial development of the parts, and
secondary syndactyly which is caused
by readhesion of adversely affected or
partially amputated adjacent parts.
Both forms of syndactyly can either
arise de novo or be secondary to
genetic causes; the latter form may
recur in succeeding generations.7 While
the subject is still controversial, we can
best begin to understand the patho
genesis of these conditions by con
sidering the evolvement of the upper
limb.
Morphogenesis of Anomalies

The upper limb begins its evolve
ment as a limb bud; within the bud a
sequential reciprocal process takes
place between the outer epiblast and
the inner mesenchyme. Epiblast thick
ens to form an ectodermal cap which
induces the mesenchyme to differen
tiate. The differentiation begins prox
imally and continues in a distal direc
tion. In this manner the various areas
of the upper arm, forearm and the hand
are established.8
This regionalization begins about
the fifth week of gestation. Each area
is destined to produce the appropriate
component parts: the proximal portion
will form the humerus and surround
ing soft tissue; the ulnar portion will
form the ulna and the ulnar digits; the
radial area will form the radius, the
thumb and the appropriate carpal
bones; and the central region will form
the index and middle fingers with their
carpal bones.6,9 Malformations occur
when any one of these regions is ad
versely affected by a deforming force,
but the force must act before differen
tiation takes place. After the seventh
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week of gestation all elements of the
hand have been laid down and normal
ly only maturation and growth will
subsequently take place.
The deforming forces affecting the
developing limb may be environmental
or genetic. The genetic manifestations
may occur sporadically as a mutation
when one or several genes may be af
fected. In addition, these genetic
alterations may be inherited in a
dominant or recessive mode. The local
defect may occur by itself or may be
part of a systemic condition associated
with other malformations. If such asso
ciations occur repetitively a syndrome
complex may be described.7,10

The malformation can occur as a
result of the adverse effect of a tera
togenic agent or of the environment on
the developing embryo. Interesting in
formation became available from care
ful analysis of pregnant mothers who
took thalidomide and subsequently gave
birth to children with malformed limbs.
It was established that the effect was
produced between the 39th and 50th
day after the last menstrual period.11
Other agents may affect the developing
limb in similar sequences, but the type
of deformity and the timing of its
production depend upon the susceptiiblity of the differentiating cells and
the specificity of the teratogenic agent.11

Fig. la

Fig. lc

Primary Syndactyly

There is a progressive division of
cartilaginous masses destined to form
the bones of individual digits from the
fifth to eighth week of embryonic de
velopment. If this evolvement is inter
fered with, either by a gene or by a
teratogenic agent, and the process of
division is delayed or arrested, syn
dactyly occurs; it may be a simple
cutaneous syndactyly or a combined
bony and cutaneous form (Figs. 1 and
2). This nondivision produces a “pri
mary” syndactyly whose complexity
depends on the timing and the severity
of action of the teratogen or on the
penetrance of the genetic factor.

Fig. 2a

Fig. 2b
Fig. lb
FIG. 1—Primary syndactyly, (a) Partial syndactyly between middle and ring fingers
in child, (b) Bilateral cutaneous syndactyly which is usually familial, (c) Cutaneous syn
dactyly between middle and ring fingers showing secondary contracture.
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FIG. 2— Complex syndactyly, (a) Com
plex syndactyly with amputation of index
finger and hypoplasia of thumb, (b) Com
plex syndactyly affecting index and long
fingers associated with absent ring and
little fingers.
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Several anomalies may be produced
simultaneously in different areas of
the body by the same gene or terato
genic factor. New syndromes are de
scribed when several anomalies con
sistently occur together in the same
individual. Several syndromes occur in
association with syndactyly: for exam
ple, craniosynostoses may be associated
with syndactyly of the fingers (Fig.
3 ) 2,5,12-u These patients suffer from a
premature closure of the cranial and
facial sutures. As a result brain growth
is restricted and brain damage may re
sult. Characteristic facial deformities
also occur. In Poland’s syndrome15"18 as
well as syndactyly there is absence of
a portion of the ipsilateral pectoralis
muscle. Digital webbing is prominent
in a number of other syndromes1,7'10'19
such as oculodentodigital dysplasia and
the orofaciodigital syndrome.

Even after the various parts of the
limb have been formed, environmental
or teratogenic factors may adversely
affect their development and bring
about secondary changes through vas
cular complications or through some
other mechanism.21 These changes may
alter or destroy developing parts and
produce necrosis. The ulcerated seg
ments then become fused during the
process of healing. Because these mal
formations result from antecedent de
fects, it may be appropriate to term
them “secondary” syndactyly. The
findings among several patients in our
series who were seen at birth and
followed through childhood substan
tiate the concept of secondary syn
dactyly (Figs. 4 and 5).
The specific cause of secondary
syndactyly is still controversial. Several
different mechanisms have been sug-

Secondary Syndactyly
Losch5'20 was the first to point out
the difference between primary and
secondary syndactyly; he based the dis
tinction on his careful anatomical
studies of a number of hands with
webbed digits. Differentiation of the
mesenchymal structures into individual
phalanges takes place about the fifth
to sixth week of gestation; consequent
ly, the end of the fifth week is the
critical time for formation of osseous
syndactyly.5 In his anatomical dissec
tions Losch was able to clarify the
detailed structural alterations of the
osseous, ligamentous, tendinous and
cutaneous elements in cutaneous and
osseous syndactyly.20

gested, each having its supporters.
Ring constrictions have been considered
important by several authors.2,5'22'23
Annular constrictions are frequently
found in individual fingers adjacent to
obviously “amputated” digital rem
nants. Constrictions are also found on
digits associated with webbing of
neighbouring digits. Under such cir
cumstances, the webbed digits invari
ably lack their distal portions. Conse
quently, this is considered to be one of
the mechanisms whereby coalescence
of raw or ulcerating neighbouring
structures can produce “secondary”
syndactyly of previously separated di
gits.1,20
It has been suggested that the forma
tion of amniotic bands associated with
some defect in the amnion is the speci
fic morphogenetic factor that leads to
intrauterine amputation. The amnion
becomes separated from the chorion
leaving a mesh of mesodermal threads
or bands in which the fetal parts be
come entangled. Such constricting
bands around trapped fingers can pro
duce edema, ischemia, atrophy or, if

Fig. 4b

FIG. 3— Complex syndactyly with
craniosynostosis of Apert’s type showing
fused nails of three fingers.
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FIG. 4— Secondary syndactyly, (a)
Right hand of 1-week-old male infant
showing constriction of middle finger by
adhesion of stump of thumb to adjacent
ring and little fingers, (b) Immediate sur
gical release was carried out to improve
circulation to middle finger. Dimple be
tween stumps of ring and little fingers is
remnant of web space.
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Fig. Sb
FIG. 5—Secondary syndactyly, (a)
Right and left hands of 7-year-old child.
Ring constriction on missing distal pha
langes on right hand suggests intrauterine
amputation (acrosyndactyly). (b) Roent
genogram of right hand shown in (a).
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presentation to consider the treatment
of various forms of syndactyly, we
would be remiss if some basic princi
ples of management were not outlined.
The ideal is to restore normal function
and appearance to the malformed limb.
There is no universal agreement re
garding the timing of the individual
surgical procedures. In complex de
formities early intervention is manda
tory, especially if in the developing
infant there is interference with pre
hensile function of the hand.26'27'32
For simple cutaneous syndactyly a
zigzag incision and fashioning of a
generous dorsal, proximally based, rec
tangular flap for the floor of the web
are usually carried out before the child
reaches 2 years of age. Full-thickness
Classification of Syndactyly
skin grafts from the groin or moder
It is essential to have a classification ately thick split-thickness grafts taken
even if it is not universally accepted; from the lateral aspect of the buttocks
otherwise the reports become a mere provide coverage for the lateral skin
listing of seemingly isolated items, and defects.
comparative studies of, for example,
Earlier separation of digits may be
the incidence and the results of treat desirable for complex syndactylies as
ment are not possible.26"29
sociated with postural deformities and
We have chosen the basic classifica flexion contractures. If several digits
tion of congenital anomalies of the up are affected, the marginal fingers are
per extremity that was originally separated first.
recommended by the American Society
In secondary syndactyly, a constrict
for Surgery of the Hand and that was ing effect may threaten the survival of
subsequently adopted by the Interna a digit soon after birth; under these cir
tional Federation of Hand Societies30’31 cumstances surgical release becomes
and later modified by the International an immediate necessity (Fig. 4).
Society of Prosthetics and Orthotics.31
It comprises seven main divisions.
Syndactyly belongs primarily to the
Table I— Classification of Syndactyly
second division of the classification,
namely, the failure of differentiation
Primary (nondivision)
of parts. The malformation of syndac
Cutaneous or simple
tyly is confined to the digits of the
Soft tissue only
Two digits only
hand, but frequently associated are
Multiple digits without postural de
conditions affecting other areas and
formities
remote organs. These too must be in
Complex
cluded in the classification. As men
Soft tissue
tioned earlier, the anomalies that are
Synonychia
due to failure of differentiation or
Multiple digits with postural de
separation are considered as “primary”,
formities
whereas those that appear to result
Skeletal
from antecedent defects and are pro
Fusion
duced by “refusion” are termed “sec
Phalangeal
Metacarpal
ondary” syndactyly. Based on these
Brachysyndactyly
considerations, the syndactylies are
Disarray
classified as described in Table I. It is
Others*
particularly difficult to provide an allSyndromes
inclusive classification of congenital
Poland’s, Apert’s, orofaciodigital,
malformations associated with syn
oculodentodigital and others
dactyly because almost any type of
Secondary (refusion)
congenital deformity involving the
Cutaneous
digits may have some element of syn
Terminal fusion
Associated with digital amputation
dactyly. While there may not be uni
versal agreement on this classification,
Skeletal
it should be adopted provisionally by
Acrosyndactyly
“ Mitten hand”
centres involved in treatment of these
Others*
conditions so that the evaluation of the
collated results will be meaningful.
‘ Syndactyly may be associated with a variety

they persist, complete amputation.19'24
The association of the amniotic band
syndrome in pregnant mothers exposed
to lysergic acid (LSD) with the birth
of infants having “distal” syndactyly
has
been
reported.22'24 However,
others19,21'25 support different theories
of etiology. They state, on the evidence
of vascular anomalies, that it is not the
amniotic bands but rather the paucity
of mesodermal proliferation or the
necrosis of tissue that is responsible
for this type of digital webbing. In any
case, these entities do not appear to be
genetically controlled,7,10 although the
problem of morphogenesis still awaits
elucidation.

of malformations such as reduction in
number of digits (ectrosyndactyly) or in
creased number of digits.

Management of Syndactyly

Recurrence of webbing and con
tracture may take place, and newer
imbalance may occur with unequal
growth of affected parts. Constant
vigilance is required to correct these
deformities.
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Renal Artery Embolism: Diagnosis and Treatment
M B. B uckspan ,

A 59-year-old woman presented with
flank pain, atrial fibrillation and a
nonfunctioning left kidney. A diagnosis
of renal artery embolism was made
and she was treated successfully by
embolectomy. A review of the literature
reaffirms the role of embolectomy,
even in cases with delayed diagnosis.

dds , m d , fr cs [c ] and

M.R. G oldberg ,

embolus must be considered. If the
diagnosis is confirmed, even after
some delay, prompt treatment may
preserve normal renal function.
Case Report

m d , m sc , fr cs [c ]

lized, exposing the aorta and the origin of
the left renal artery. The kidney was soft
and cyanotic and no pulsation was noted
in the left renal artery distal to its origin.
The embolus was removed through a trans
verse arteriotomy and a Fogarty catheter
was passed proximally and distally. The
vessel bled immediately and retrograde
bleeding was also noted. The arterial in
cision was closed with 6-0 Polydek vascu
lar sutures. Good pulsations were evident
and there was some bleeding from cap
sular vessels at the lower pole of the
kidney.

A 59-year-old woman was admitted for
elective cholecystectomy. She had rheu
Une femme de 59 ans s’est presentee
matic heart disease with chronic atrial
fibrillation but no other cardiac symp
souffrant de douleur au flanc, de
toms. Her blood pressure was 140/90
fibrillation auriculaire et de blocage
mm Hg and her pulse rate 90 beats/min
du rein gauche. Un diagnostic d'embolie
and irregular. There was a grade 2 mitral
de I'artere renale a ete pose et la
diastolic murmur and no clinical evidence
patiente a ete traite avec succes par
of heart failure. The electrocardiogram
embolectomie. Une revue de la
showed atrial fibrillation and right ventri
litterature confirme le role de I’embocular hypertrophy.
lectomie, meme dans les cas ou le
Digitalization was commenced and 24
diagnostic est retarde.
hours later she suddenly experienced
severe left flank pain associated with
Renal artery embolism as a clinical tenderness in the left loin, and nausea
vomiting. A provisional diagnosis of
entity is uncommon. However, Hoxie and ureteral
colic was made, but urinalysis
and Coggin1 reported finding renal in left
at that time disclosed no abnormal find
farction in 1.4% of 14 411 consecutive ings.
pyelography did not
autopsies. Trabue2 first described this visualizeIntravenous
the left collecting system. Cys
condition in 1856, but it was not until toscopy revealed no efflux of urine from
1962 that a successful renal artery em the left ureteric orifice, and on retrograde
bolectomy was described by Duncan pyelography the left collecting system
and Dexter.3
appeared unobstructed (Fig. 1). An isotope
In patients who present with flow study and renal scan showed no
of the left kidney (Figs. 2 and
the syndrome of flank pain, atrial perfusion
An emergency aortogram showed a
fibrillation and a nonfunctioning kid 3).
single left renal artery, which was ob
ney, the possibility of a renal artery structed
just distal to its origin (Fig. 4).
Selective arteriography demonstrated the
From the department of surgery, Mount occlusive embolus and propagated thrombi
Sinai Hospital and the University of
in several of the secondary intrarenal
Toronto, Toronto, Ont.
vessels (Fig. 5).
Operation was performed approximately
Reprint requests to: Dr. M.B. Buckspan,
12 hours after the onset of symptoms.
Ste. 441, Mount Sinai Hospital,
FIG. 1— Preoperative retrograde pye600 University A ve., Toronto, Ont.
The abdomen was opened through a long logram
showing unobstructed left collect
M5G 1X5
midline incision and the left colon mobi ing system.
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Discussion
The principal condition, antecedent
to acute renal artery embolism is mitral
valvular disease with fibrillation, sec
ondary to rheumatic or atherosclerotic
heart disease. Other less common
causes are congenital valvular disease,
mural thrombi developing after myo
cardial infarction, subacute bacterial
endocarditis and emboli from prosthetic
heart valves and primary cardiac tu
mours. Paradoxical emboli originating
in the deep venous system can pass
across intracardiac septal defects into
the systemic circulation.4
In recent years, atheroembolic renal
disease has been reported with increas
ing frequency, either as a primary con
dition presenting as rapidly progressive
irreversible renal failure, or as an acute
complication of aortic surgery or aorto
FIG. 2—Preoperative renal isotope flow study showing no perfusion of left kidney.
graphy.5 There have been reports of
bilateral renal artery embolism,6 and
The patient received heparin intra
venously 12 hours after the operation and emboli to a solitary kidney.7 In both
warfarin after 24 hours. Her postoperative these circumstances the patients were
course was uneventful and her renal func anuric and this would constitute a
tion and blood pressure were unchanged surgical emergency.
Renal artery embolism usually affects
from their preoperative values. A renal
scan obtained on the fourth postoperative the elderly. The youngest reported pa
day showed improved renal perfusion tient was aged 25 years. The reported
(Fig. 6) and an intravenous pyelogram on duration of ischemia has ranged from
the 10th postoperative day showed a func 5 hours8 to 35 days9 before surgical
tioning left kidney (Fig. 7).
She was discharged from hospital on intervention. In all reported cases there
the 12th postoperative day and treatment was sudden onset of flank pain, failure
with digoxin and oral anticoagulants was of the kidney to be visualized on intra
continued. Three months later her blood venous pyelography and no evidence of
pressure and renal function were normal. ureteral obstruction.
The length of time before irrevers
FIG. 3—Preoperative renal isotope scan
Mitral commissurotomy is to be conshowing nonfunctioning left kidney.
sidered.
ible, total loss of function occurs in the
human ischemic kidney is not known,
but has been estimated at 20 minutes

FIG. 4— Preoperative aortogram showing single left renal artery obstructed distal
to its origin.
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FIG. 5—Preoperative selective left
renal arteriogram showing embolus just
distal to artery’s origin, with propagated
thrombi in several secondary branches
and poor parenchymal perfusion.
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to 2 hours. Recent investigations have
shown collateral intrarenal arterial
anastomoses and an extrarenal supply
from capsular vessels.10 Therefore,
acute renal artery obstruction, while
rendering the kidney ischemic, may not
actually produce necrosis. U rine form a
tion may be suppressed temporarily but
may improve after revascularization.
While prom pt recognition and treat
ment are important, a delay should not

contraindicate embolectomy in patients
medically fit for surgery. N or should
the gross appearance of the kidney at
operation lead to nephrectomy or aban
donment of planned embolectomy.
In patients whose condition contra
indicates emergency surgery, systemic
anticoagulation or selective administra
tion of thrombolytic agents through the
angiography catheter may be given a
trial.11
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FIG. 6— Postoperative isotope renal scan showing improved left renal function,
especially at upper pole.

FIG- 7—Postoperative nephrotomogram showing functioning left kidney.
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treated patients with lymphedema, but
they have had insufficient concrete in
formation on which to base their planning
for long-term management. Investigators
interested in experimental and clinical re
search of the lymphatic system have been
confronted with a diverse literature. Papers
often were written in a foreign language
and appeared in foreign journals. The
editor of this text has solved many of
these problems by bringing together an
international panel of authorities to deal
with the subject; they have done their
work in a refreshingly critical scientific
manner.
In two excellent chapters, Clodius cor
relates detailed experimental investigations
with carefully documented clinical cases
providing the requisite long-term follow
up. The review of secondary lymphedema
of the arm will be of particular interest to
the general surgeon and to the radiother
apist. Olszewski offers a rational scheme
explaining the pathophysiology of lym
phedema, which is supported by detailed
experimental studies. Casley-Smith, Foldi
and other contributors offer a stimulating
and scholarly review of new concepts in
lymphatic anatomy and physiology. The
book is profusely illustrated with accurate
photographs plus the necessary tables and
is extensively referenced.
The only criticism of the text is directed
at its publisher. There are numerous spell
ing errors and an inconsistency in refer-
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Cake Kidney with Abdominal Aneurysm
M artin G. M c L oughlin , md , frcs [c ], T imothy J. G ardner ,
and G. M elville W illiam , md

The authors describe a case of cake
kidney occurring in association with
a ruptured abdominal aneurysm with
special reference to preoperative
evaluation by angiography. They discuss
the need to prepare these patients for
possible in-vivo or ex-vivo renal
manipulation during the removal of the
aneurysm and the placement of the
Dacron graft.
Les auteurs decrivent un patient ayant
un rein en galette et une rupture
d’anevrisme abdominal. Une attention
particuliere est accordee a revaluation
preoperatoire par angiographie. Ms
discutent egalement du besoin de
preparer ces patients en vue d’une
manipulation renale eventuelle in vivo
ou ex vivo, durant la resection de
I'anevrisme et la pose d’un greffon
de Dacron.

aneurysm. The incision was closed, the
patient’s condition was stabilized and he
was transferred to the Johns Hopkins
Hospital, Baltimore, for further assessment.
His blood pressure on admission was
210/120 mm Hg, his pulse rate was 100
beats/min and his temperature was nor
mal. Blood urea nitrogen concentration
was 13.6 mmol/L (38 mg/dL) and serum
creatinine concentration 221 i/.mol/L (2.5
mg/dL). After the blood pressure was
controlled, a retrograde femoral arterio
gram was obtained which confirmed the
presence of an abdominal aortic aneurysm
with an overlying cake kidney. The vas
cular supply to this kidney appeared as a
single anteriorly placed vessel originating
proximal to the aneurysm. Severe back
pain indicated further leakage from the
aneurysm. An exploratory operation dis
closed a large retroperitoneal hematoma
that had extended up into the lesser sac.
Compression of the aorta below the origin
of the single renal artery provided enough
vascular control to allow the cake kidney
to be separated from the aneurysm,
aneurysmectomy performed and a bi
furcation Dacron graft inserted. Postoperatively the patient required supportive
therapy for respiratory, hepatic and renal
insufficiency but was discharged after 4
weeks with a serum creatinine value of
309 jxmol/L (3.5 mg/dL) and a blood
urea nitrogen value of 23.2 mmol/L (65
mg/dL) (he had some renal ischemia but
was recovering). He is now enjoying an
active life and requires no medication.

md

from the section of the aorta involved
in the aneurysm, we were prepared to
remove the kidney, perfuse it in an
ex-vivo setting, then perform the aneu
rysmectomy and place the Dacron graft
and finally replace the cake kidney in
the abdomen and anastomose its vas
cular supply to the vena cava and Da
cron graft. This patient was fortunate
to have the renal blood supply arising
above the aneurysm, thus permitting
proximal control of the aorta below its
origin after mobilization of the cake
kidney anteriorly.
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Complete fusion of the nephroblastic
masses early in fetal development
results in the formation of a solitary
renal mass commonly termed a cake
ence styles. In the second edition one
kidney. This rare renal anomaly
would like to see an expanded format
has been described in association with
dealing with each aspect of the lymphatic
renal vascular malformations1 but not
system from embryology through pathol
with an abdominal aortic aneurysm.
ogy to diagnostic modalities and treatment.
We describe one such case, associated
Both primary and secondary lymphedema
should be covered.
with a ruptured abdominal aneurysm,
In summary, this text will be of value
with special reference to the use of
to
surgeons of all specialties and to re
angiography in defining the renal blood
Discussion
searchers dealing with the various vascular
supply. By this means the surgeon can
We are all indebted to Leo
prepare the patient for possible in-vivo
The early fusion of the metanephric systems.
Clodius
for
its obvious academic excel
or ex-vivo renal manipulation to ensure elements in utero prevents the ascent lence and careful
editing. He has, in the
adequate exposure for removal of the and rotation of the renal mass to its final analysis, produced
the modern equiv
leaking aneurysm.
normal position.2,3 In its lower ab alent to Gasparo Aselli’s classical treatise
dominal ectopic position the single on the structure and function of the lym
Case Report
fused cake kidney is usually described phatic system, but with emphasis on clin
A 64-year-old man experienced sudden as a flat retroperitoneal mass with a ically important conditions and surgical
onset of abdominal pain on the left side lobulated anterior surface and an an treatments.
radiating to his left hip. He was admitted teriorly placed pelvis.4 The blood sup R ollin K. D aniel
to his local hospital where a diagnosis of ply
variable but usually arises from Chief of plastic surgery,
a leaking abdominal aneurysm led to an the isadjacent
vessels. These abnormally Royal Victoria Hospital,
emergency laparotomy. Exploration re situated
kidneys are prone to ureteral Montreal, PQ
vealed a large retroperitoneal hematoma
and a cake kidney overlying an aortic obstruction, blunt trauma and infective PHYSIOLOGY OF THE HEART AND
episodes.
CIRCULATION. Robert C. Little. 334
The association of cake kidney with
pp. Illust. Year Book Medical Publish
From the division of transplantation,
department of surgery, The Johns
ers, Inc., Chicago, 1977. Price not
ruptured aortic aneurysm has not been stated,
Hopkins Hospital, Baltimore, MD
paperbound. ISBN 0-8151-5475-5.
previously reported. Angiography in our
patient defined the anomalous blood This text contains material presented to
Reprint requests to: Dr. Martin G.
McLoughlin, Director, University of
supply to the kidney and enabled us medical and beginning graduate students.
British Columbia urology clinic,
to plan the definitive surgical proce The author, who is chairman of the de855 W 10th Ave., Vancouver, BC
continued on page 372
dure. If the blood supply had arisen
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Interstitial Pregnancy Following Ipsilateral
Salpingo-oophorectomy
Louis B urg en er , md and R onald C. S trickler , m d , fr cs [c ]

A case of interstitial pregnancy, which
occurred 12 years after ipsilateral
salpingo-oophorectomy, was managed
by cornual wedge resection.
Internal (transuterine) migration
of the fertilized ovum is the most
probable explanation for this ectopic
gestation. During the past 10 years
three other cases of interstitial
gestation have been managed at
St. Michael's Hospital, Toronto, an
incidence of 3% of all ectopic
pregnancies seen at the hospital during
that period.

Case Report

A 31-year-old white woman complained
of crampy abdominal pain located in the
midline and left lower quadrant that was
associated with nausea and the passage of
several loose stools during the previous
2 days. These symptoms, although an
noying, had not prevented her from per
forming housework and supervising young
children at a day-care centre. Her last
menstrual period had begun 6 weeks pre
viously; she was not using contraception
and a urine test for pregnancy done by
her family doctor 3 days earlier had given
a negative result.
At the age of 19 years the patient had
line grossesse interstitielle, survenant
had
a serous cystadenoma of the right
12 ans apres une salpingo-oophorectomie
ovary which had necessitated salpingoipsilaterale, a ete traitee par resection
oophorectomy. The operative report de
en pointe de la corne uterine. Une
scribed cross-clamping of the right cornual
migration interne (transuterine) de
area which was then oversewn. In 1974
I'ovule fertilise est I'explication la
she was delivered vaginally at term of a
plus plausible de cette gestation
normal female infant. In October 1976,
following a Shirodkar procedure for cer
ectopique. Durant les 10 dernieres
vical incompetence at 24 weeks’ gestation,
annees, trois autres cas de gestation
premature labour began and she was
interstitielle ont ete soignes au
delivered of a stillborn infant.
St. Michael's Hospital, Toronto, pour
On admission the patient weighed more
une incidence de 3% de toutes les
than 145 kg and was not greatly dis
grossesses ectopiques vues a I’hopital
tressed. Mild lower abdominal tenderness,
durant la meme periode.
especially to the left of the midline, was
present but there was no guarding or re
Interstitial (uterine cornual) pregnancy bound tenderness. There was no vaginal
is an uncommon type of ectopic gesta bleeding. Bimanual examination was un
tion and its occurrence following total satisfactory because of the extreme obesity
of the cervix to the right
ipsilateral salpingectomy, with or with but movement
pain.
out associated oophorectomy, is rare. produced
24 hours of observation and bed
Kalchman and Meltzer1 found 73 re restDuring
the patient’s symptoms remained un
ports of interstitial pregnancy in the changed.
Because of persisting cervical
literature up to 1966 and added two excitational pain, laparoscopy was under
cases which occurred after ipsilateral taken. Clotted blood was seen on the
salpingectomy. Our search of the world fundus of the uterus. At laparotomy, per
literature located three reports2-4 not in formed through a Pfannenstiel incision,
cluded in the Kalchman and Meltzer approximately 300 mL of old clotted
blood was seen in the peritoneal cavity.
total and a further 12 cases5"12 re The
ovary contained a corpus luteum
ported after 1966. We describe what and left
normal left fallopian tube was
is presumably the 91st such case freelythemobile.
uterus, which was
and review our experience with inter slightly enlarged The
and
soft, had a bluish
stitial ectopic pregnancy during the swelling 3 cm in diameter
at the right
past 10 years.
cornu, to which organized blood clot and
omentum were adherent. No active bleed
ing was evident. Trophoblast had invaded
From the department of obstetrics and
and penetrated the cornual area and had
gynaecology, St. Michael’s Hospital,
become implanted on the peritoneum overUniversity of Toronto, Toronto, Ont.
lying the bladder. No tubal remnant could
be identified and the right ovary was
Reprint requests to: Dr. R.C. Strickler,
Department of obstetrics and gynecology, absent.
A deep wedge resection of the cornual
Washington University school of
medicine, 4911 Barnes Hospital Plaza,
lesion was performed and the uterine de
St. Louis, MO 63110, USA
fect was closed in layers. The right round
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ligament was used to cover the cornual
scar. The implant of trophoblast on the
bladder peritoneum was incompletely re
moved by blunt dissection and hemostasis
effected by electrocauterization. The ab
dominal wall was closed in layers and
drains were placed in the subfascial and
subcutaneous spaces.
Despite the patient’s obesity, there were
no respiratory or wound complications.
She was discharged home on the seventh
postoperative day. Menstruation resumed
5 weeks after the operation. When the
patient was seen 2 months postoperatively
she was completely well, was following a
program for weight reduction and had
agreed to use contraception for at least
1 year.

Discussion
The rare cases of interstitial preg
nancy following total ipsilateral adnexectomy emphasize that salpingec
tomy, with or without cornual resec
tion, does not invariably protect
against a subsequent ectopic gestation
at the ipsilateral cornual area. There
are several theories to explain this oc
currence. Implantation of the fertilized
ovum on the serosal surface of the
uterus and subsequent invasion of the
myometrium has been suggested.13 Or
the cornual remnant of the tube may
recanalize to open onto the serosal
surface and thus permit entry of the
fertilized ovum at the site of previous
surgery. However, the observation that
the fallopian tube is attracted to the
developing follicle and that the fimbria
are almost a necessity for egg entrap
ment makes the random transfer of an
ovum from the ovary to a nonmobile
uterine aperture seem improbable.14
When the ipsilateral ovary is also ab
sent, as in the case we report, transperitoneal migration of the ovum, a sec
ond improbable occurrence, must also
be postulated. We believe that internal
migration across the uterine cavity of
an ovum that was captured by, fer
tilized in and transported through the
contralateral normal fallopian tube is
a distinct possibility. The internal route
of migration favoured in the recent
literature reflects a better appreciation
of the requirements for ovum capture
than was available a decade ago.6,15’16
In support of the internal migration
CANADIAN IOURNAL OF SURGERY

theory is the explanation of McElin
and Iffy17 that reflux menstrual flow,
which occurs early when the concep
tion cycle has a shortened luteal phase,
carries the embryo to the uterine cor
nual area.
Interstitial pregnancies, and indeed
ectopic gestations whatever their loca
tion, usually rupture through the im
plantation site and the conceptus dies.
It has been postulated that abdominal
pregnancy occurs in most cases as a
result of the gradual delivery of the
intact
“embryo-trophoblastic
unit”
through the uterine wall.18 In our case
the trophoblast had penetrated the
uterine cornu and become implanted
on the peritoneum overlying the blad
der. Although intraperitoneal bleeding
had occurred, the cornu had not rup
tured and the omentum was sealing off
the area of trophoblastic invasion.
These findings are consistent with the
above genesis of abdominal pregnancy,
but whether this interstitial pregnancy
would have suffered the same fate can
only be conjectured.
In most reports the ipsilateral in
terstitial pregnancy has developed
shortly after the total salpingectomy.
Since the healing operative site may
predispose to ectopic implantation,
contraception for at least a year fol
lowing cornual resection has been ad
vised.19 The interval of 12 years be
tween the initial operation and the
interstitial gestation in this case is
longer than in all earlier reports but
one20 and the interposition of two in
trauterine pregnancies is unusual.
Between January 1966 and March
1977 three other patients with an in
terstitial ectopic pregnancy were
managed at St. Michael’s Hospital,
Toronto, out of a total of 135 women
in whom a diagnosis of ectopic preg
nancy was proven by the pathological
findings. The incidence of interstitial
pregnancy has therefore been 3 %; in
the literature the figure varies from
1% to 6% of all extrauterine gesta
tions.7 The thickness of the uterine wall
surrounding the interstitial portion of
the tube in comparison with the peri
toneum covering the remainder of its
length permits longer growth of a preg
nancy in the cornual area. Consequent
ly, interstitial,21 angular,5 and cornual22
ectopic pregnancies usually cause
symptoms late in the first or in the
second trimester. This greater gesta
tional size combined with the vascu
larity of the uterine cornu can lead to
severe hemorrhage. Most patients with
an interstitial pregnancy are first seen
when in hemorrhagic shock and repre
sent an acute surgical emergency. The
benign presentation in this case was
unusual. A pregnancy at the cornual
area, although it may in theory be
suspected from the asymmetrical ute
VOLUME 21, NO. 4, JULY 1978
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rine growth, is usually not recognized
prior to rupture.
The surgical management of ectopic
gestation in all locations is individual
ized according to anatomic factors
(extent of the rupture, associated pelvic
disease), the patient’s desire for more
children, and her clinical state at the
time of operation. When salpingectomy
is indicated, we believe that a cornual
resection (which should not be so deep
as to enter the uterine cavity) will
prevent a “stump recurrence” and will
lessen, although not eliminate, the pos
sibility of a future interstitial preg
nancy.
According to reports in the litera
ture of women with an interstitial
gestation as many have had a hysterec
tomy as have had a wedge resection
of the cornual area.1,6,7'21 The more
conservative form of operative manage
ment can be accomplished without
hazard to most patients. Prompt rec
ognition of intraperitoneal bleeding,
accessibility of surgical units, early
operation, availability of blood and
fluid replacement, improved techniques
of anesthesia and accurate physiologic
monitoring of acutely ill patients have
reduced the surgical risk to women with
ectopic gestation. In performing an
extensive cornual resection we recog
nize that a myometrial scar is left
similar to that produced at a classical
cesarean section or a uterine reunifica
tion procedure, and infrequently the
scar may rupture during a subsequent
pregnancy.23 Simpson, Alford and
Miller16 found in the literature at least
nine recorded instances of rupture of
the gravid uterus at the site of a de
fective cornual scar. We have discov
ered one further case19 reported since
1961. Therefore, we believe that there
is insufficient evidence to justify the
conclusion that conservative surgery
may jeopardize future reproduction.
Furthermore, there is no evidence to
support or refute the suggested desir
ability of performing elective cesarean
section in women who have had a
previous cornual resection for an in
terstitial pregnancy.7’16
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Total Replacement of the Hip Joint Affected
by Paget’s Disease
G.B. H a ’E r i ,

m d * and

J. Sch atzker ,

m d , b sc , fr c s [c ]

A

In seven patients with Paget’s disease
involving the bones about the hip
joint, associated degenerative changes
of the joint caused such severe pain
and disability that total hip replacement
was necessary. The results were
uniformly satisfactory and no serious
complications were encountered.
Chez sept patients souffrant de maladie
de Paget avec atteinte des os de la
hanche, les modifications degeneratives
de cette articulation qui s’ensuivirent
ont ete la cause de tellement de
douleur et d'incapacite qu'un remplacement complet de la hanche a ete
necessaire. Les resultats ont ete
uniformement satisfaisants et aucune
complication serieuse n’est survenue.

Total hip replacement has provided re
lief of pain and improvement in func
tion for patients suffering from various
pathologic conditions of the hip joint.
One of these conditions is Paget’s dis
ease, where involvement of one or both
hip joints may cause disability suffi
cient to justify total hip replacement.
Yet the orthopedic surgeon is often
reluctant to perform replacement in
such patients because of the possibility
of excessive bleeding and later loosening
of the prosthesis, and because of tech
nical problems related to bowing of
the femur. This paper describes our
experience with total hip replacement
in seven patients with Paget’s disease
involving the hip, in none of whom
these complications developed.

1975. All had severe pain and stiffness
of the hip. Six patients could walk on
ly with the help of a cane and one was
unable to walk at all. All were women.
Their average age was 75.5 years. At
the time of writing all patients were
alive. The shortest follow-up was 2
years and the longest 7 years (average,
44 months).
Only one patient was receiving cal
citonin preoperatively (60 MRC units
three times a week, subcutaneously).
She had the most severely deteriorated
hip joint, associated with advanced
Paget’s disease involving the pelvis and
femora. A similar dosage of calcitonin
was prescribed for another patient fol
lowing surgery. Two of our patients
had Paget’s disease of the pelvis
and femur (Fig. 1), and the other
five of the pelvis only (Fig. 2). The
serum alkaline phosphatase value
was elevated in all of our patients
(average, 343 IU; normal range 25 to 90
IU). All our patients except one had an
elevated erythrocyte sedimentation rate
(average, 34.4 mm/h; normal value:
men, < 10 and women, < 20 mm/h).
There was no serious technical diffi
culty owing to hardness of bone. Blood

loss ranged from 500 mL to 1500 mL
(average, 915 mL), without the use of
hypotensive anesthesia. (The blood loss
in total hip replacement in 10 random
ly selected uncomplicated osteoarthritic patients ranged from 400 mL to
1500 mL [average, 850 mL].) The ra
diologic appearance of degenerative
arthritis of the hip associated with
Paget’s disease has been described
previously.2,3
The results of total hip replacement
were assessed clinically and radiologically with respect to fixed flexion
deformity (FFD), flexion, abduction,
adduction, and external and internal
rotation, using the Harris hip rating.1
R esults and D iscussion

The overall subjective and objective
results were satisfactory. Pain was re
lieved in all seven patients, except in
one woman with a Pagetoid pelvis, who
complained of only minor hip pain 6
years after the hip replacement.
This patient had no clinical or labo
ratory evidence of infection. Radiographic examination revealed progres
sion of the Paget’s disease so that it
involved the whole pelvis. There was
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Patient Data

Seven patients underwent total hip
replacement for Paget’s disease (by
Muller’s technique1) at the Wellesley
Hospital, Toronto between 1970 and
A

From the division of orthopedic surgery,
The Wellesley Hospital, Toronto, Ont.
*Clinical research fellow, division of
orthopedic surgery, The Wellesley
Hospital, Toronto
t Active staff, division of orthopedic
surgery, The Wellesley Hospital, Toronto
Reprint requests to: Dr. Joseph Schatzker,
Division of orthopedic surgery, The
Wellesley Hospital, 160 Wellesley St. E,
Toronto, Ont. M4Y 1J3
370

FIG- 1— Paget’s disease of pelvis and femur with associated degenerative arthritis
o f hip joint.
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FIG. 2—Paget’s disease of pelvis with associated degenerative arthritis of hip joint.
Table I— Comparison of Range of Movement (in Degrees) (Pre- and Postoperatively) in Seven
Patients Who Had Total Hip Replacement
Fixed
flexion
deformity
Patient
no.
i
2
3
4
5
6
7

Pre
15
15
5
0
20
5
10

Post
0
0
0
0
5
0
0

Flexion

Abduction

Adduction

External
rotation

Pre

Post

Pre

Post

Pre

Post

Pre

Post

60
95
75
70
70
115
70

90
90
90
90
80
95
90

5
20
10
20
10
5
10

25
45
30
45
20
20
30

5
25
5
20
20
5
15

15
30
20
30
20
20
25

5
10
10
20
5
15
10

20
40
25
40
15
25
20

Internal
rotation
Pre
5
0
5
0
0
0
5

Post
15
15
25
30
10
10
15

no indication of loosening of the pros
thetic components. We believe there
fore that the pain was due to active
Pagetoid involvement of the pelvis.
Postoperatively, five patients were
able to walk independently and two
required a cane. Hip flexion contrac
tures were corrected, and all had a
greater range of joint movement (Table
I). The results were uniformly satis
factory; according to the Harris hip
rating,4 the average increase was from
39 preoperatively to 91 postoperatively.
Although this is a small series, our
experience parallels that of others5 and
indicates that total hip replacement is
an effective method of treatment for
patients with pain and deformity asso
ciated with Paget’s disease and hip in
volvement. We believe that operative
bleeding is not excessive when com
pared with that of total hip arthroplasty
for other arthritic conditions.
The increased osteoclastic resorption
of existing bone which occurs in Paget’s
disease could theoretically produce an
increased incidence of prosthetic
loosening. However, our early results
in the small number of cases reported
here do not support this supposition.
References
1. M uller ME: Total hip prostheses.
Clin Orthop 72: 46, 1970
2. R oper BA: Paget’s disease involving
hip joint. A classification. Clin Orthop
80: 33, 1971
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The Royal College of Physicians and Surgeons of Canada

THORACIC SURGERY — EXAMINATIONS
The first examinations leading to the Certificate of Special Competence in the specialty of Thoracic Surgery will be held in
September, 1979. Prospective candidates should note the following:
1. Only candidates who are Royal College Certificants in General Surgery are eligible to take the examinations in Thoracic Surgery.
2. Candidates who wish to take the examinations in 1979 should send a documented account of their training in Thoracic Surgery to the
address below as soon as possible, and, in any case, not later than December 1,1978. Only candidates whose assessment of creden
tials is complete will be eligible to take the examinations. There is no charge for this assessment.
3. Further information may be obtained from:
Division of Training and Evaluation,
Royal College of Physicians and Surgeons of Canada,
74 Stanley Avenue,
Ottawa, Ontario, Canada, K1M 1P4.

Le College Royal des Medecins et Chirurgiens du Canada

EXAMENS — CHIRURGIE THORACIQUE
Le premier examen en vue du certificat de competence particuliere en chirurgie thoracique aura lieu a I’automne de 1979. Tous les
candidats qui sont intbresses a se presenter a cet examen devront prendre connaissance de ce qui suit:
1. Les candidats qui ddsirent se presenter aux examens en chirurgie thoracique doivent etre detenteurs du certificat de specialiste en
chirurgie gbnbrale du College royal.
2. Les candidats qui ddsirent se presenter aux examens en 1979 doivent envoyer les details de leur formation en chirurgie thoracique,
avec preuve a I'appui, a I'adresse ci-dessous, le plus tot possible et au plus tard le 1er decembre 1978. Les candidats ne peuvent etre
admis a I’examen avant que (’appreciation de la formation soit terminee. II n’y a pas de frais a payer pour cette appreciation.
3. On peut obtenir de plus ampies renseignements a I’adresse suivante:
Division de la Formation et de I’Evaluation,
College royal des Medecins et Chirurgiens du Canada,
74, avenue Stanley,
Ottawa, Ontario, K1M 1P4.
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The book does not pretend to be en
cyclopedic, and for the sake of brevity
conflicting interpretations have been
avoided in favour of generally accepted
opinion. The book is of special value
because it is the work of a single author
who has a broad perspective and experi
ence. The text includes much worthwhile
information and it is illustrated with
clear line drawings, graphs and charts.
The author has succeeded in providing
a concise readable text that summarizes
basic cardiovascular physiology.
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4. H arris WH: Traumatic arthritis of
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bular fractures: treatment by mold
arthroplasty. An end-result study using
a new method of result evaluation. J

Abbott Laboratories
Ensure

continued from page 371

312

Searle, G. D.
M etam ucil

372,

Inside back cover

Sm ith Kline & French
Tagam et

342 ,

343, 344

Swann-Morton Ltd.
Surgical B lades

282

Upjohn Co. of Canada Ltd., The
D alacin C
G elfoam

348 , 349
358, 359

W inthrop Laboratories
M arcaine

378

continued from page 367
partment of physiology and professor of
medicine at the Medical College of
Georgia School of Medicine in Augusta,
has designed the book with these readers
in mind, although it would also constitute
an excellent concise review of the field
for those further advanced in their careers.
There are three sections, on physiologic
principles, the heart and the circulation.
The first section considers fluid movement
in the body, composition of blood, cardiac
anatomy and biophysics of the cardiac cell.
The second concerns the electrical and
mechanical aspects of myocardial contrac
tion, electrocardiography, cardiac output
and its control, and cardiac metabolism.
In the final section the author describes
the anatomy, hemodynamics and regula
tion of the circulation; particular emphasis
is placed on the control of blood pressure
and regional circulation.
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TECHNIQUES OF PATIENT CARE. A
MANUAL OF BEDSIDE PROCE
DURES. 2nd ed. Clarence E. Zimmer
man, 272 pp. Illust. Little, Brown and
Company, Inc., Boston, 1976. Price
not stated, paperbound. ISBN 0-31698868-5.
This small book attempts to discuss the
bedside procedures that most of us learned
by unsupervised trial and error or by word
of mouth from our peers. Four of the
chapters concern the use of needles in
vascular techniques, aspiration techniques,
lumbar puncture and biopsy. Three chap
ters about tubes include respiratory tech
niques, nasogastric intubation and urethral
catheterization. The remaining chapters
deal with skin preparation and infiltration,
endoscopy, nasal packing, dialysis tech
niques, dressing care and techniques of
resuscitation.
In general, each section is treated by
listing the material and equipment neces
sary followed by a detailed description of
“how I do it”. Reference is made to in
dications, complications and subsequent
management. Adequate line drawings and
diagrams supplement the text in most
instances.
The book will be a source of reassur
ance to medical students, interns and in
some areas to junior residents. It will
provide easily readable information about
the techniques of patient care that are so
often relegated to that group. Senior res
idents and consultants having mastered
the techniques described will find little of
interest.
J.E. D evitt
Associate dean,
Department of Continuing Medical
Education,
University of Ottawa,
Ottawa, Ont.
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